Contrast,Database,Pathway,pvalue,p.adjust,GeneRatio
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,4.7933036173360705e-76,3.949682180684922e-73,259/2407
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,3.272504097905985e-60,8.988477922248439e-58,200/2407
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,1.8149118428055172e-52,3.7387183961793657e-50,190/2407
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,7.111140324211967e-49,1.1719159254301322e-46,167/2407
OUD_vs_Control_Female,C8_CellType,HU_FETAL_RETINA_MICROGLIA,9.064699797534638e-48,1.2448854388614237e-45,168/2407
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,2.846368789287655e-28,2.345407882373028e-26,80/2407
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,7.590824903708184e-19,3.292020905608181e-17,65/2407
OUD_vs_Control_Female,GO_BP,cytokine production,1.5030906675387285e-17,2.862260403660624e-14,184/2058
OUD_vs_Control_Female,GO_BP,regulation of cytokine production,2.6385555894300798e-17,4.0195755849377835e-14,182/2058
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,2.1463249028698112e-14,5.705070064402337e-13,59/2407
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,2.607838741801751e-13,6.1395974949846945e-12,96/2407
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine production,2.3569709233373846e-14,1.994783058117873e-11,123/2058
OUD_vs_Control_Female,GO_BP,response to cytokine,3.8094939095652905e-14,2.9016915109158818e-11,200/2058
OUD_vs_Control_Female,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,6.720061984788411e-14,5.0064461786673665e-11,34/1231
OUD_Effect_Male_vs_Female,C8_CellType,HU_FETAL_RETINA_MICROGLIA,6.849078648898008e-12,5.60254633479857e-10,93/2057
OUD_vs_Control_Female,GO_BP,cellular response to cytokine stimulus,1.2678570086555964e-12,5.680745197017457e-10,180/2058
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,1.1174379666266507e-11,8.309675060914547e-10,83/2057
OUD_vs_Control_Female,GO_BP,regulation of immune response,4.8277872510861915e-12,1.4709302196609409e-9,196/2058
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_2,3.423485735073683e-10,1.7502570820564206e-8,47/2057
OUD_Effect_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,5.172255725704715e-10,2.324644489868386e-8,64/2057
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,2.3266035790096853e-9,2.6626685404221956e-8,60/2407
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,1.025096908335728e-9,3.992996528660121e-8,119/2057
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,1.1457913648749628e-9,4.260260620307816e-8,55/2057
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,5.823519230940604e-9,6.07415170417096e-8,50/2407
OUD_vs_Control_Female,GO_BP,synapse organization,6.991670186538062e-10,1.298915897825864e-7,129/2058
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,4.053350414853852e-9,1.4142472204276355e-7,84/2057
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,4.26162981145442e-9,1.4142472204276355e-7,95/2057
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,3.049368195928244e-9,2.358178071517842e-7,53/2332
OUD_vs_Control_Female,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,2.9541980151038866e-8,2.675010070819343e-7,187/2407
OUD_vs_Control_Female,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,3.670893016895191e-8,3.217889197788976e-7,114/2407
OUD_vs_Control_Female,GO_BP,negative regulation of immune system process,2.1526703548315556e-9,3.3463041005616244e-7,115/2058
OUD_vs_Control_Female,GO_BP,positive regulation of immune response,4.301778174928949e-9,6.182385728006377e-7,153/2058
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_MICROGLIA,3.03315351860283e-8,7.297410524167985e-7,92/2057
OUD_Effect_Male_vs_Female,GO_CC,glutamatergic synapse,2.4337884676606167e-9,8.258410941838702e-7,116/1867
OUD_vs_Control_Female,GO_BP,cytokine-mediated signaling pathway,2.2762210026411248e-8,2.4419683629742885e-6,111/2058
OUD_vs_Control_Female,GO_BP,adaptive immune response,2.386347476226897e-8,2.5245567675583717e-6,102/2058
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_MICROGLIA,1.317256056691586e-7,2.6280864740822373e-6,43/2057
OUD_vs_Control_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway,3.240845712469842e-8,3.248094972616156e-6,82/2058
OUD_vs_Control_Female,GO_BP,regulation of immune effector process,3.322270243622366e-8,3.2864587591781245e-6,89/2058
OUD_Effect_Male_vs_Female,GO_CC,GABA-ergic synapse,2.95236128449962e-8,3.4241497998405687e-6,34/1867
OUD_Effect_Male_vs_Female,GO_CC,dendrite,4.805947016748456e-8,4.53894996026243e-6,119/1867
OUD_vs_Control_Female,GO_BP,tumor necrosis factor superfamily cytokine production,6.209255142609549e-8,5.5642231083831685e-6,48/2058
OUD_vs_Control_Female,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,6.209255142609549e-8,5.5642231083831685e-6,48/2058
OUD_vs_Control_Female,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7.162672015992351e-8,6.090027149356474e-6,53/2058
OUD_vs_Control_Female,GO_BP,regulation of adaptive immune response,7.32597095599599e-8,6.090027149356474e-6,56/2058
OUD_vs_Control_Female,GO_BP,immune response-regulating signaling pathway,7.456291032280078e-8,6.106942880954555e-6,116/2058
OUD_vs_Control_Female,GO_BP,immune effector process,2.2702471282852189e-7,1.6011548496433805e-5,126/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,4.842219413378754e-7,1.8147148447677918e-5,50/2332
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,2.8165745814919913e-6,1.8566859641195204e-5,42/2407
OUD_Effect_Male_vs_Female,GO_CC,postsynapse,2.4762991891199547e-7,2.1048543107519616e-5,138/1867
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,1.1528890806462765e-7,2.3882797870535e-5,49/2013
OUD_vs_Control_Female,GO_BP,positive regulation of programmed cell death,5.356384141951688e-7,3.114471603759237e-5,111/2058
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,5.2832261206697815e-6,3.1546219735013767e-5,27/2407
OUD_vs_Control_Female,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,5.490597561003726e-6,3.2316088501907646e-5,60/2407
OUD_vs_Control_Female,DO,bone inflammation disease,1.333444948320215e-7,3.259437200928018e-5,63/1094
OUD_Effect_Male_vs_Female,GO_CC,neuronal cell body,5.559402410401934e-7,3.93791004070137e-5,94/1867
OUD_vs_Control_Female,GO_BP,cytokine production involved in immune response,7.440951259878972e-7,4.048408981892723e-5,37/2058
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,1.6270335289809481e-6,4.69047772378413e-5,51/2332
OUD_vs_Control_Female,GO_BP,immune response-activating signaling pathway,8.76880763074139e-7,4.703662515729378e-5,105/2058
OUD_vs_Control_Female,GO_BP,neuron projection development,8.976385523332653e-7,4.776220883990524e-5,186/2058
OUD_vs_Control_Female,GO_BP,negative regulation of immune response,1.1276173047352207e-6,5.7260406734454504e-5,51/2058
OUD_vs_Control_Female,GO_BP,immune response-activating cell surface receptor signaling pathway,1.356195584200335e-6,6.621885746701252e-5,72/2058
OUD_vs_Control_Female,GO_BP,activation of immune response,1.4758163064631445e-6,6.982169444925324e-5,114/2058
OUD_Effect_Male_vs_Female,GO_BP,synapse organization,6.43516203151471e-8,7.888436123631781e-5,109/1775
OUD_vs_Control_Female,GO_BP,regulation of cytokine production involved in immune response,1.7275432395450357e-6,7.926925816635262e-5,36/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,3.794734288683154e-6,9.480997668956064e-5,50/2332
OUD_vs_Control_Female,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2.2736512581183804e-6,9.953104386832013e-5,70/2058
OUD_vs_Control_Female,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,2.185911138656634e-5,1.1472552727726537e-4,88/2407
OUD_vs_Control_Female,GO_BP,regulation of production of molecular mediator of immune response,2.8167876601040597e-6,1.1853851716581561e-4,48/2058
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,9.461922347691255e-6,1.2483633032921688e-4,35/2057
OUD_vs_Control_Female,GO_CC,axon,2.8243546481139008e-6,1.3822723924886854e-4,128/2168
OUD_vs_Control_Female,GO_BP,negative regulation of programmed cell death,3.4834647369087704e-6,1.426534994679253e-4,158/2058
OUD_vs_Control_Female,GO_CC,main axon,3.608073005870345e-6,1.5799561794126984e-4,25/2168
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,3.291856172297035e-5,1.614577074983784e-4,13/2407
OUD_vs_Control_Female,GO_BP,negative regulation of immune effector process,6.000270327624743e-6,2.3270348390890344e-4,35/2058
OUD_vs_Control_Female,GO_BP,production of molecular mediator of immune response,6.055267732094795e-6,2.3294431472407098e-4,53/2058
OUD_vs_Control_Female,GO_BP,innate immune response,6.5360023418447854e-6,2.4892364918915866e-4,163/2058
OUD_vs_Control_Female,GO_BP,cell activation involved in immune response,7.593524960851374e-6,2.7282962088115523e-4,67/2058
OUD_vs_Control_Female,GO_BP,axon development,8.536238595511747e-6,2.996337759539768e-4,102/2058
OUD_vs_Control_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,1.6461042371131767e-5,3.0149698658704497e-4,48/2332
OUD_vs_Control_Female,DO,immune system disease,5.314805706042543e-6,3.164725215870787e-4,121/1094
OUD_vs_Control_Female,GO_BP,leukocyte activation involved in immune response,9.201104501408053e-6,3.2002197711061706e-4,66/2058
OUD_vs_Control_Female,GO_BP,axon guidance,9.691516570637156e-6,3.355467350842874e-4,55/2058
OUD_vs_Control_Female,Hallmark,HALLMARK_APOPTOSIS,6.164623426299144e-5,3.602451593580952e-4,45/703
OUD_vs_Control_Female,GO_BP,neuron projection guidance,1.1130444075220954e-5,3.785568148540046e-4,55/2058
OUD_Effect_Male_vs_Female,GO_CC,axon,6.689591406005086e-6,3.790768463402882e-4,112/1867
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_ASTROCYTE_1,3.671989137750495e-5,3.802135588202411e-4,23/2057
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,4.014262893803415e-5,4.1045838089139914e-4,34/2057
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,1.0605769912014556e-4,4.436118988578677e-4,23/2407
OUD_vs_Control_Female,GO_CC,dendrite,1.2513199042986425e-5,4.526513740767263e-4,123/2168
OUD_vs_Control_Female,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,1.424502459847048e-5,4.6769117399374845e-4,30/2058
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine production,1.4485242897754901e-5,4.7151322714614994e-4,63/2058
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,5.14538684361655e-5,5.01062671199802e-4,29/2057
OUD_vs_Control_Female,GO_BP,neuron projection morphogenesis,1.5822491679970584e-5,5.106776234166777e-4,124/2058
OUD_vs_Control_Female,DO,autoimmune disease,1.1284713521993643e-5,5.685759505312182e-4,73/1094
OUD_Effect_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,6.50570731747628e-5,5.847987456808348e-4,76/2057
OUD_vs_Control_Female,GO_BP,T cell activation involved in immune response,1.9516319900866235e-5,5.970112798590286e-4,34/2058
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,7.09135071487656e-5,6.049922715986409e-4,36/2057
OUD_vs_Control_Female,GO_CC,neuronal cell body,1.9397744700896947e-5,6.724551496310942e-4,99/2168
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,1.8412284109015732e-4,7.294097166263924e-4,10/2407
OUD_vs_Control_Female,GO_CC,distal axon,2.4206197350475488e-5,7.627017065672438e-4,61/2168
OUD_vs_Control_Female,GO_BP,positive regulation of immune effector process,2.9994065292128964e-5,8.621313031326275e-4,56/2058
OUD_vs_Control_Female,GO_BP,chemokine production,3.6773227479861874e-5,0.0010111973780292704,27/2058
OUD_vs_Control_Female,GO_BP,regulation of chemokine production,3.6773227479861874e-5,0.0010111973780292704,27/2058
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,2.857816289438488e-4,0.0010902039918969048,24/2407
OUD_vs_Control_Female,GO_BP,central nervous system neuron differentiation,4.023431038262202e-5,0.0010906218583075868,47/2058
OUD_vs_Control_Female,GO_BP,positive regulation of microglial cell migration,4.0683029205795805e-5,0.001098874586739527,6/2058
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_MICROGLIA,1.331620226209728e-4,0.0011002680252924825,85/2057
OUD_Effect_Male_vs_Female,GO_BP,synapse assembly,2.3685838056347645e-6,0.0012443524207459782,58/1775
OUD_vs_Control_Female,GO_CC,glutamatergic synapse,4.7870616916732265e-5,0.001254898032047897,112/2168
OUD_Effect_Male_vs_Female,C8_CellType,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1.622859142955065e-4,0.0012888337659584883,87/2057
OUD_vs_Control_Female,GO_BP,synapse assembly,5.2271301621584854e-5,0.0013041258462124035,60/2058
OUD_vs_Control_Female,GO_BP,positive regulation of production of molecular mediator of immune response,5.733811013413114e-5,0.0013998217464476826,35/2058
OUD_vs_Control_Female,GO_BP,axonogenesis,6.254472890639285e-5,0.0014841221186292657,89/2058
OUD_vs_Control_Female,GO_BP,regulation of complement activation,6.469022413408483e-5,0.001516139806859459,10/2058
OUD_vs_Control_Female,GO_MF,cytokine activity,5.988016110620572e-6,0.0015863020583903,45/2121
OUD_vs_Control_Female,GO_BP,multicellular organismal response to stress,6.987490409763222e-5,0.001607967203962733,27/2058
OUD_vs_Control_Female,GO_BP,regulation of type 2 immune response,7.089889243137927e-5,0.001626482744218953,13/2058
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,1.3603973877723886e-4,0.0016528319384606176,45/2332
OUD_vs_Control_Female,GO_BP,"synaptic transmission, glutamatergic",7.282984234606534e-5,0.0016559549526865066,30/2058
OUD_vs_Control_Female,GO_BP,type 2 immune response,7.383521323635586e-5,0.0016712727699533631,15/2058
OUD_vs_Control_Female,KEGG,Cytokine-cytokine receptor interaction,1.5045888544200088e-5,0.0017252618864016102,59/1075
OUD_vs_Control_Female,GO_BP,"regulation of synaptic transmission, glutamatergic",8.971434598896255e-5,0.001975012061843722,23/2058
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_STOMACH_ENS_NEURONS,2.792635721328277e-4,0.0020579964144563337,20/2057
OUD_Effect_Male_vs_Female,GO_BP,neuron projection development,7.239918891534538e-6,0.002129984137889461,160/1775
OUD_vs_Control_Female,GO_BP,regulation of T-helper 1 type immune response,9.995488599548809e-5,0.002150724199513087,12/2058
OUD_vs_Control_Female,GO_BP,cell morphogenesis involved in neuron differentiation,1.1196507139017076e-4,0.0023755931720861575,109/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,2.5876152154803266e-4,0.0027828648711514694,43/2332
OUD_vs_Control_Female,GO_BP,microglial cell migration,1.437162323329929e-4,0.002918355278098464,6/2058
OUD_vs_Control_Female,GO_BP,regulation of microglial cell migration,1.437162323329929e-4,0.002918355278098464,6/2058
OUD_vs_Control_Female,GO_BP,positive regulation of type 2 immune response,1.4384111216165756e-4,0.002918355278098464,9/2058
OUD_Effect_Male_vs_Female,GO_CC,neuron projection membrane,7.260273405615028e-5,0.00293868209274894,19/1867
OUD_Effect_Male_vs_Female,GO_BP,response to cytokine,1.3427726432579809e-5,0.002992755391261348,145/1775
OUD_vs_Control_Female,GO_BP,T cell differentiation involved in immune response,1.5364790938988637e-4,0.003071748361739539,26/2058
OUD_vs_Control_Female,GO_CC,neuron spine,1.393970479612284e-4,0.003134549835236271,43/2168
OUD_vs_Control_Female,GO_MF,immune receptor activity,1.6935414511953705e-5,0.003149987099223389,37/2121
OUD_Effect_Male_vs_Female,GO_BP,cellular response to cytokine stimulus,1.5296495384886917e-5,0.003308991869289508,133/1775
OUD_vs_Control_Female,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.74944538353543e-4,0.0033650316884821637,31/2058
OUD_vs_Control_Female,GO_CC,neuron projection terminus,1.581966310707166e-4,0.0033748614628419543,32/2168
OUD_vs_Control_Female,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,3.188276947457411e-5,0.0033932376083653875,41/1231
OUD_vs_Control_Female,GO_BP,astrocyte differentiation,1.848629973007528e-4,0.0034940482641186953,25/2058
OUD_vs_Control_Female,GO_CC,GABA-ergic synapse,1.7106601923847262e-4,0.003558173200160231,29/2168
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.0010531245766868687,0.003600724693734356,30/2407
OUD_vs_Control_Female,DO,glucose metabolism disease,1.8790608404174597e-4,0.003907253493566464,122/1094
OUD_vs_Control_Female,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",2.222226875438108e-4,0.00402059432546605,24/2058
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,6.011302290698751e-4,0.00414168169226212,16/2057
OUD_vs_Control_Female,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,2.5266500700442894e-5,0.004444377473207905,64/1379
OUD_Effect_Male_vs_Female,GO_BP,neuron projection morphogenesis,2.61282622239694e-5,0.004451492600750309,109/1775
OUD_vs_Control_Female,GO_BP,alpha-beta T cell activation involved in immune response,2.71263108258063e-4,0.004688134818664818,24/2058
OUD_vs_Control_Female,GO_BP,alpha-beta T cell differentiation involved in immune response,2.71263108258063e-4,0.004688134818664818,24/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neuron differentiation,2.71263108258063e-4,0.004688134818664818,24/2058
OUD_vs_Control_Female,KEGG,Morphine addiction,5.880919815146774e-5,0.004980402793585666,28/1075
OUD_vs_Control_Female,GO_BP,T cell cytokine production,3.013677763368178e-4,0.005089841136047763,14/2058
OUD_vs_Control_Female,GO_BP,regulation of T cell cytokine production,3.013677763368178e-4,0.005089841136047763,14/2058
OUD_Effect_Male_vs_Female,GO_CC,neuron to neuron synapse,1.7705310794968244e-4,0.005788274682970387,73/1867
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,9.239972277018389e-4,0.005904919783282064,27/2057
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_APOPTOSIS,5.955957955677085e-4,0.005955957955677085,36/572
OUD_vs_Control_Female,GO_BP,negative regulation of neuron projection development,4.3338280338752307e-4,0.0067095057182982995,32/2058
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,8.137992057383273e-4,0.006968066309942233,42/2332
OUD_vs_Control_Female,GO_BP,positive regulation of adaptive immune response,4.549989634736718e-4,0.006987353033828545,31/2058
OUD_vs_Control_Female,GO_CC,postsynapse,4.686046534690743e-4,0.0070887103942958146,138/2168
OUD_vs_Control_Female,GO_BP,regulation of innate immune response,4.7281140464509554e-4,0.007152271905305809,86/2058
OUD_vs_Control_Female,GO_BP,sensory perception of pain,4.8004047673484576e-4,0.00717083245277216,22/2058
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine production involved in immune response,4.823818218311207e-4,0.007176371751733685,23/2058
OUD_vs_Control_Female,DO,adult respiratory distress syndrome,4.286594051335787e-4,0.007178865782877121,15/1094
OUD_vs_Control_Female,GO_BP,positive regulation of T cell cytokine production,4.899076608551829e-4,0.007253866443642759,11/2058
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.002434854283668076,0.007542556126851484,5/2407
OUD_vs_Control_Female,KEGG,Viral protein interaction with cytokine and cytokine receptor,3.0974792157815176e-4,0.007605234384764356,23/1075
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter transport,5.515227899661789e-4,0.008094314241179932,26/2058
OUD_vs_Control_Female,GO_BP,response to chemokine,5.668549141315523e-4,0.008239950154465714,20/2058
OUD_vs_Control_Female,GO_BP,cellular response to chemokine,5.668549141315523e-4,0.008239950154465714,20/2058
OUD_vs_Control_Female,GO_BP,myeloid cell activation involved in immune response,5.757659437449616e-4,0.0083060780180026,24/2058
OUD_vs_Control_Female,GO_BP,regulation of neuron projection development,6.101641762144577e-4,0.008674925470250828,83/2058
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.002877932327947228,0.00871844205231072,18/2407
OUD_vs_Control_Female,KEGG,Nicotine addiction,4.3709356548600123e-4,0.00884471685454026,15/1075
OUD_vs_Control_Female,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.002995511730907444,0.009008400241853043,21/2407
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse organization,7.69307779839341e-5,0.009126223743094117,59/1775
OUD_Effect_Male_vs_Female,KEGG,Nicotine addiction,4.954448120914663e-5,0.009166326704211388,15/889
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.0016099018715746737,0.009406426649629164,19/2057
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.0011662252450598052,0.009453992335992298,43/2332
OUD_Effect_Male_vs_Female,KEGG,GABAergic synapse,9.293489823769327e-5,0.009540974832028998,24/889
OUD_Effect_Male_vs_Female,KEGG,Morphine addiction,1.378753588443497e-4,0.009540974832028998,24/889
OUD_vs_Control_Female,GO_BP,forebrain neuron differentiation,6.969307299187609e-4,0.009704792266528706,20/2058
OUD_vs_Control_Female,DO,"autoimmune disease of eyes, ear, nose and throat",6.601206807724401e-4,0.009716383054066254,9/1094
OUD_vs_Control_Female,GO_BP,complement receptor mediated signaling pathway,7.224879392251292e-4,0.009757430200492568,7/2058
OUD_vs_Control_Female,GO_BP,negative regulation of complement activation,7.224879392251292e-4,0.009757430200492568,7/2058
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.0035736801608304753,0.010516830187586828,37/2407
OUD_Effect_Male_vs_Female,GO_BP,cell morphogenesis involved in neuron differentiation,9.209680217770006e-5,0.010559452504737917,97/1775
OUD_vs_Control_Female,GO_BP,positive regulation of response to cytokine stimulus,8.124113486094772e-4,0.010724674596808297,18/2058
OUD_vs_Control_Female,GO_BP,neuronal action potential,8.315938971946596e-4,0.010920976887307315,13/2058
OUD_vs_Control_Female,GO_BP,regulation of T-helper 17 type immune response,8.315938971946596e-4,0.010920976887307315,13/2058
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.0021500908744572795,0.011725162235373697,64/2057
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine-mediated signaling pathway,9.693409030219589e-4,0.012204082079864894,17/2058
OUD_vs_Control_Female,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9.693409030219589e-4,0.012204082079864894,17/2058
OUD_vs_Control_Female,GO_BP,lymphocyte activation involved in immune response,9.786231756302782e-4,0.012300615063986515,45/2058
OUD_vs_Control_Female,GO_BP,negative regulation of adaptive immune response,0.001007080476084466,0.012554716835246116,18/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse structure or activity,1.348352924750657e-4,0.012850748174079983,59/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.002501847687033078,0.0128511733159452,11/2057
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.0018786303282406433,0.013131545135134023,41/2332
OUD_Effect_Male_vs_Female,GO_CC,asymmetric synapse,4.222586074331354e-4,0.013293326530302409,66/1867
OUD_vs_Control_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.0019369018714669361,0.013423308560152081,38/2332
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune system process,1.6246840489113554e-4,0.013659643265895137,85/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron projection development,1.6343284940839866e-4,0.013659643265895137,30/1775
OUD_vs_Control_Female,GO_BP,ensheathment of neurons,0.0011215150244421074,0.013756167377094255,36/2058
OUD_vs_Control_Female,GO_BP,axon ensheathment,0.0011215150244421074,0.013756167377094255,36/2058
OUD_vs_Control_Female,GO_BP,negative regulation of innate immune response,0.0011437079820612376,0.013942206746763879,24/2058
OUD_vs_Control_Female,GO_BP,T-helper 17 type immune response,0.0011531561310832669,0.013942206746763879,16/2058
OUD_vs_Control_Female,GO_CC,presynapse,0.0010306604066973694,0.014057532104462481,112/2168
OUD_vs_Control_Female,GO_BP,positive regulation of synapse assembly,0.0012401507146607743,0.014852559738319369,18/2058
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.0022119053348108276,0.01502985047586939,39/2332
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,7.159440599259347e-4,0.015034825258444628,35/2013
OUD_Effect_Male_vs_Female,GO_BP,axonogenesis,1.973821609626067e-4,0.015444104190212473,77/1775
OUD_vs_Control_Female,GO_BP,immunoglobulin mediated immune response,0.001310848792664551,0.015504247288394231,30/2058
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.005773665607125605,0.015547387125070257,10/2407
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,7.789126224491512e-4,0.015878084922896506,38/2013
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine production involved in immune response,0.0013860240169646938,0.01629219897719147,11/2058
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.0061743854260661694,0.016411914809930723,31/2407
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron differentiation,2.2401923485679633e-4,0.01681287216705854,22/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine production,2.2831157488472083e-4,0.016961935689667893,117/1775
OUD_vs_Control_Female,GO_BP,forebrain generation of neurons,0.001479463400874719,0.01706043459480621,21/2058
OUD_vs_Control_Female,GO_BP,L-glutamate import across plasma membrane,0.001491087864604075,0.01706043459480621,8/2058
OUD_vs_Control_Female,GO_BP,cerebral cortex neuron differentiation,0.0014939359163365815,0.01706043459480621,10/2058
OUD_vs_Control_Female,GO_BP,positive regulation of chemokine production,0.0015205103188411704,0.017234712944364874,19/2058
OUD_vs_Control_Female,GO_MF,cytokine binding,3.1784770912716753e-4,0.01759838746167887,33/2121
OUD_vs_Control_Female,GO_BP,microglial cell activation involved in immune response,0.0015666891675022551,0.017613001905859765,4/2058
OUD_vs_Control_Female,GO_BP,regulation of neuron differentiation,0.0015846459523950992,0.017690693171863947,39/2058
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_SYSTEM,4.2810289601775937e-4,0.017718703196290594,26/1231
OUD_vs_Control_Female,GO_CC,neuron projection membrane,0.0014509030103379247,0.017772445256471696,18/2168
OUD_vs_Control_Female,GO_CC,axon initial segment,0.0015008984687276126,0.017827689767938908,9/2168
OUD_vs_Control_Female,GO_BP,T-helper 1 type immune response,0.0016119521956776994,0.017872256003605584,14/2058
OUD_vs_Control_Female,KEGG,Starch and sucrose metabolism,0.001171601749435036,0.018319590991166017,12/1075
OUD_vs_Control_Female,GO_BP,dendrite development,0.0017067965333339814,0.018679122405754218,49/2058
OUD_vs_Control_Female,GO_BP,neuron migration,0.0017667751203908498,0.019061651688409495,39/2058
OUD_Effect_Male_vs_Female,GO_CC,dendrite membrane,7.437472030354202e-4,0.019157124926669915,13/1867
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse assembly,2.708616408526861e-4,0.019341624936616564,35/1775
OUD_vs_Control_Female,GO_BP,microglial cell proliferation,0.0018777655428302712,0.019837642357473196,5/2058
OUD_vs_Control_Female,GO_BP,negative regulation of production of molecular mediator of immune response,0.0018892491390768494,0.019903749228697594,13/2058
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.0044446090228537245,0.020311118327901376,6/2057
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.008139567174414478,0.020448180950358323,30/2407
OUD_vs_Control_Female,Reactome,Cytokine Signaling in Immune system,2.751348316609778e-4,0.020694927457318265,131/1379
OUD_vs_Control_Female,GO_BP,regulation of synapse structure or activity,0.002011289511392746,0.020986290696271982,61/2058
OUD_vs_Control_Female,GO_BP,regulation of synapse organization,0.002024695777603681,0.021097274607397045,60/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,5.5999218474108356e-5,0.021139704973975906,35/1002
OUD_Effect_Male_vs_Female,GO_BP,axon development,3.0212584086848686e-4,0.021366688072958853,84/1775
OUD_Effect_Male_vs_Female,GO_CC,presynapse,9.076114184523942e-4,0.021429714046792638,99/1867
OUD_Effect_Male_vs_Female,GO_CC,excitatory synapse,9.585584327010376e-4,0.02144143862620742,18/1867
OUD_vs_Control_Female,Hallmark,HALLMARK_COMPLEMENT,0.004354284914129546,0.021597729719163634,47/703
OUD_vs_Control_Female,GO_BP,neurotransmitter transport,0.00212767695875122,0.02190069647947033,43/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.0036691590648055745,0.02190703794575093,39/2332
OUD_vs_Control_Female,GO_BP,cytokine production involved in inflammatory response,0.002216269772872567,0.022508435813293794,16/2058
OUD_vs_Control_Female,GO_BP,regulation of cytokine production involved in inflammatory response,0.002216269772872567,0.022508435813293794,16/2058
OUD_vs_Control_Female,GO_CC,excitatory synapse,0.0021016352343594807,0.02270857811671543,19/2168
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.009336687053973745,0.022897113489507043,86/2407
OUD_vs_Control_Female,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,3.559596827768428e-4,0.023190114148313574,17/1379
OUD_Effect_Male_vs_Female,GO_BP,cytokine production,3.358407897034013e-4,0.023207095421350358,117/1775
OUD_vs_Control_Female,Reactome,Glycosaminoglycan metabolism,3.7640289293534596e-4,0.023646167452616912,32/1379
OUD_vs_Control_Female,GO_BP,excitatory synapse assembly,0.0024245696296543297,0.02401553559047728,13/2058
OUD_vs_Control_Female,GO_BP,regulation of axonogenesis,0.002440057529781372,0.024106249292275887,32/2058
OUD_Effect_Male_vs_Female,GO_CC,main axon,0.0011453993656708747,0.024963832328724192,18/1867
OUD_vs_Control_Female,Reactome,Axon guidance,4.2178265868655375e-4,0.02558329988378097,100/1379
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of microglial cell migration,3.9214619541093224e-4,0.025733624273640673,5/1775
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.00602767320408328,0.026088024766878957,4/2057
OUD_vs_Control_Male,GO_MF,G protein-coupled neurotransmitter receptor activity,0.003527220266453357,0.026454151998400177,1/5
OUD_vs_Control_Female,GO_MF,complement receptor activity,8.136306953195721e-4,0.02670623105813654,6/2121
OUD_Effect_Male_vs_Female,Reactome,Neuronal System,1.771512093897418e-5,0.02789311917713886,77/1194
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.0066393831120759705,0.028286538467073668,6/2057
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine production,4.612611761389559e-4,0.029246344400879486,78/1775
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.007035849857816106,0.0296666246582143,5/2057
OUD_Effect_Male_vs_Female,GO_MF,neurotransmitter receptor activity,2.993098298718937e-4,0.030903739934273023,23/1824
OUD_vs_Control_Female,GO_CC,asymmetric synapse,0.0031625086623739192,0.031323895322560726,70/2168
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.013454345348465666,0.03149539933845372,25/2407
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.01375186107674995,0.032100661550260506,5/2407
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.014264139312131328,0.03302019113440537,9/2407
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.014266004907582903,0.03302019113440537,6/2407
OUD_Effect_Male_vs_Female,GO_CC,distal axon,0.0015933308210597998,0.033032468241483655,48/1867
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.008104009823223336,0.03331195997686778,18/2057
OUD_vs_Control_Female,GO_BP,central nervous system neuron development,0.003720462392938956,0.03367323124819095,22/2058
OUD_vs_Control_Female,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.0014657496856405896,0.0352720676166185,49/1231
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.0015246929718451187,0.0352720676166185,28/1231
OUD_vs_Control_Female,GO_CC,neuronal cell body membrane,0.0037131031480340487,0.035509216312233666,10/2168
OUD_vs_Control_Female,GO_CC,axon terminus,0.003858602289180751,0.03617661696330269,25/2168
OUD_vs_Control_Female,GO_BP,mast cell cytokine production,0.004188243332915932,0.036459256533509316,4/2058
OUD_vs_Control_Female,GO_BP,regulation of mast cell cytokine production,0.004188243332915932,0.036459256533509316,4/2058
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.007677796735546992,0.03793734857564396,39/2332
OUD_Effect_Male_vs_Female,GO_BP,"regulation of synaptic transmission, glutamatergic",7.641243795534421e-4,0.03945224683570863,19/1775
OUD_vs_Control_Female,GO_MF,cytokine receptor binding,0.0018918687771988748,0.03958735416288646,43/2121
OUD_vs_Control_Female,GO_BP,regulation of humoral immune response,0.00463228261471961,0.03968964755491482,12/2058
OUD_vs_Control_Female,GO_BP,chemokine-mediated signaling pathway,0.004795633250337638,0.04040745405732499,16/2058
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter secretion,0.004818239455901099,0.04050831118719501,20/2058
OUD_vs_Control_Female,GO_BP,mast cell activation involved in immune response,0.004885917713337711,0.04094173291803448,14/2058
OUD_vs_Control_Female,GO_CC,neuron to neuron synapse,0.0045244850938817235,0.041001430333905,75/2168
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 1 type immune response,0.004965875137043769,0.04133887532116108,7/2058
OUD_vs_Control_Female,GO_BP,negative regulation of humoral immune response,0.004965875137043769,0.04133887532116108,7/2058
OUD_vs_Control_Female,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.004965875137043769,0.04133887532116108,7/2058
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.018944075659833845,0.04162644891654157,4/2407
OUD_vs_Control_Female,GO_BP,regulation of astrocyte differentiation,0.005040856634552898,0.04187154305931235,10/2058
OUD_Effect_Male_vs_Female,GO_BP,forebrain neuron differentiation,8.509813220786228e-4,0.041876341532952506,18/1775
OUD_Effect_Male_vs_Female,GO_BP,cytokine-mediated signaling pathway,8.651432385044414e-4,0.041876341532952506,81/1775
OUD_Effect_Male_vs_Female,GO_BP,central nervous system neuron differentiation,9.288350285573735e-4,0.042735394995351936,38/1775
OUD_Effect_Male_vs_Female,GO_BP,tumor necrosis factor superfamily cytokine production,9.434451197302456e-4,0.042735394995351936,33/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of tumor necrosis factor superfamily cytokine production,9.434451197302456e-4,0.042735394995351936,33/1775
OUD_Effect_Male_vs_Female,GO_BP,microglial cell migration,9.436110502216437e-4,0.042735394995351936,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of microglial cell migration,9.436110502216437e-4,0.042735394995351936,5/1775
OUD_Effect_Male_vs_Female,GO_BP,axon guidance,9.449744328362775e-4,0.042735394995351936,43/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.010879024663438878,0.042990541906729476,4/2057
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.009144911480137387,0.04342495977702666,37/2332
OUD_Effect_Male_vs_Female,GO_MF,ionotropic glutamate receptor binding,6.072410837965915e-4,0.044300585090259505,10/1824
OUD_vs_Control_Female,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.005523019914285502,0.0454307156448301,11/2058
OUD_vs_Control_Female,Reactome,Neuronal System,0.0011138631471401047,0.045564773856266144,78/1379
OUD_Effect_Male_vs_Female,GO_BP,neuron projection guidance,0.0010366228247179208,0.045654855543714415,43/1775
OUD_vs_Control_Female,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.0025944705769552516,0.04602096618646815,8/1231
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.009951839053696065,0.04614669045330111,38/2332
OUD_Effect_Male_vs_Female,GO_CC,axon initial segment,0.00250840233563882,0.04635091272376081,8/1867
OUD_vs_Control_Male,Hallmark,HALLMARK_COMPLEMENT,0.046421663442940075,0.046421663442940075,1/1
OUD_vs_Control_Female,GO_BP,glutamate receptor signaling pathway,0.005869045054459452,0.04735647900404412,15/2058
OUD_vs_Control_Female,GO_BP,integrated stress response signaling,0.005947680034925867,0.0477884797742936,14/2058
OUD_vs_Control_Female,KEGG,Central carbon metabolism in cancer,0.005561442315097679,0.04905477324086158,19/1075
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.004268159260268003,0.04942304651050662,35/2013
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_EYE_ASTROCYTES,0.023420271405788957,0.04948282984197462,10/2407
OUD_vs_Control_Male,Reactome,Cellular response to heat stress,0.026208731151407982,0.05087577223508608,1/3
OUD_vs_Control_Female,GO_BP,response to fluid shear stress,0.0065434248679416525,0.051598522118900425,10/2058
OUD_vs_Control_Female,GO_BP,neuronal action potential propagation,0.0066560570781255815,0.05168112819988028,5/2058
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of response to cytokine stimulus,0.0012576193029193111,0.05225870041226855,16/1775
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.01385868167054667,0.052483340770866554,8/2057
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.01176140326186706,0.05269572575391855,38/2332
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron projection development,0.0012754999695330105,0.05270389467263587,72/1775
OUD_Effect_Male_vs_Female,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.001325457724343556,0.0530187577205498,6/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor diffusion trapping,0.001325457724343556,0.0530187577205498,6/1775
OUD_vs_Control_Male,GO_MF,postsynaptic neurotransmitter receptor activity,0.021330001767397522,0.053325004418493804,1/5
OUD_Effect_Male_vs_Female,GO_BP,"synaptic transmission, glutamatergic",0.0013635813261227187,0.05376393355948832,24/1775
OUD_vs_Control_Female,KEGG,Apoptosis,0.007032637546248625,0.05385175932609931,31/1075
OUD_vs_Control_Female,KEGG,Glutamatergic synapse,0.0070462742347355825,0.05385175932609931,27/1075
OUD_vs_Control_Female,GO_BP,neuron projection regeneration,0.007022948859452094,0.05393575950045058,15/2058
OUD_Effect_Male_vs_Female,GO_BP,dendrite development,0.0013963093744129773,0.054018057231915,44/1775
OUD_vs_Control_Female,GO_BP,macrophage activation involved in immune response,0.00717710340132358,0.05455887885018135,7/2058
OUD_vs_Control_Female,GO_BP,regulation of sensory perception of pain,0.00717710340132358,0.05455887885018135,7/2058
OUD_vs_Control_Female,GO_BP,astrocyte development,0.007207854083929171,0.05457477590187723,12/2058
OUD_vs_Control_Female,GO_BP,"complement activation, alternative pathway",0.007372143240583061,0.055160722066327286,6/2058
OUD_vs_Control_Female,GO_BP,pyramidal neuron differentiation,0.007372143240583061,0.055160722066327286,6/2058
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.027502323523573298,0.05665478645856099,28/2407
OUD_Effect_Male_vs_Female,GO_BP,integrated stress response signaling,0.0014951342989438599,0.05667891244977509,14/1775
OUD_Effect_Male_vs_Female,GO_BP,forebrain generation of neurons,0.0015104101754120894,0.05667891244977509,19/1775
OUD_Effect_Male_vs_Female,GO_CC,neuron spine,0.0034055246403734167,0.05675874400622361,34/1867
OUD_vs_Control_Female,GO_BP,"synaptic transmission, dopaminergic",0.007680154277988373,0.05679585935479362,9/2058
OUD_vs_Control_Female,GO_BP,ionotropic glutamate receptor signaling pathway,0.007680154277988373,0.05679585935479362,9/2058
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.02781698587736967,0.057160090680679815,12/2407
OUD_vs_Control_Female,GO_BP,neuron apoptotic process,0.007755913284502333,0.05730047671004294,54/2058
OUD_vs_Control_Female,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.0037758235409550717,0.05740792934717405,5/1231
OUD_vs_Control_Female,GO_BP,dendrite morphogenesis,0.00779817370801515,0.05744554074850232,30/2058
OUD_Effect_Male_vs_Female,DO,withdrawal disorder,0.00187501662867599,0.057668194360010326,12/920
OUD_vs_Control_Female,KEGG,Arachidonic acid metabolism,0.008295006407498418,0.059447545920405326,15/1075
OUD_vs_Control_Female,GO_BP,neuron projection extension,0.008196353379822705,0.05985774083807243,34/2058
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter receptor activity,0.008371334134502847,0.060728049621436374,10/2058
OUD_vs_Control_Female,GO_MF,lipopolysaccharide immune receptor activity,0.004092034141335743,0.06171229867203634,4/2121
OUD_Effect_Male_vs_Female,GO_BP,"positive regulation of synaptic transmission, glutamatergic",0.0017050919850793837,0.06208391856563795,11/1775
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSIS,0.004455643663304316,0.06233732774923014,23/1231
OUD_vs_Control_Female,GO_BP,T-helper 1 cell cytokine production,0.008713921478444544,0.06244020686859087,4/2058
OUD_vs_Control_Female,GO_BP,regulation of T-helper 1 cell cytokine production,0.008713921478444544,0.06244020686859087,4/2058
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 1 cell cytokine production,0.008713921478444544,0.06244020686859087,4/2058
OUD_vs_Control_Male,GO_MF,neurotransmitter receptor activity,0.029195060026889763,0.06256084291476377,1/5
OUD_vs_Control_Female,GO_BP,regulation of dopamine secretion,0.008885326808208499,0.06272431352930874,8/2058
OUD_vs_Control_Female,GO_BP,astrocyte activation,0.008885326808208499,0.06272431352930874,8/2058
OUD_vs_Control_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.004642344411082082,0.0628826652046573,12/1231
OUD_vs_Control_Female,GO_BP,humoral immune response,0.009031294787037942,0.06363679222281962,39/2058
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.017345137123703093,0.064200552792711,8/2057
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of synapse assembly,0.001828969227310903,0.06467340705226773,16/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_EYE_MICROGLIA,0.01776131807961495,0.06515138201401359,27/2057
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.033118572717134476,0.0657583226961899,8/2407
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.006854733878218634,0.06706076998931966,33/2013
OUD_Effect_Male_vs_Female,GO_BP,regulation of axonogenesis,0.0019459333488433311,0.06744070696881928,29/1775
OUD_Effect_Male_vs_Female,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.001257038168181482,0.06833726415125442,15/1824
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.005417408874225476,0.06840626459827084,24/1231
OUD_Effect_Male_vs_Female,DO,bone inflammation disease,0.002285028585646697,0.06860526301191631,43/920
OUD_Effect_Male_vs_Female,GO_BP,maintenance of synapse structure,0.0022055674737725024,0.0699674856343316,10/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of complement activation,0.0022165090622432715,0.0699674856343316,6/1775
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_HEME_METABOLISM,0.018447179408295204,0.07095069003190463,36/572
OUD_vs_Control_Male,GO_BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.005979652021753767,0.07108341507017486,1/5
OUD_vs_Control_Male,GO_BP,retrograde axonal transport,0.007635579482175192,0.07108341507017486,1/5
OUD_vs_Control_Male,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.010610687221172976,0.07108341507017486,1/5
OUD_vs_Control_Male,GO_BP,postsynaptic neurotransmitter receptor internalization,0.010940813785330072,0.07108341507017486,1/5
OUD_vs_Control_Male,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.012260438940868368,0.07108341507017486,1/5
OUD_vs_Control_Male,GO_BP,neurotransmitter receptor internalization,0.012919723104963365,0.07108341507017486,1/5
OUD_vs_Control_Male,GO_BP,dopamine transport,0.013578655181394783,0.07108341507017486,1/5
OUD_Effect_Male_vs_Female,GO_BP,radial glia-guided pyramidal neuron migration,0.002395248753459358,0.07132410761819262,4/1775
OUD_vs_Control_Female,GO_BP,regulation of axon extension,0.010490127852748386,0.07166215592321476,19/2058
OUD_vs_Control_Female,GO_BP,response to axon injury,0.010490127852748386,0.07166215592321476,19/2058
OUD_vs_Control_Female,GO_BP,neuron recognition,0.01059549810815968,0.07212324315447032,13/2058
OUD_vs_Control_Female,GO_BP,negative regulation of astrocyte differentiation,0.010881234193331478,0.07219717844129431,6/2058
OUD_vs_Control_Male,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.015553340294934492,0.07226421332124418,1/5
OUD_vs_Control_Male,GO_BP,anterograde axonal transport,0.016539496221295025,0.07226421332124418,1/5
OUD_Effect_Male_vs_Female,GO_CC,neuronal cell body membrane,0.0046839135621524995,0.07238775505144772,9/1867
OUD_Effect_Male_vs_Female,DO,autoimmune disease,0.0026000860714642787,0.07286018969147678,55/920
OUD_vs_Control_Male,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.007376701181851075,0.07308965747755164,1/3
OUD_vs_Control_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.006327913594266851,0.07321945975149294,11/1231
OUD_vs_Control_Female,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.006343355019459044,0.07321945975149294,6/1231
OUD_Effect_Male_vs_Female,GO_MF,postsynaptic neurotransmitter receptor activity,0.0014778390972655909,0.07398152086917444,17/1824
OUD_Effect_Male_vs_Female,GO_CC,proximal dendrite,0.004964189782540322,0.07402739149402235,4/1867
OUD_vs_Control_Female,GO_MF,glutamate receptor activity,0.005579598332601681,0.07426699466864681,9/2121
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.03784023167481519,0.0744161119332881,17/2407
OUD_Effect_Male_vs_Female,GO_BP,ensheathment of neurons,0.002717528095413153,0.0750339278371336,31/1775
OUD_Effect_Male_vs_Female,GO_BP,axon ensheathment,0.002717528095413153,0.0750339278371336,31/1775
OUD_Effect_Male_vs_Female,GO_BP,neuronal action potential,0.0027975830802460626,0.07519543416321635,11/1775
OUD_vs_Control_Female,Reactome,Selenoamino acid metabolism,0.0021428539316211944,0.07538560131443361,26/1379
OUD_vs_Control_Female,GO_CC,Schaffer collateral - CA1 synapse,0.009160144703990547,0.07621240393720136,22/2168
OUD_vs_Control_Male,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.018509437190578293,0.07668195407525294,1/5
OUD_vs_Control_Male,GO_BP,positive regulation of response to cytokine stimulus,0.019820976485398267,0.07703616634015616,1/5
OUD_vs_Control_Female,GO_BP,regulation of synapse assembly,0.01180331179499444,0.07737162301417612,33/2058
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.03955126747586563,0.07741150688863012,65/2407
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.022346488037269643,0.07827692468217798,11/2057
OUD_vs_Control_Male,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.0208037105473734,0.07842998876359772,1/5
OUD_vs_Control_Female,GO_CC,axonal growth cone,0.0097187129388200209,0.07862004668650416,9/2168
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.008897643771145944,0.07924921472216277,34/2013
OUD_vs_Control_Female,GO_BP,negative regulation of axonogenesis,0.0121655497506195,0.07926859918774057,14/2058
OUD_vs_Control_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.040599142344163744,0.07927415471940977,34/2407
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.041791844452937606,0.08083680711084644,13/2407
OUD_Effect_Male_vs_Female,GO_BP,postsynapse organization,0.0033816524976372155,0.08177286767370794,42/1775
OUD_Effect_Male_vs_Female,GO_BP,pyramidal neuron differentiation,0.003493750447393372,0.08177286767370794,6/1775
OUD_Effect_Male_vs_Female,GO_BP,dendrite morphogenesis,0.00351207800745189,0.08177286767370794,28/1775
OUD_vs_Control_Female,GO_BP,positive regulation of innate immune response,0.012653775057285831,0.08198179061579648,65/2058
OUD_vs_Control_Male,GO_BP,axonal transport,0.022439848896724013,0.08213420421422285,1/5
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.04325073532324501,0.0828804788519858,3/2407
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.04325073532324501,0.0828804788519858,3/2407
OUD_vs_Control_Female,GO_BP,L-glutamate transmembrane transport,0.013173260954968319,0.08446189284006203,10/2058
OUD_vs_Control_Female,GO_BP,negative regulation of axon extension,0.013173260954968319,0.08446189284006203,10/2058
OUD_vs_Control_Female,GO_BP,regulation of immunoglobulin mediated immune response,0.013561430171147392,0.08636907492778402,15/2058
OUD_Effect_Male_vs_Female,GO_MF,glutamate-gated calcium ion channel activity,0.0018383756827764965,0.08677133222705063,5/1824
OUD_vs_Control_Female,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.008280020923541102,0.08844921103036327,11/1231
OUD_Effect_Male_vs_Female,Reactome,Transmission across Chemical Synapses,2.0373052037201813e-4,0.08862277636182789,52/1194
OUD_Effect_Male_vs_Female,GO_MF,glutamate receptor binding,0.00226570630511583,0.08889725269646974,13/1824
OUD_Effect_Male_vs_Female,GO_MF,lipopolysaccharide immune receptor activity,0.002313911541130871,0.08889725269646974,4/1824
OUD_vs_Control_Female,GO_CC,neuronal dense core vesicle,0.0114881611567652,0.08909493889438513,8/2168
OUD_vs_Control_Male,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.034240914319861426,0.08938336671682007,1/3
OUD_vs_Control_Male,GO_BP,regulation of response to endoplasmic reticulum stress,0.028637240664192154,0.09023867745137154,1/5
OUD_vs_Control_Male,C8_CellType,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.0024073171475197386,0.0902743930319902,1/8
OUD_Effect_Male_vs_Female,GO_BP,regulation of complement activation,0.004420291665925519,0.09277791177666837,7/1775
OUD_vs_Control_Female,GO_BP,positive regulation of humoral immune response,0.015424901154879076,0.09437843797839524,6/2058
OUD_vs_Control_Female,GO_BP,"regulation of complement activation, classical pathway",0.01555007741405882,0.09437843797839524,4/2058
OUD_vs_Control_Female,GO_BP,antibacterial innate immune response,0.01555007741405882,0.09437843797839524,4/2058
OUD_vs_Control_Female,KEGG,Axon guidance,0.016843721014248577,0.0949875414574018,38/1075
OUD_vs_Control_Female,GO_BP,postsynapse organization,0.015937868954143144,0.09634821255849867,44/2058
OUD_vs_Control_Female,GO_BP,synapse maturation,0.016050948867792375,0.0964196194999799,11/2058
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine-mediated signaling pathway,0.004700654295343581,0.09657349816271518,14/1775
OUD_vs_Control_Female,GO_MF,chemokine receptor binding,0.008346298159321659,0.09684638605769753,11/2121
OUD_vs_Control_Female,GO_MF,CCR chemokine receptor binding,0.008562285027801216,0.09684638605769753,8/2121
OUD_vs_Control_Female,GO_CC,astrocyte projection,0.01336998533754354,0.09757743684944056,7/2168
OUD_vs_Control_Female,GO_BP,postsynaptic neurotransmitter receptor diffusion trapping,0.016511873059780552,0.0977241158479786,5/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor diffusion trapping,0.016511873059780552,0.0977241158479786,5/2058
OUD_vs_Control_Female,GO_BP,negative regulation of neuron migration,0.016511873059780552,0.0977241158479786,5/2058
OUD_Effect_Male_vs_Female,GO_BP,inhibitory synapse assembly,0.0048588852364260205,0.09844931381243356,9/1775
OUD_vs_Control_Male,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.03835856718147679,0.10042485991261631,1/5
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of tumor necrosis factor superfamily cytokine production,0.005292815973456855,0.10298587694384967,21/1775
OUD_vs_Control_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.05716814759296123,0.10307779784814017,27/2407
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.05747233688506913,0.10317473985467747,12/2407
OUD_Effect_Male_vs_Female,GO_BP,neuron projection extension,0.0053568315976558,0.10395645488326757,31/1775
OUD_vs_Control_Female,DO,glucose intolerance,0.019786101908803352,0.10409555622703771,6/1094
OUD_vs_Control_Female,KEGG,Cholinergic synapse,0.021605892906731695,0.10538067543213013,25/1075
OUD_vs_Control_Female,KEGG,Galactose metabolism,0.023323523058185004,0.10538067543213013,9/1075
OUD_vs_Control_Female,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.018239917198702955,0.10597073094426747,15/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.03063231185044431,0.10759958423602356,35/2332
OUD_Effect_Male_vs_Female,GO_BP,pyramidal neuron development,0.005731840835280324,0.10782017734907107,5/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune effector process,0.005885836466720312,0.10959576509551366,24/1775
OUD_vs_Control_Female,GO_BP,positive regulation of immunoglobulin mediated immune response,0.019293416955208868,0.11082802183093962,11/2058
OUD_vs_Control_Female,KEGG,Chemokine signaling pathway,0.02538693723216578,0.110914420877089,35/1075
OUD_vs_Control_Female,KEGG,Fluid shear stress and atherosclerosis,0.02547162572468032,0.110914420877089,28/1075
OUD_vs_Control_Female,DO,withdrawal disorder,0.02144045109570645,0.11101577444812431,11/1094
OUD_vs_Control_Female,GO_BP,axon ensheathment in central nervous system,0.01945459889172786,0.1113106351578796,8/2058
OUD_vs_Control_Female,GO_BP,regulation of dendrite extension,0.01945459889172786,0.1113106351578796,8/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of astrocyte differentiation,0.006226188241923657,0.111488381046634,9/1775
OUD_vs_Control_Female,GO_BP,regulation of neuron projection regeneration,0.019912408893654646,0.11168058001917935,9/2058
OUD_vs_Control_Female,GO_BP,maintenance of synapse structure,0.019912408893654646,0.11168058001917935,9/2058
OUD_vs_Control_Female,GO_BP,T cell proliferation involved in immune response,0.02071742937732709,0.11168058001917935,3/2058
OUD_vs_Control_Female,GO_BP,commitment of neuronal cell to specific neuron type in forebrain,0.02071742937732709,0.11168058001917935,3/2058
OUD_vs_Control_Female,GO_BP,regulation of hippocampal neuron apoptotic process,0.02071742937732709,0.11168058001917935,3/2058
OUD_vs_Control_Female,GO_BP,pyroptotic cell death,0.02071742937732709,0.11168058001917935,3/2058
OUD_vs_Control_Female,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.020997011160115153,0.11294447209766925,15/2058
OUD_vs_Control_Female,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.021129824437334736,0.11294447209766925,6/2058
OUD_vs_Control_Female,GO_BP,regulation of axon extension involved in axon guidance,0.021129824437334736,0.11294447209766925,6/2058
OUD_vs_Control_Female,GO_BP,glutamatergic neuron differentiation,0.021129824437334736,0.11294447209766925,6/2058
OUD_Effect_Male_vs_Female,GO_BP,excitatory synapse assembly,0.0066387694760778335,0.1162574988013154,11/1775
OUD_vs_Control_Male,GO_BP,regulation of cytokine-mediated signaling pathway,0.05215658373315779,0.11659669564799965,1/5
OUD_vs_Control_Male,GO_BP,regulation of response to cytokine stimulus,0.05470609049261932,0.11659669564799965,1/5
OUD_Effect_Male_vs_Female,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,8.405370579577961e-4,0.1166626351271422,40/1194
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.016228067105071322,0.11708869271898603,32/2013
OUD_vs_Control_Male,KEGG,Cholinergic synapse,0.04574981084369423,0.11800141307750299,1/3
OUD_vs_Control_Male,KEGG,Dopaminergic synapse,0.05187812930872793,0.11800141307750299,1/3
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.06767168808686551,0.1181155151110723,3/2407
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.06767168808686551,0.1181155151110723,3/2407
OUD_vs_Control_Female,KEGG,Fructose and mannose metabolism,0.028981209839971288,0.11945007832530101,9/1075
OUD_vs_Control_Female,KEGG,GABAergic synapse,0.029703094444483574,0.11945007832530101,20/1075
OUD_vs_Control_Male,GO_CC,axon,0.02163496977624604,0.11996725024454515,2/6
OUD_vs_Control_Male,GO_CC,axon cytoplasm,0.023197505215431957,0.11996725024454515,1/6
OUD_vs_Control_Male,GO_CC,postsynapse,0.031210914517939507,0.11996725024454515,2/6
OUD_vs_Control_Male,GO_CC,neuron projection cytoplasm,0.03242358114717436,0.11996725024454515,1/6
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.039249551776552316,0.12024769046149736,5/2057
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.017458215445661854,0.12137662121071838,33/2013
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.017464082813775365,0.12137662121071838,32/2013
OUD_vs_Control_Female,GO_BP,retinal ganglion cell axon guidance,0.0234918137194679,0.12279592868311319,7/2058
OUD_vs_Control_Female,GO_BP,negative regulation of chemokine production,0.0234918137194679,0.12279592868311319,7/2058
OUD_vs_Control_Female,GO_BP,regulation of excitatory synapse assembly,0.0234918137194679,0.12279592868311319,7/2058
OUD_Effect_Male_vs_Female,GO_BP,central nervous system neuron development,0.007219625511269802,0.12351803573794011,19/1775
OUD_vs_Control_Female,GO_BP,dopamine secretion,0.02441225978172345,0.12421344762443778,8/2058
OUD_vs_Control_Female,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.024428481625496625,0.12421344762443778,9/2058
OUD_vs_Control_Female,GO_BP,"regulation of synaptic transmission, dopaminergic",0.02499106883476724,0.1244976921611655,4/2058
OUD_vs_Control_Female,GO_MF,chemokine binding,0.012247715791383233,0.12578328978389897,9/2121
OUD_Effect_Male_vs_Female,GO_BP,neuron cell-cell adhesion,0.007565151110284901,0.1261716245264069,6/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.0187413220789031,0.12617468087052208,33/2013
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.04204794954179925,0.1264530247249698,7/2057
OUD_vs_Control_Female,GO_CC,ionotropic glutamate receptor complex,0.018775967842286297,0.12700492068928618,11/2168
OUD_vs_Control_Female,GO_BP,complement activation,0.025680042695038888,0.12742989264372065,12/2058
OUD_vs_Control_Female,GO_BP,myeloid leukocyte cytokine production,0.025680042695038888,0.12742989264372065,12/2058
OUD_vs_Control_Female,Reactome,Arachidonate metabolism,0.004785592324724193,0.12762302576485532,15/1379
OUD_vs_Control_Female,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.004788584252689284,0.12762302576485532,16/1379
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.042894391013204324,0.1280569775503691,13/2057
OUD_vs_Control_Female,DO,opioid abuse,0.027587754772097777,0.12861195285212842,6/1094
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex neuron differentiation,0.008252798288872765,0.13054356479985627,8/1775
OUD_Effect_Male_vs_Female,GO_BP,axon ensheathment in central nervous system,0.008252798288872765,0.13054356479985627,8/1775
OUD_vs_Control_Male,GO_BP,cellular response to oxidative stress,0.07396622618084403,0.1320249534666683,1/5
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.045223475281983005,0.13259069097011505,3/2057
OUD_vs_Control_Female,Reactome,Diseases associated with glycosaminoglycan metabolism,0.005386905396276327,0.13536523702928657,12/1379
OUD_vs_Control_Female,KEGG,Complement and coagulation cascades,0.036110509624705855,0.1357723554145604,18/1075
OUD_Effect_Male_vs_Female,GO_BP,dendrite arborization,0.0088792573430923,0.1362527581872246,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuronal synaptic plasticity,0.008962675671797296,0.1362527581872246,14/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynapse organization,0.009059117479758547,0.1362527581872246,27/1775
OUD_Effect_Male_vs_Female,GO_BP,antibacterial innate immune response,0.009188493278159538,0.1362527581872246,4/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron differentiation,0.009221545920683942,0.13646774697511146,32/1775
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.04760033334765759,0.13758682925223997,57/2057
OUD_vs_Control_Male,GO_BP,vesicle-mediated transport in synapse,0.08052362810323399,0.13789492526554964,1/5
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.009457607682861843,0.1388437215717542,23/1775
OUD_vs_Control_Female,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.028655768416501644,0.13893761173042204,16/2058
OUD_vs_Control_Male,GO_BP,response to endoplasmic reticulum stress,0.08642445681344635,0.14104770657432586,1/5
OUD_vs_Control_Female,GO_BP,regulation of neuronal synaptic plasticity,0.029705534129545345,0.14218227799755917,14/2058
OUD_vs_Control_Female,GO_BP,positive regulation of dendrite extension,0.02988215174314391,0.14218227799755917,7/2058
OUD_vs_Control_Female,GO_BP,axon regeneration,0.029903637830128636,0.14218227799755917,12/2058
OUD_vs_Control_Female,GO_BP,glutamate secretion,0.030189803349924427,0.14247567045624188,8/2058
OUD_vs_Control_Female,GO_MF,chemokine activity,0.014726052645302752,0.14249371172391218,8/2121
OUD_Effect_Male_vs_Female,GO_BP,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.009826643918203901,0.1425541736062913,9/1775
OUD_vs_Control_Female,GO_BP,response to toxic substance,0.030366857534251893,0.14319676786936206,42/2058
OUD_vs_Control_Male,GO_BP,innate immune response-activating signaling pathway,0.08920899143962191,0.14360967082888082,1/5
OUD_Effect_Male_vs_Female,GO_BP,neuron migration,0.010004980950181446,0.14372389626676665,32/1775
OUD_vs_Control_Female,DO,metal metabolism disorder,0.033090701156758856,0.14497932613830805,15/1094
OUD_vs_Control_Female,DO,glycogen metabolism disorder,0.03411454342334572,0.145292905943595,7/1094
OUD_vs_Control_Female,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.016271190204851058,0.14529318586993578,8/1231
OUD_Effect_Male_vs_Female,GO_MF,G protein-coupled neurotransmitter receptor activity,0.005508737477813627,0.14661525702670578,5/1824
OUD_vs_Control_Female,GO_CC,dendrite membrane,0.022390000686209017,0.1466809493773693,11/2168
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of humoral immune response,0.0105402713225203,0.14682518101730457,6/1775
OUD_vs_Control_Male,GO_BP,cellular response to chemical stress,0.09506515790434955,0.14735839274603094,1/5
OUD_vs_Control_Male,GO_BP,activation of innate immune response,0.09537254066321366,0.14735839274603094,1/5
OUD_vs_Control_Female,GO_BP,microglial cell activation,0.031909614748980845,0.1495726372572228,11/2058
OUD_vs_Control_Female,GO_BP,L-glutamate import,0.031909614748980845,0.1495726372572228,11/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of excitatory synapse assembly,0.010892441048827138,0.1500260372923663,7/1775
OUD_Effect_Male_vs_Female,GO_CC,kainate selective glutamate receptor complex,0.013497178415893835,0.1509552849146021,3/1867
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon extension,0.011184213506953561,0.15205155331542225,17/1775
OUD_vs_Control_Female,GO_BP,commissural neuron axon guidance,0.03301602612615748,0.1526916035233403,5/2058
OUD_vs_Control_Female,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.01860332725042386,0.15296920854123094,10/1231
OUD_vs_Control_Female,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.018890366744379626,0.15296920854123094,12/1231
OUD_vs_Control_Female,WikiPathways,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.01909548509306641,0.15296920854123094,15/1231
OUD_vs_Control_Female,DO,autoimmune disease of peripheral nervous system,0.03814997687104994,0.1554943090338039,4/1094
OUD_Effect_Male_vs_Female,GO_CC,neuron projection terminus,0.014534603026851221,0.15638496927624732,23/1867
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.09487969555645533,0.15762272003733707,63/2407
OUD_vs_Control_Female,GO_BP,regulation of neuron migration,0.03460540074970068,0.1583846905418276,12/2058
OUD_vs_Control_Female,GO_BP,response to pain,0.03554974929319194,0.1583846905418276,9/2058
OUD_vs_Control_Female,GO_BP,innate immune response-activating signaling pathway,0.036809761728117917,0.1583846905418276,49/2058
OUD_vs_Control_Female,GO_BP,regulation of axon regeneration,0.036839625328615726,0.1583846905418276,8/2058
OUD_vs_Control_Female,GO_BP,inhibitory synapse assembly,0.036839625328615726,0.1583846905418276,8/2058
OUD_vs_Control_Female,GO_BP,G protein-coupled opioid receptor signaling pathway,0.03721441000586165,0.1583846905418276,4/2058
OUD_vs_Control_Female,GO_BP,complement-dependent cytotoxicity,0.03721441000586165,0.1583846905418276,4/2058
OUD_vs_Control_Female,GO_BP,motor neuron migration,0.03721441000586165,0.1583846905418276,4/2058
OUD_vs_Control_Female,GO_BP,negative regulation of T-helper 1 type immune response,0.03724661542173831,0.1583846905418276,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of dopamine secretion,0.03724661542173831,0.1583846905418276,3/2058
OUD_vs_Control_Female,GO_BP,glutamate reuptake,0.03724661542173831,0.1583846905418276,3/2058
OUD_vs_Control_Female,GO_BP,chemorepulsion of axon,0.03724661542173831,0.1583846905418276,3/2058
OUD_vs_Control_Female,GO_BP,anterograde axonal transport of mitochondrion,0.03724661542173831,0.1583846905418276,3/2058
OUD_vs_Control_Female,GO_BP,regulation of translation at postsynapse,0.03724661542173831,0.1583846905418276,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of cardiac muscle hypertrophy in response to stress,0.03724661542173831,0.1583846905418276,3/2058
OUD_Effect_Male_vs_Female,GO_CC,Schaffer collateral - CA1 synapse,0.015283304886483553,0.1588895774304278,19/1867
OUD_vs_Control_Male,DO,autoimmune disease,0.11904771510755319,0.16106455573374845,1/3
OUD_Effect_Male_vs_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway,0.012314148356922803,0.16260423907570415,53/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.028352639257432213,0.1638600930749819,32/2013
OUD_vs_Control_Male,GO_BP,positive regulation of innate immune response,0.11487202951212072,0.16404073911389966,1/5
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_ASTROCYTE,0.05946595658649285,0.16433497462078092,7/2057
OUD_Effect_Male_vs_Female,GO_BP,regulation of forebrain neuron differentiation,0.01370772900133932,0.16637723733567986,3/1775
OUD_vs_Control_Male,GO_BP,response to oxidative stress,0.118490453411779,0.16648467679589357,1/5
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter transport,0.013783010894732281,0.16650108804926167,35/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.012874183106984826,0.16658777262062638,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.012874183106984826,0.16658777262062638,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_IRON_METABOLISM_IN_PLACENTA,0.01321963546278943,0.16658777262062638,5/1002
OUD_vs_Control_Female,GO_MF,C-X3-C chemokine binding,0.020364593496997575,0.16710945840183303,3/2121
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.06253926499584951,0.16995720520466742,5/2057
OUD_vs_Control_Female,GO_CC,apical dendrite,0.027612515636701435,0.172733932404027,6/2168
OUD_vs_Control_Female,GO_MF,neurotransmitter receptor activity,0.021475363774896575,0.17283537961142725,20/2121
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.059841910909793766,0.17426765687538268,32/2332
OUD_Effect_Male_vs_Female,GO_BP,anterograde axonal protein transport,0.015006109424921725,0.1743600866039483,4/1775
OUD_vs_Control_Female,Reactome,Modulation by Mtb of host immune system,0.00933124328968508,0.17634768974221107,4/1379
OUD_vs_Control_Female,Reactome,Sialic acid metabolism,0.009524178809272343,0.17634768974221107,10/1379
OUD_vs_Control_Female,Reactome,Regulation of necroptotic cell death,0.009524178809272343,0.17634768974221107,10/1379
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.06583014565310931,0.17655429227620792,3/2057
OUD_vs_Control_Female,KEGG,Amino sugar and nucleotide sugar metabolism,0.05160756889458255,0.17753003699736397,10/1075
OUD_vs_Control_Male,GO_CC,distal axon,0.09638494340895143,0.17831214530656014,1/6
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.01594206484782066,0.1800044688742791,13/1002
OUD_vs_Control_Female,GO_BP,response to laminar fluid shear stress,0.044083422092570504,0.18004473248209624,5/2058
OUD_vs_Control_Female,GO_BP,negative regulation of T-helper 17 type immune response,0.044083422092570504,0.18004473248209624,5/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.06373963102231835,0.18245563004743537,32/2332
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.06978224029900762,0.1829286505152092,24/2057
OUD_vs_Control_Female,DO,autoimmune disease of endocrine system,0.051214321028749614,0.1834446523372854,13/1094
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.045934844806226414,0.1848096930034851,7/2058
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter uptake,0.04621195233512808,0.1848096930034851,6/2058
OUD_vs_Control_Female,GO_BP,dopamine transport,0.046366197102489175,0.1848096930034851,10/2058
OUD_vs_Control_Female,Reactome,Diseases of Immune System,0.01122875364053559,0.18533847854926455,9/1379
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.011508940828548808,0.1855475912799026,1/8
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.012939376872868391,0.1855475912799026,1/8
OUD_vs_Control_Male,GO_BP,regulation of innate immune response,0.1393628125091344,0.18565293397859953,1/5
OUD_Effect_Male_vs_Female,GO_BP,sensory perception of pain,0.016725480810337066,0.1863202308038637,16/1775
OUD_Effect_Male_vs_Female,GO_BP,receptor localization to synapse,0.016725480810337066,0.1863202308038637,16/1775
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.06611917978444261,0.18652729815275298,33/2332
OUD_Effect_Male_vs_Female,DO,immune system disease,0.016197065804789502,0.18743629932168027,87/920
OUD_vs_Control_Male,GO_BP,positive regulation of cytokine production,0.14290088457323047,0.18903029292669432,1/5
OUD_vs_Control_Female,GO_MF,glutamate-gated calcium ion channel activity,0.02447035369728442,0.19141762658529962,4/2121
OUD_vs_Control_Female,GO_BP,cellular response to toxic substance,0.04935030220860097,0.1951719895757599,23/2058
OUD_vs_Control_Female,GO_BP,positive regulation of axon extension,0.04971838614232241,0.19591564782517837,9/2058
OUD_vs_Control_Female,GO_BP,dendrite extension,0.04971838614232241,0.19591564782517837,9/2058
OUD_vs_Control_Male,C8_CellType,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.06233297536981275,0.19605317849214415,1/8
OUD_vs_Control_Male,C8_CellType,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.06369884118110059,0.19605317849214415,1/8
OUD_vs_Control_Male,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.06415374275224983,0.19605317849214415,1/8
OUD_vs_Control_Male,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.08084973453574651,0.19605317849214415,1/8
OUD_vs_Control_Male,C8_CellType,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.08887744091643868,0.19605317849214415,1/8
OUD_Effect_Male_vs_Female,WikiPathways,WP_NEUROINFLAMMATION,0.019223594604136304,0.19613262062328257,5/1002
OUD_vs_Control_Male,GO_BP,immune response-activating signaling pathway,0.15169517830893542,0.19622988555492152,1/5
OUD_vs_Control_Male,GO_BP,cytokine-mediated signaling pathway,0.15198707316190208,0.19622988555492152,1/5
OUD_vs_Control_Female,DO,opiate dependence,0.05733434743960857,0.19713384552726307,14/1094
OUD_Effect_Male_vs_Female,GO_CC,hippocampal mossy fiber to CA3 synapse,0.021208933399997618,0.19729391345252426,11/1867
OUD_Effect_Male_vs_Female,GO_CC,perineuronal net,0.022282606695814507,0.19729391345252426,4/1867
OUD_vs_Control_Female,GO_BP,neurotransmitter secretion,0.05030138221221403,0.1975343469251862,27/2058
OUD_vs_Control_Female,GO_BP,signal release from synapse,0.05030138221221403,0.1975343469251862,27/2058
OUD_vs_Control_Female,Reactome,Protein-protein interactions at synapses,0.013476754344797275,0.1975467574374867,20/1379
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.0394457590119309,0.19873809504253084,31/2013
OUD_Effect_Male_vs_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.07917821798922743,0.19914703371021025,23/2057
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.0399591655363585,0.1992641294709709,30/2013
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter transport,0.019811432713242698,0.2010592935146359,19/1775
OUD_vs_Control_Male,GO_BP,regulation of cellular response to stress,0.1569370046557662,0.20130244273638065,1/5
OUD_Effect_Male_vs_Female,GO_CC,astrocyte projection,0.023642959300200772,0.20177960288596047,6/1867
OUD_vs_Control_Male,C8_CellType,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.107806893822318,0.20213792591684626,1/8
OUD_vs_Control_Female,GO_BP,pyramidal neuron development,0.052286322940700306,0.20259474110166753,4/2058
OUD_vs_Control_Female,GO_BP,T-helper 2 cell cytokine production,0.052286322940700306,0.20259474110166753,4/2058
OUD_vs_Control_Female,GO_BP,regulation of T-helper 2 cell cytokine production,0.052286322940700306,0.20259474110166753,4/2058
OUD_vs_Control_Female,DO,heroin dependence,0.06032030862846893,0.20418502403952016,10/1094
OUD_vs_Control_Male,GO_BP,immune response-regulating signaling pathway,0.1633084581093961,0.20522429569080775,1/5
OUD_vs_Control_Female,GO_BP,activation of innate immune response,0.05325343351700321,0.20559118251343814,51/2058
OUD_vs_Control_Female,GO_CC,neurotransmitter receptor complex,0.03625549342347505,0.20578810228401256,11/2168
OUD_vs_Control_Female,GO_CC,perineuronal net,0.036731535781002606,0.20578810228401256,4/2168
OUD_vs_Control_Female,GO_CC,basal dendrite,0.03685387889461283,0.20578810228401256,3/2168
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.043101889820641184,0.20915578406988433,29/2013
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.13335334282945135,0.20930124665041508,4/2407
OUD_vs_Control_Female,GO_MF,glutamate-gated receptor activity,0.027339408355874874,0.20993655774190156,6/2121
OUD_Effect_Male_vs_Female,GO_BP,multicellular organismal response to stress,0.02102567830155614,0.21036176846107943,18/1775
OUD_vs_Control_Female,Reactome,Innate Immune System,0.014778866558775496,0.21036239835306458,151/1379
OUD_vs_Control_Female,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.014980934266855421,0.21036239835306458,12/1379
OUD_vs_Control_Female,GO_BP,axon extension,0.05483069134217578,0.210825530516584,21/2058
OUD_vs_Control_Male,GO_BP,activation of immune response,0.16849276155047,0.21103578440042256,1/5
OUD_vs_Control_Female,GO_BP,regulation of neuron apoptotic process,0.05658847274593854,0.21241446361955874,41/2058
OUD_vs_Control_Female,GO_BP,positive regulation of immune response to tumor cell,0.05711002251879395,0.21241446361955874,5/2058
OUD_vs_Control_Female,GO_BP,regulation of glutamate secretion,0.05711002251879395,0.21241446361955874,5/2058
OUD_vs_Control_Female,GO_BP,negative regulation of neuron projection regeneration,0.05711002251879395,0.21241446361955874,5/2058
OUD_vs_Control_Female,GO_BP,dendrite self-avoidance,0.05711002251879395,0.21241446361955874,5/2058
OUD_vs_Control_Female,GO_BP,synapse pruning,0.05711002251879395,0.21241446361955874,5/2058
OUD_vs_Control_Female,GO_BP,axonal fasciculation,0.05745357826493008,0.21241446361955874,6/2058
OUD_vs_Control_Female,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.05745357826493008,0.21241446361955874,6/2058
OUD_vs_Control_Female,GO_BP,axon extension involved in axon guidance,0.05745357826493008,0.21241446361955874,6/2058
OUD_vs_Control_Female,GO_BP,neuron projection fasciculation,0.05745357826493008,0.21241446361955874,6/2058
OUD_vs_Control_Female,GO_BP,neuron projection extension involved in neuron projection guidance,0.05745357826493008,0.21241446361955874,6/2058
OUD_vs_Control_Female,GO_BP,positive regulation of natural killer cell mediated immune response to tumor cell,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of humoral immune response mediated by circulating immunoglobulin,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,forebrain neuron fate commitment,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,"negative regulation of complement activation, classical pathway",0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of axon extension involved in axon guidance,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,spontaneous neurotransmitter secretion,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,hippocampal neuron apoptotic process,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,regulation of complement-dependent cytotoxicity,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of microglial cell activation,0.05864613587920861,0.21241446361955874,3/2058
OUD_vs_Control_Male,Reactome,Cellular responses to stress,0.19801430120683428,0.21274281184884222,1/3
OUD_vs_Control_Male,Reactome,Metabolism of RNA,0.199587335812345,0.21274281184884222,1/3
OUD_vs_Control_Male,Reactome,Cytokine Signaling in Immune system,0.19984930810042756,0.21274281184884222,1/3
OUD_Effect_Male_vs_Female,DO,"autoimmune disease of eyes, ear, nose and throat",0.022672356888970523,0.2133570301268047,6/920
OUD_Effect_Male_vs_Female,GO_BP,neuronal action potential propagation,0.022702783025803683,0.21601419036841665,4/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation in response to endoplasmic reticulum stress,0.022702783025803683,0.21601419036841665,4/1775
OUD_Effect_Male_vs_Female,GO_BP,AMPA glutamate receptor clustering,0.022702783025803683,0.21601419036841665,4/1775
OUD_Effect_Male_vs_Female,GO_BP,glutamate receptor clustering,0.022702783025803683,0.21601419036841665,4/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.04588810597472713,0.21663454681092112,29/2013
OUD_vs_Control_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.0840238955918597,0.21973398782798736,26/2332
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.04730105767259041,0.2211619510372941,31/2013
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation in response to stress,0.024233679679542004,0.22198267675272315,6/1775
OUD_Effect_Male_vs_Female,GO_BP,protein localization to synapse,0.024737283501134896,0.22198267675272315,17/1775
OUD_Effect_Male_vs_Female,GO_BP,astrocyte differentiation,0.024737283501134896,0.22198267675272315,17/1775
OUD_Effect_Male_vs_Female,GO_BP,glutamate receptor signaling pathway,0.024866274870479297,0.22198267675272315,12/1775
OUD_vs_Control_Female,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.03060414303210559,0.22280475765768304,5/1231
OUD_vs_Control_Female,Reactome,Vitamin C (ascorbate) metabolism,0.016615118101989824,0.22363204262819114,4/1379
OUD_vs_Control_Female,DO,drug dependence,0.06809757308510955,0.22406705156883455,16/1094
OUD_vs_Control_Female,GO_MF,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,0.0307018674224872,0.22842189362330478,13/2121
OUD_Effect_Male_vs_Female,GO_BP,neuron apoptotic process,0.025929685242444604,0.2286724639786332,45/1775
OUD_Effect_Male_vs_Female,GO_BP,response to chemokine,0.026078968910876035,0.22889118894927593,14/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to chemokine,0.026078968910876035,0.22889118894927593,14/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.026062859190667573,0.23228802998687598,9/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.02615163251507875,0.23228802998687598,11/1002
OUD_vs_Control_Female,Reactome,Chemokine receptors bind chemokines,0.01827093316349375,0.23288819880134423,11/1379
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.032903465220505204,0.23345791989787024,12/1231
OUD_vs_Control_Male,C8_CellType,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.16048108665443672,0.23351826433248976,1/8
OUD_vs_Control_Male,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.16213393663818942,0.23351826433248976,1/8
OUD_vs_Control_Male,C8_CellType,HU_FETAL_RETINA_MICROGLIA,0.1641959945062046,0.23351826433248976,1/8
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C3_ASTROCYTE,0.1650195734616261,0.23351826433248976,1/8
OUD_Effect_Male_vs_Female,GO_MF,kainate selective glutamate receptor activity,0.01336138853687964,0.2348192964140975,3/1824
OUD_Effect_Male_vs_Female,GO_MF,C-X3-C chemokine binding,0.01336138853687964,0.2348192964140975,3/1824
OUD_vs_Control_Female,GO_MF,L-glutamate transmembrane transporter activity,0.03223142962353397,0.2350246294377248,5/2121
OUD_Effect_Male_vs_Female,GO_MF,glutamate-gated receptor activity,0.01366087995314598,0.23681052387888937,6/1824
OUD_Effect_Male_vs_Female,GO_MF,glutamate binding,0.014536325430586368,0.237185464269979,4/1824
OUD_Effect_Male_vs_Female,GO_MF,chemokine binding,0.01563218863755248,0.237185464269979,8/1824
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.1869894709480323,0.23781093228031067,1/8
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.15559727227821268,0.23831255084990197,2/2407
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendrite extension,0.027620891766763984,0.2387211033425959,7/1775
OUD_vs_Control_Male,C8_CellType,ZHONG_PFC_C3_MICROGLIA,0.20333084435662885,0.24059050266948845,1/8
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of programmed cell death,0.028119937675260945,0.24161465140367316,115/1775
OUD_vs_Control_Female,GO_MF,postsynaptic neurotransmitter receptor activity,0.03358932948150431,0.24236438600016472,15/2121
OUD_vs_Control_Female,GO_MF,complement binding,0.035476269090332316,0.2424134145270824,6/2121
OUD_vs_Control_Female,GO_BP,negative regulation of type 2 immune response,0.07017354788116012,0.2431248025682207,4/2058
OUD_vs_Control_Female,GO_BP,peripheral nervous system neuron development,0.07017354788116012,0.2431248025682207,4/2058
OUD_vs_Control_Female,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.07018923996947844,0.2431248025682207,6/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter uptake,0.07045329645478973,0.24352792889569153,10/2058
OUD_vs_Control_Female,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.03547663104356221,0.24390704714037023,8/1231
OUD_Effect_Male_vs_Female,GO_CC,inhibitory synapse,0.032092588546443986,0.24684792316377627,5/1867
OUD_vs_Control_Female,GO_BP,stress response to metal ion,0.07210177171940185,0.2469420841666744,5/2058
OUD_vs_Control_Male,GO_BP,positive regulation of immune response,0.21592576162654442,0.2481829638207538,1/5
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.16535296640520097,0.24867876339770753,12/2407
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.16689242252297604,0.24867876339770753,3/2407
OUD_vs_Control_Female,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.16689242252297604,0.24867876339770753,3/2407
OUD_vs_Control_Female,GO_BP,dopaminergic neuron differentiation,0.07292073209805948,0.2487403566461796,8/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter reuptake,0.07292073209805948,0.2487403566461796,8/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of presynapse assembly,0.029333771062542594,0.24913381774249513,8/1775
OUD_vs_Control_Female,GO_BP,neuron projection organization,0.07319841403856221,0.24957579218071996,18/2058
OUD_vs_Control_Male,DO,immune system disease,0.21162648205545742,0.24961072242438567,1/3
OUD_vs_Control_Male,GO_BP,regulation of cytokine production,0.21893637546139477,0.250028438470472,1/5
OUD_vs_Control_Male,GO_BP,cytokine production,0.22084740055879892,0.250028438470472,1/5
OUD_vs_Control_Female,DO,autoimmune lymphoproliferative syndrome,0.0806207507692846,0.2502682073643669,3/1094
OUD_Effect_Male_vs_Female,GO_BP,T cell cytokine production,0.029945117941465624,0.25228676112196985,9/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of T cell cytokine production,0.029945117941465624,0.25228676112196985,9/1775
OUD_vs_Control_Male,Reactome,Innate Immune System,0.2541066007924866,0.2541066007924866,1/3
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.06066278055604626,0.25588663798186784,30/2013
OUD_Effect_Male_vs_Female,GO_BP,immune response-activating cell surface receptor signaling pathway,0.030759724716394838,0.2560604256340553,47/1775
OUD_Effect_Male_vs_Female,GO_BP,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.030775991333855186,0.2560604256340553,13/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,0.03230274198467642,0.2567217915624284,3/1002
OUD_vs_Control_Male,GO_BP,cellular response to cytokine stimulus,0.23787887769368743,0.25844477490063444,1/5
OUD_vs_Control_Female,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.03884099682648057,0.26068957329484704,7/1231
OUD_Effect_Male_vs_Female,GO_BP,presynapse organization,0.03218976948565408,0.26216217245461215,12/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of astrocyte differentiation,0.032400464277531266,0.26216217245461215,4/1775
OUD_Effect_Male_vs_Female,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.032400464277531266,0.26216217245461215,4/1775
OUD_Effect_Male_vs_Female,GO_BP,protein localization to presynapse,0.032400464277531266,0.26216217245461215,4/1775
OUD_vs_Control_Male,GO_BP,negative regulation of programmed cell death,0.24508627614484502,0.26324081511853725,1/5
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron projection regeneration,0.0327797151236992,0.26377987388928625,5/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of programmed cell death,0.03306679232702134,0.2655090148092161,75/1775
OUD_vs_Control_Female,GO_BP,detection of stimulus involved in sensory perception of pain,0.07878764910253452,0.26554226690885196,7/2058
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.11702630687737718,0.26739530454104615,3/2057
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.06544162396015134,0.2674761677297461,29/2013
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T cell cytokine production,0.033600246380889445,0.26803667259375474,7/1775
OUD_Effect_Male_vs_Female,GO_BP,ionotropic glutamate receptor signaling pathway,0.033600246380889445,0.26803667259375474,7/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.11886580706921922,0.26934135784659646,2/2057
OUD_vs_Control_Male,GO_BP,innate immune response,0.255663574609272,0.2699864639431248,1/5
OUD_Effect_Male_vs_Female,GO_BP,regulation of immune response,0.03410537586605726,0.27089097137672913,124/1775
OUD_vs_Control_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.11286791541680238,0.27128390918138195,32/2332
OUD_vs_Control_Male,GO_BP,response to cytokine,0.26012286517718086,0.2724064449216589,1/5
OUD_Effect_Male_vs_Female,GO_BP,regulation of presynapse organization,0.03483997500715639,0.2726536583196018,8/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of humoral immune response,0.034984035262659696,0.2726536583196018,9/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor internalization,0.034984035262659696,0.2726536583196018,9/1775
OUD_vs_Control_Male,GO_BP,regulation of immune response,0.2653416998166084,0.2740652625503051,1/5
OUD_vs_Control_Female,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.08441949603801864,0.27460120451764475,8/2058
OUD_vs_Control_Female,GO_BP,immune response-inhibiting cell surface receptor signaling pathway,0.08450377095829845,0.27460120451764475,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of glutamate secretion,0.08450377095829845,0.27460120451764475,3/2058
OUD_vs_Control_Female,GO_BP,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",0.08450377095829845,0.27460120451764475,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 2 cell cytokine production,0.08450377095829845,0.27460120451764475,3/2058
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.11528715814334428,0.2756030591140203,33/2332
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.12449540631544496,0.27598168662881833,6/2057
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.1248504935708468,0.2760208209214937,10/2057
OUD_vs_Control_Female,WikiPathways,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.04335193106882739,0.27604434740407185,5/1231
OUD_Effect_Male_vs_Female,GO_BP,response to osmotic stress,0.035657341700741016,0.2773570618126029,16/1775
OUD_vs_Control_Male,GO_CC,glutamatergic synapse,0.19850633100979576,0.27925114399907636,1/6
OUD_vs_Control_Male,GO_CC,dendrite,0.21408850061505724,0.27925114399907636,1/6
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.19275679879520224,0.2801262825524632,4/2407
OUD_vs_Control_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.19275679879520224,0.2801262825524632,4/2407
OUD_Effect_Male_vs_Female,GO_CC,axon terminus,0.03947806255733203,0.2819861611238002,19/1867
OUD_vs_Control_Female,DO,autoimmune thrombocytopenic purpura,0.09482911650861654,0.28297526794142974,6/1094
OUD_vs_Control_Female,KEGG,Nicotinate and nicotinamide metabolism,0.09596067016547795,0.2834734673313225,9/1075
OUD_vs_Control_Female,GO_BP,ectopic germ cell programmed cell death,0.08902315124404099,0.285511302326678,5/2058
OUD_vs_Control_Female,GO_BP,cellular response to fluid shear stress,0.08902315124404099,0.285511302326678,5/2058
OUD_vs_Control_Female,GO_BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.08902315124404099,0.285511302326678,5/2058
OUD_vs_Control_Female,GO_BP,regulation of microglial cell activation,0.08902315124404099,0.285511302326678,5/2058
OUD_vs_Control_Female,GO_BP,peripheral nervous system neuron differentiation,0.09075845959537944,0.2870877021337231,4/2058
OUD_vs_Control_Female,GO_CC,hippocampal mossy fiber to CA3 synapse,0.0552365715022318,0.28767724317141863,11/2168
OUD_vs_Control_Male,GO_BP,neuron projection development,0.2854145219717874,0.28770394327102633,1/5
OUD_vs_Control_Female,KEGG,Cortisol synthesis and secretion,0.10013274610941215,0.28872892450635507,13/1075
OUD_Effect_Male_vs_Female,GO_MF,opioid receptor binding,0.024408865532628384,0.29009673280505105,3/1824
OUD_vs_Control_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.12499706542542428,0.29026963906228176,32/2332
OUD_vs_Control_Female,KEGG,Serotonergic synapse,0.10571576405581795,0.29063968660564926,21/1075
OUD_vs_Control_Female,Reactome,Regulation of innate immune responses to cytosolic DNA,0.02571989240668011,0.2918792951183891,5/1379
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axon extension involved in axon guidance,0.03998582706299076,0.29380195609220483,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cortisol biosynthetic process,0.03998582706299076,0.29380195609220483,3/1775
OUD_Effect_Male_vs_Female,GO_BP,glutamate secretion,0.04038125505688002,0.2940634959835174,7/1775
OUD_Effect_Male_vs_Female,GO_BP,synapse maturation,0.040575877168976045,0.29508350299913805,9/1775
OUD_Effect_Male_vs_Female,GO_BP,chemokine-mediated signaling pathway,0.04093948916982187,0.295964602294254,12/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axon extension,0.04100447719073349,0.295964602294254,8/1775
OUD_Effect_Male_vs_Female,GO_BP,response to pain,0.04100447719073349,0.295964602294254,8/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.04100447719073349,0.295964602294254,8/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron apoptotic process,0.041093154411151626,0.2963138732294316,26/1775
OUD_vs_Control_Female,GO_BP,cellular response to chemical stress,0.09414196166748028,0.29643626375411214,49/2058
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of type 2 immune response,0.042046150040857065,0.29735522456779206,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon extension involved in axon guidance,0.042046150040857065,0.29735522456779206,5/1775
OUD_Effect_Male_vs_Female,GO_BP,stress response to metal ion,0.042046150040857065,0.29735522456779206,5/1775
OUD_Effect_Male_vs_Female,GO_BP,glutamatergic neuron differentiation,0.042046150040857065,0.29735522456779206,5/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_SYSTEM,0.040107383492403385,0.29764128808748125,17/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.04029390407122077,0.29764128808748125,8/1002
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.07887131455635926,0.29857113016206865,28/2013
OUD_Effect_Male_vs_Female,GO_CC,symmetric synapse,0.0433896144283526,0.2998469289764204,4/1867
OUD_Effect_Male_vs_Female,GO_CC,synapse-associated extracellular matrix,0.0433896144283526,0.2998469289764204,4/1867
OUD_vs_Control_Female,GO_MF,cytokine receptor activity,0.04838980286850876,0.3011320817913891,18/2121
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.2116095409775604,0.302949523581066,6/2407
OUD_Effect_Male_vs_Female,GO_BP,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.044575246330927125,0.3041971711036419,30/1775
OUD_Effect_Male_vs_Female,GO_BP,axon extension,0.044962852459806926,0.3056131559419425,19/1775
OUD_Effect_Male_vs_Female,GO_BP,presynapse assembly,0.04506989386440606,0.3056131559419425,10/1775
OUD_Effect_Male_vs_Female,KEGG,Amphetamine addiction,0.024582614676948847,0.3056971606335437,14/889
OUD_Effect_Male_vs_Female,KEGG,Glutamatergic synapse,0.03318601375252851,0.3056971606335437,21/889
OUD_Effect_Male_vs_Female,GO_CC,ionotropic glutamate receptor complex,0.04537184728667612,0.30607992217202146,9/1867
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.2145392949652513,0.3063784732259394,7/2407
OUD_vs_Control_Female,GO_MF,axon guidance receptor activity,0.05126900310479336,0.3109576492660293,4/2121
OUD_vs_Control_Female,GO_MF,G protein-coupled neurotransmitter receptor activity,0.05126900310479336,0.3109576492660293,4/2121
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.13790439823588385,0.3113393087141919,32/2332
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter secretion,0.0463327440197348,0.3121516557175101,15/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendrite extension,0.04647261223802495,0.3121516557175101,6/1775
OUD_vs_Control_Female,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.10122467186042525,0.31362577367548344,10/2058
OUD_vs_Control_Female,DO,autoimmune disease of skin and connective tissue,0.11406535261337039,0.3165160066278508,6/1094
OUD_vs_Control_Female,DO,autoimmune disease of blood,0.11406535261337039,0.3165160066278508,6/1094
OUD_vs_Control_Female,GO_CC,AMPA glutamate receptor complex,0.06547475359231061,0.3193721462864415,7/2168
OUD_vs_Control_Female,GO_CC,stress fiber,0.06564018871992969,0.3193721462864415,17/2168
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.045349706840495316,0.31961210089210107,10/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.04689044429626098,0.31961210089210107,5/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHEMOKINE_SIGNALING,0.04746052291972406,0.31961210089210107,27/1002
OUD_vs_Control_Female,DO,substance abuse,0.11610027983070961,0.3201923506910097,49/1094
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.15032339455162763,0.3202201477688318,7/2057
OUD_vs_Control_Female,GO_MF,structural constituent of synapse,0.05414122005700459,0.3202558387824229,7/2121
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axonogenesis,0.04855465988196376,0.3205740784845991,11/1775
OUD_Effect_Male_vs_Female,DO,opioid abuse,0.04795303711123794,0.3210127086715272,5/920
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.1524336809174852,0.32136791492397654,21/2057
OUD_vs_Control_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.054472046034709926,0.3215476520679336,8/1231
OUD_vs_Control_Female,WikiPathways,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.05567737868021938,0.3215476520679336,3/1231
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.1446481637915797,0.3222340438923531,32/2332
OUD_Effect_Male_vs_Female,Reactome,Linoleic acid (LA) metabolism,0.005507808595926721,0.32364834691092215,4/1194
OUD_Effect_Male_vs_Female,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.005640379040507658,0.32364834691092215,9/1194
OUD_vs_Control_Female,GO_BP,response to osmotic stress,0.10542987847629078,0.32552062600482645,16/2058
OUD_vs_Control_Female,GO_MF,chemokine receptor activity,0.0560093053027713,0.3255540870723582,6/2121
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.06085937401823967,0.3261887312488385,14/1231
OUD_vs_Control_Female,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.06085937401823967,0.3261887312488385,14/1231
OUD_vs_Control_Female,GO_BP,mature B cell differentiation involved in immune response,0.10666077702455719,0.32852209405420624,7/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.05198156280480963,0.3292664387789585,14/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.0523337386138742,0.3292664387789585,7/1002
OUD_vs_Control_Female,GO_MF,CCR5 chemokine receptor binding,0.05772499740597367,0.32980083842184277,3/2121
OUD_vs_Control_Female,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.10780133277932229,0.3304316908571822,5/2058
OUD_vs_Control_Female,GO_BP,positive regulation of T-helper 17 type immune response,0.10780133277932229,0.3304316908571822,5/2058
OUD_vs_Control_Female,GO_CC,synapse-associated extracellular matrix,0.06932436228762441,0.33148200817990525,4/2168
OUD_Effect_Male_vs_Female,C8_CellType,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.16324455806333815,0.33223368328670033,13/2057
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.16408607340810138,0.33223368328670033,2/2057
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.16408607340810138,0.33223368328670033,2/2057
OUD_vs_Control_Female,GO_BP,negative regulation of neuron apoptotic process,0.11072594230484845,0.3329454282428572,27/2058
OUD_vs_Control_Female,GO_BP,negative regulation of immunoglobulin mediated immune response,0.11385543298306823,0.3329454282428572,4/2058
OUD_vs_Control_Female,GO_BP,regulation of response to osmotic stress,0.11385543298306823,0.3329454282428572,4/2058
OUD_vs_Control_Female,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.11385543298306823,0.3329454282428572,4/2058
OUD_vs_Control_Female,GO_BP,negative regulation of synapse organization,0.11385543298306823,0.3329454282428572,4/2058
OUD_vs_Control_Female,GO_BP,assembly of actomyosin apparatus involved in cytokinesis,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,regulation of L-glutamate import across plasma membrane,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,natural killer cell cytokine production,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of T cell cytokine production,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,regulation of natural killer cell cytokine production,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,spinal cord association neuron differentiation,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,astrocyte cell migration,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,autophagic cell death,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,protein localization to axon,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,regulation of translation at synapse,0.11426012202006416,0.3329454282428572,3/2058
OUD_vs_Control_Female,GO_BP,regulation of cardiac muscle hypertrophy in response to stress,0.11426012202006416,0.3329454282428572,3/2058
OUD_Effect_Male_vs_Female,KEGG,Chemokine signaling pathway,0.0404432562333596,0.33296075699500144,29/889
OUD_Effect_Male_vs_Female,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.051760203395404235,0.33541523874290585,16/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.05508562196160048,0.33559239952532743,19/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.05651715681543992,0.33559239952532743,6/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.05950686954793169,0.33559239952532743,12/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_IRON_METABOLISM_DISORDERS,0.059562094750190565,0.33559239952532743,5/1002
OUD_Effect_Male_vs_Female,GO_BP,ectopic germ cell programmed cell death,0.05273391351376973,0.33650320018694224,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of sensory perception of pain,0.05273391351376973,0.33650320018694224,5/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter-gated ion channel clustering,0.05273391351376973,0.33650320018694224,5/1775
OUD_Effect_Male_vs_Female,GO_BP,L-glutamate import across plasma membrane,0.05273391351376973,0.33650320018694224,5/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.05273391351376973,0.33650320018694224,5/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of chemokine production,0.0532399768745068,0.3384442782299028,13/1775
OUD_vs_Control_Female,GO_BP,regulation of immune response to tumor cell,0.11721172300595793,0.3390815397403652,6/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of immune effector process,0.05413889456759918,0.33912018299744257,54/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axon extension,0.05540126207058061,0.33912018299744257,8/1775
OUD_Effect_Male_vs_Female,GO_BP,dendrite extension,0.05540126207058061,0.33912018299744257,8/1775
OUD_Effect_Male_vs_Female,GO_BP,chemokine production,0.05647049270275884,0.33912018299744257,16/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine production,0.05647049270275884,0.33912018299744257,16/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of glutamate secretion,0.058464227333889486,0.33912018299744257,3/1775
OUD_Effect_Male_vs_Female,GO_BP,meiotic cytokinesis,0.058464227333889486,0.33912018299744257,3/1775
OUD_Effect_Male_vs_Female,GO_BP,cortisol biosynthetic process,0.058464227333889486,0.33912018299744257,3/1775
OUD_Effect_Male_vs_Female,GO_BP,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",0.058464227333889486,0.33912018299744257,3/1775
OUD_Effect_Male_vs_Female,GO_CC,apical dendrite,0.05168402133350974,0.34055362894173086,5/1867
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune response,0.05983040134249186,0.3456815411422055,30/1775
OUD_vs_Control_Female,Hallmark,HALLMARK_HEME_METABOLISM,0.15562845698533406,0.3457321584465436,37/703
OUD_Effect_Male_vs_Female,GO_CC,neuronal dense core vesicle,0.054747480520491165,0.3472787943463992,6/1867
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.06086150928577509,0.3483548967886057,11/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron projection regeneration,0.06086150928577509,0.3483548967886057,11/1775
OUD_Effect_Male_vs_Female,GO_BP,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.060956186562465736,0.3483548967886057,15/1775
OUD_Effect_Male_vs_Female,GO_BP,postsynapse assembly,0.060956186562465736,0.3483548967886057,15/1775
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.16388661565106488,0.3518975722573769,31/2332
OUD_vs_Control_Female,Reactome,Glucose metabolism,0.03463645041484474,0.3562895688872041,17/1379
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.06427609742893833,0.35682686440329736,17/1002
OUD_vs_Control_Female,GO_BP,macrophage cytokine production,0.12485395165117959,0.3568527391095816,8/2058
OUD_vs_Control_Female,GO_BP,regulation of macrophage cytokine production,0.12485395165117959,0.3568527391095816,8/2058
OUD_Effect_Male_vs_Female,DO,glucose metabolism disease,0.060013217286797066,0.35869570324776007,89/920
OUD_vs_Control_Female,KEGG,Adipocytokine signaling pathway,0.13856636504825348,0.35894848414974606,14/1075
OUD_Effect_Male_vs_Female,GO_BP,glutamate metabolic process,0.06579378330715056,0.3604197341135963,7/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron projection regeneration,0.06579378330715056,0.3604197341135963,7/1775
OUD_Effect_Male_vs_Female,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.009093393317065872,0.3608573064141538,9/1194
OUD_Effect_Male_vs_Female,Reactome,Glucose metabolism,0.009407338537597185,0.3608573064141538,17/1194
OUD_Effect_Male_vs_Female,Reactome,Vitamin C (ascorbate) metabolism,0.009967142903484974,0.3608573064141538,4/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of carbohydrates and carbohydrate derivatives,0.010369462827992927,0.3608573064141538,47/1194
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.25859720724241925,0.36177266344270537,4/2407
OUD_Effect_Male_vs_Female,GO_BP,alpha-beta T cell activation involved in immune response,0.06645593544544923,0.3623010399412422,15/1775
OUD_Effect_Male_vs_Female,GO_BP,alpha-beta T cell differentiation involved in immune response,0.06645593544544923,0.3623010399412422,15/1775
OUD_Effect_Male_vs_Female,GO_BP,T cell differentiation involved in immune response,0.06675840567931658,0.3623675821190948,16/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.06713602680989124,0.3636424532743649,9/1002
OUD_vs_Control_Female,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.12833112626072038,0.36433747998315436,5/2058
OUD_Effect_Male_vs_Female,GO_BP,activation of immune response,0.06728291910954166,0.36494533189578093,76/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.07024515521861083,0.3682992513197998,21/1002
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter uptake,0.06883956110879015,0.37011328359294704,9/1775
OUD_Effect_Male_vs_Female,GO_BP,T-helper 1 type immune response,0.06883956110879015,0.37011328359294704,9/1775
OUD_Effect_Male_vs_Female,KEGG,Dopaminergic synapse,0.05996447518891314,0.370494793131499,22/889
OUD_Effect_Male_vs_Female,GO_BP,regulation of adaptive immune response,0.06905797791866541,0.37101638246295404,31/1775
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.2694100818232291,0.373099004071161,2/2407
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.2694100818232291,0.373099004071161,2/2407
OUD_vs_Control_Female,KEGG,Phenylalanine metabolism,0.14990854510246443,0.37368506895107073,4/1075
OUD_vs_Control_Female,GO_BP,response to oxidative stress,0.13563054988780235,0.3741198787704876,59/2058
OUD_vs_Control_Female,GO_BP,cellular response to osmotic stress,0.136788248068724,0.3741198787704876,11/2058
OUD_vs_Control_Female,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.13922707330688572,0.3741198787704876,4/2058
OUD_vs_Control_Female,GO_BP,negative regulation of axon regeneration,0.13922707330688572,0.3741198787704876,4/2058
OUD_vs_Control_Female,GO_BP,immune complex clearance,0.14140621386113086,0.3741198787704876,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of glutamate secretion,0.14140621386113086,0.3741198787704876,2/2058
OUD_vs_Control_Female,GO_BP,C-X-C chemokine receptor CXCR4 signaling pathway,0.14140621386113086,0.3741198787704876,2/2058
OUD_vs_Control_Female,GO_BP,NMDA selective glutamate receptor signaling pathway,0.14140621386113086,0.3741198787704876,2/2058
OUD_vs_Control_Female,GO_BP,response to psychosocial stress,0.14140621386113086,0.3741198787704876,2/2058
OUD_vs_Control_Female,GO_BP,regulation of forebrain neuron differentiation,0.14140621386113086,0.3741198787704876,2/2058
OUD_vs_Control_Female,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.0770513620815015,0.3745844211196707,5/1231
OUD_vs_Control_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.0789392672695145,0.3745844211196707,8/1231
OUD_vs_Control_Female,WikiPathways,WP_PHOSPHOINOSITIDES_METABOLISM,0.0803583828288845,0.37652198243722607,12/1231
OUD_vs_Control_Female,Reactome,Keratan sulfate/keratin metabolism,0.03949764869612044,0.37848997545384555,9/1379
OUD_vs_Control_Female,Reactome,Glutamate Neurotransmitter Release Cycle,0.040846547455393026,0.37893188619743046,7/1379
OUD_vs_Control_Female,GO_BP,regulation of cytokine-mediated signaling pathway,0.14568773405995183,0.38144494152738817,27/2058
OUD_vs_Control_Female,GO_BP,immune response-inhibiting signal transduction,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of axon regeneration,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,amino acid neurotransmitter reuptake,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of synapse assembly,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,regulation of chemokine-mediated signaling pathway,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neuron projection regeneration,0.14727971288329378,0.38144494152738817,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.14727971288329378,0.38144494152738817,3/2058
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.1239688523010939,0.3815390072084204,28/2013
OUD_vs_Control_Female,DO,substance dependence,0.14432722947938934,0.381956910339394,23/1094
OUD_vs_Control_Female,Reactome,Transmission across Chemical Synapses,0.04249093744252632,0.3832900459559169,47/1379
OUD_Effect_Male_vs_Female,GO_BP,type 2 immune response,0.07266042216000874,0.38336973098053395,8/1775
OUD_Effect_Male_vs_Female,GO_BP,detection of mechanical stimulus involved in sensory perception of pain,0.07384800151563048,0.3843963560845451,4/1775
OUD_vs_Control_Female,GO_BP,presynapse organization,0.14974046333041124,0.38742293110996684,11/2058
OUD_Effect_Male_vs_Female,DO,opiate dependence,0.0690316159516043,0.38745105462320184,12/920
OUD_vs_Control_Female,KEGG,Amphetamine addiction,0.16127346806597873,0.3879585525503264,13/1075
OUD_vs_Control_Female,WikiPathways,WP_GLYCOSPHINGOLIPID_METABOLISM,0.08605641813453191,0.38880775495943887,6/1231
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immune response,0.07507855794754756,0.38942369090565043,97/1775
OUD_vs_Control_Female,GO_BP,positive regulation of stress fiber assembly,0.15256145623606082,0.39232296156315843,10/2058
OUD_Effect_Male_vs_Female,DO,metal metabolism disorder,0.07683922401651955,0.3932657275050996,12/920
OUD_Effect_Male_vs_Female,KEGG,Fructose and mannose metabolism,0.0725063124109837,0.3946233787339347,7/889
OUD_Effect_Male_vs_Female,KEGG,Fluid shear stress and atherosclerosis,0.07413444976215537,0.3946233787339347,22/889
OUD_Effect_Male_vs_Female,GO_BP,immune response-regulating signaling pathway,0.08001907724263137,0.397453922271554,73/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation at synapse,0.08019328628837338,0.397453922271554,3/1775
OUD_vs_Control_Female,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.15490953739528643,0.3975559118395879,9/2058
OUD_Effect_Male_vs_Female,GO_BP,T-helper 17 type immune response,0.0807120425879375,0.39814693040528526,10/1775
OUD_vs_Control_Female,GO_BP,regulation of response to cytokine stimulus,0.1561215557966948,0.39897038525264683,28/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor internalization,0.1565124652865822,0.39897038525264683,8/2058
OUD_vs_Control_Female,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.15692730395390966,0.39897038525264683,7/2058
OUD_vs_Control_Female,GO_BP,regulation of response to oxidative stress,0.15692730395390966,0.39897038525264683,7/2058
OUD_Effect_Male_vs_Female,KEGG,Adipocytokine signaling pathway,0.07647933835893292,0.4009371374574362,13/889
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.21163111265854895,0.4014071344818833,2/2057
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.21163111265854895,0.4014071344818833,2/2057
OUD_vs_Control_Female,GO_BP,postsynapse assembly,0.1580686918871407,0.4014702321121543,15/2058
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.1357947452692087,0.40291839156612963,28/2013
OUD_vs_Control_Female,GO_BP,positive regulation of neuron apoptotic process,0.15930086269533264,0.4039263219541773,12/2058
OUD_vs_Control_Female,DO,drug-induced mental disorder,0.1749734698234214,0.40425969218462443,2/1094
OUD_vs_Control_Female,DO,drug psychosis,0.1749734698234214,0.40425969218462443,2/1094
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron apoptotic process,0.08443763452309105,0.4126503667224815,35/1775
OUD_Effect_Male_vs_Female,GO_BP,response to axon injury,0.08508228278131691,0.414423966792441,14/1775
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.31549879019759863,0.4152891423687241,6/2407
OUD_vs_Control_Female,GO_BP,neuron cell-cell adhesion,0.16659942356958288,0.4172929330251604,4/2058
OUD_vs_Control_Female,GO_BP,response to L-glutamate,0.16659942356958288,0.4172929330251604,4/2058
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.14611784270626385,0.4214837949466652,27/2013
OUD_Effect_Male_vs_Female,KEGG,Central carbon metabolism in cancer,0.083977362303989,0.4219134514130051,13/889
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter reuptake,0.0870848283548484,0.4227781600989505,7/1775
OUD_vs_Control_Female,GO_BP,regulation of dendrite development,0.16985308755539777,0.424326325978834,17/2058
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.22968464928247953,0.4279773191641646,4/2057
OUD_Effect_Male_vs_Female,GO_BP,protein localization to postsynapse,0.08946266905408895,0.4309089265833819,10/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to cytokine stimulus,0.09088765526987909,0.431305369434065,26/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of innate immune response,0.09126256447935528,0.431305369434065,62/1775
OUD_Effect_Male_vs_Female,GO_BP,response to laminar fluid shear stress,0.0916472152051298,0.431305369434065,4/1775
OUD_Effect_Male_vs_Female,GO_BP,response to morphine,0.0916472152051298,0.431305369434065,4/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axon regeneration,0.0916472152051298,0.431305369434065,4/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of production of molecular mediator of immune response,0.09283523160046034,0.43141265348739916,8/1775
OUD_Effect_Male_vs_Female,GO_BP,axon extension involved in axon guidance,0.09332121437096562,0.43141265348739916,5/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron projection extension involved in neuron projection guidance,0.09332121437096562,0.43141265348739916,5/1775
OUD_vs_Control_Female,GO_BP,central nervous system projection neuron axonogenesis,0.17628260963839473,0.4335630085940112,6/2058
OUD_vs_Control_Female,GO_BP,peripheral nervous system axon ensheathment,0.17628260963839473,0.4335630085940112,6/2058
OUD_Effect_Male_vs_Female,GO_MF,cytokine receptor binding,0.049126878470110595,0.43399787824931924,32/1824
OUD_vs_Control_Female,WikiPathways,WP_CHEMOKINE_SIGNALING,0.10797912331595513,0.4358499069619008,30/1231
OUD_vs_Control_Female,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.10898746884045406,0.4358499069619008,8/1231
OUD_Effect_Male_vs_Female,C8_CellType,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.23866508333380132,0.4384740015307005,117/2057
OUD_Effect_Male_vs_Female,GO_BP,forebrain neuron development,0.09903158606406334,0.43923398711423506,7/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of adaptive immune response,0.09996121713700712,0.43923398711423506,11/1775
OUD_Effect_Male_vs_Female,GO_BP,axonal transport,0.10040226878980137,0.43923398711423506,12/1775
OUD_Effect_Male_vs_Female,GO_BP,cortisol metabolic process,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,G protein-coupled opioid receptor signaling pathway,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of translational initiation in response to stress,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,response to nitrosative stress,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of synapse assembly,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,motor neuron migration,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.10483207340090324,0.43923398711423506,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of receptor localization to synapse,0.10488220679508939,0.43923398711423506,6/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron maturation,0.10699307982405312,0.43923398711423506,9/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of tumor necrosis factor superfamily cytokine production,0.10923302113413266,0.43923398711423506,11/1775
OUD_Effect_Male_vs_Female,GO_BP,axon midline choice point recognition,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of translational initiation in response to stress,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of translation in response to endoplasmic reticulum stress,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,NMDA glutamate receptor clustering,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of glutamate receptor clustering,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of hippocampal neuron apoptotic process,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of AMPA glutamate receptor clustering,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,response to psychosocial stress,0.10949055668389654,0.43923398711423506,2/1775
OUD_Effect_Male_vs_Female,GO_BP,motor neuron axon guidance,0.10958455015018645,0.43923398711423506,5/1775
OUD_vs_Control_Female,GO_BP,positive regulation of axonogenesis,0.1805038369803299,0.43948464265909276,13/2058
OUD_vs_Control_Female,GO_BP,natural killer cell mediated immune response to tumor cell,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of macrophage cytokine production,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of astrocyte differentiation,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,granzyme-mediated programmed cell death signaling pathway,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of execution phase of apoptosis,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,regulation of hydrogen peroxide-mediated programmed cell death,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,GO_BP,protein localization to presynapse,0.18290223411176632,0.43948464265909276,3/2058
OUD_vs_Control_Female,KEGG,Inositol phosphate metabolism,0.19183942814254853,0.439779592905066,14/1075
OUD_vs_Control_Female,KEGG,Intestinal immune network for IgA production,0.19340480391573672,0.439779592905066,9/1075
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immune response to tumor cell,0.11126971523227344,0.44046757563690586,4/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of glutamate secretion,0.11126971523227344,0.44046757563690586,4/1775
OUD_vs_Control_Female,DO,substance-related disorder,0.1978421604667008,0.4407707996792144,61/1094
OUD_Effect_Male_vs_Female,GO_CC,neurotransmitter receptor complex,0.07533834589034927,0.44163857935721984,9/1867
OUD_vs_Control_Female,GO_MF,neurotransmitter transmembrane transporter activity,0.08715456370771045,0.44580849978418446,5/2121
OUD_vs_Control_Female,GO_BP,regulation of axon diameter,0.19348601308082716,0.44891348207025905,2/2058
OUD_vs_Control_Female,GO_BP,chemokine (C-X-C motif) ligand 12 signaling pathway,0.19348601308082716,0.44891348207025905,2/2058
OUD_vs_Control_Female,GO_BP,radial glia-guided pyramidal neuron migration,0.19348601308082716,0.44891348207025905,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of protein localization to synapse,0.19348601308082716,0.44891348207025905,2/2058
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.16630608265132288,0.44905007094922234,27/2013
OUD_vs_Control_Female,GO_BP,central nervous system neuron axonogenesis,0.19542746750657114,0.4497469007440456,7/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neurotransmitter secretion,0.19567562413886927,0.4497469007440456,4/2058
OUD_vs_Control_Female,GO_BP,GABAergic neuron differentiation,0.19567562413886927,0.4497469007440456,4/2058
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.16928430575808745,0.4534101911233656,25/2013
OUD_vs_Control_Female,GO_BP,muscle hypertrophy in response to stress,0.19900654092834358,0.45397808393267236,5/2058
OUD_vs_Control_Female,GO_BP,cardiac muscle hypertrophy in response to stress,0.19900654092834358,0.45397808393267236,5/2058
OUD_vs_Control_Female,GO_BP,response to immobilization stress,0.19900654092834358,0.45397808393267236,5/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neurotransmitter transport,0.19900654092834358,0.45397808393267236,5/2058
OUD_vs_Control_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.23451858882268176,0.45430400188632425,28/2332
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.2360227894877876,0.4554071407463371,29/2332
OUD_vs_Control_Female,GO_BP,negative regulation of neuron differentiation,0.20047147181057404,0.4569093958052491,12/2058
OUD_vs_Control_Female,KEGG,Platinum drug resistance,0.2053891296936504,0.457594867812263,13/1075
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.1733622877096946,0.4592827981085547,27/2013
OUD_Effect_Male_vs_Female,GO_BP,cellular response to osmotic stress,0.11897872680820037,0.4603506606678032,10/1775
OUD_vs_Control_Female,WikiPathways,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.12192654471738686,0.46109277063174214,3/1231
OUD_Effect_Male_vs_Female,GO_BP,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.11962468447805352,0.4614959229043266,42/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon regeneration,0.11972269994477527,0.4614959229043266,6/1775
OUD_vs_Control_Female,Reactome,Activation of kainate receptors upon glutamate binding,0.058089968448222604,0.46222686384141587,8/1379
OUD_Effect_Male_vs_Female,GO_CC,neuron projection cytoplasm,0.08186075645164169,0.46281327517860094,15/1867
OUD_vs_Control_Female,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.12410206147045981,0.4646031949522239,9/1231
OUD_vs_Control_Female,GO_CC,immunological synapse,0.11075822689404692,0.46777078566419816,10/2168
OUD_vs_Control_Female,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.0611674856775852,0.4686992996029568,5/1379
OUD_vs_Control_Female,Reactome,Linoleic acid (LA) metabolism,0.061551755661332024,0.4686992996029568,3/1379
OUD_Effect_Male_vs_Female,DO,heroin dependence,0.1145602278027825,0.46902176346503016,8/920
OUD_Effect_Male_vs_Female,DO,drug dependence,0.11911873452166762,0.46902176346503016,13/920
OUD_Effect_Male_vs_Female,DO,glycogen metabolism disorder,0.12975431863197825,0.46902176346503016,5/920
OUD_Effect_Male_vs_Female,DO,morphine dependence,0.12975431863197825,0.46902176346503016,5/920
OUD_Effect_Male_vs_Female,DO,drug-induced mental disorder,0.13046590976259725,0.46902176346503016,2/920
OUD_Effect_Male_vs_Female,DO,drug psychosis,0.13046590976259725,0.46902176346503016,2/920
OUD_Effect_Male_vs_Female,DO,autosomal dominant distal hereditary motor neuronopathy,0.13241217112890621,0.46902176346503016,3/920
OUD_Effect_Male_vs_Female,DO,plasma protein metabolism disease,0.13241217112890621,0.46902176346503016,3/920
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of innate immune response,0.12229175981698824,0.4696897615947512,15/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron projection organization,0.12229175981698824,0.4696897615947512,15/1775
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.12831881289728322,0.4709237222092414,12/1231
OUD_Effect_Male_vs_Female,DO,autoimmune disease of endocrine system,0.13392456257237578,0.4730500655567671,10/920
OUD_Effect_Male_vs_Female,GO_MF,chemokine receptor binding,0.06093492122301818,0.4748324993416323,8/1824
OUD_vs_Control_Female,GO_BP,cellular response to oxidative stress,0.2102249275345384,0.4760057292005288,36/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.2561482868140914,0.4790612105022086,30/2332
OUD_Effect_Male_vs_Female,GO_BP,immune response-activating signaling pathway,0.12592971303475498,0.4804396514532071,66/1775
OUD_Effect_Male_vs_Female,GO_BP,muscle hypertrophy in response to stress,0.12711564401467587,0.4804396514532071,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopamine secretion,0.12711564401467587,0.4804396514532071,5/1775
OUD_Effect_Male_vs_Female,GO_BP,cardiac muscle hypertrophy in response to stress,0.12711564401467587,0.4804396514532071,5/1775
OUD_Effect_Male_vs_Female,GO_BP,anterograde axonal transport,0.12976178362624674,0.48245769839246694,9/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine-mediated signaling pathway,0.13063275555584675,0.48245769839246694,24/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of macrophage cytokine production,0.1319939268221677,0.48245769839246694,3/1775
OUD_Effect_Male_vs_Female,GO_BP,"CD4-positive, alpha-beta T cell cytokine production",0.13256927375270913,0.48245769839246694,4/1775
OUD_vs_Control_Female,DO,autoimmune thyroiditis,0.22948905369035075,0.48259082223828426,4/1094
OUD_vs_Control_Female,DO,newborn respiratory distress syndrome,0.23797990165338292,0.48259082223828426,3/1094
OUD_vs_Control_Female,GO_MF,glutamate receptor binding,0.09806619825635904,0.48429091823720083,10/2121
OUD_vs_Control_Female,KEGG,Thiamine metabolism,0.22517440901207658,0.48716979056700843,3/1075
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine production involved in immune response,0.1355384577994624,0.4893889823834295,6/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of type 2 immune response,0.1355384577994624,0.4893889823834295,6/1775
OUD_Effect_Male_vs_Female,GO_BP,response to arsenic-containing substance,0.1355384577994624,0.4893889823834295,6/1775
OUD_vs_Control_Female,GO_BP,stress response to copper ion,0.2204784628553016,0.4916230830119532,3/2058
OUD_vs_Control_Female,GO_BP,immune response to tumor cell,0.22112758802957425,0.49177484321788817,6/2058
OUD_vs_Control_Female,GO_BP,programmed cell death involved in cell development,0.22503319058369137,0.4949906558103522,5/2058
OUD_vs_Control_Female,GO_BP,neutrophil activation involved in immune response,0.22614775925167727,0.4949906558103522,4/2058
OUD_vs_Control_Female,GO_BP,axonal transport of mitochondrion,0.22614775925167727,0.4949906558103522,4/2058
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axonogenesis,0.13800595998613455,0.4973218205281821,12/1775
OUD_vs_Control_Female,WikiPathways,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.14044660206119067,0.49825104064565257,4/1231
OUD_vs_Control_Female,WikiPathways,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.14044660206119067,0.49825104064565257,4/1231
OUD_Effect_Male_vs_Female,Reactome,Response of endothelial cells to shear stress,0.023190003551941004,0.4992622434545414,18/1194
OUD_Effect_Male_vs_Female,Reactome,Bile acid and bile salt metabolism,0.025294745018457503,0.4992622434545414,10/1194
OUD_Effect_Male_vs_Female,Reactome,Glycosaminoglycan metabolism,0.02549175611101937,0.4992622434545414,23/1194
OUD_Effect_Male_vs_Female,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.026614361525787316,0.4992622434545414,3/1194
OUD_Effect_Male_vs_Female,Reactome,Protein-protein interactions at synapses,0.027005772237317833,0.4992622434545414,17/1194
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 17 type immune response,0.13986149376460455,0.501222994623228,7/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress fiber assembly,0.1420303671135503,0.5048977042630075,9/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.20967205226042424,0.5078489607602589,26/2013
OUD_Effect_Male_vs_Female,GO_BP,programmed cell death involved in cell development,0.1458323140548749,0.5088589988772713,5/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T-helper 1 type immune response,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dopamine secretion,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,chemokine (C-X-C motif) ligand 12 signaling pathway,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,glutamate reuptake,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,chemorepulsion of axon,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to nitrosative stress,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of translation at postsynapse,0.1517257304012351,0.5088589988772713,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cardiac muscle hypertrophy in response to stress,0.1517257304012351,0.5088589988772713,2/1775
OUD_vs_Control_Female,KEGG,Porphyrin metabolism,0.24159028756556075,0.509859257193576,6/1075
OUD_Effect_Male_vs_Female,C8_CellType,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.2938627994407989,0.510360445737948,8/2057
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine production involved in immune response,0.15439255971195778,0.5110980838405974,18/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,0.15537937667812043,0.5110980838405974,4/1775
OUD_vs_Control_Female,GO_BP,regulation of postsynapse organization,0.2346218113986157,0.5117738652414822,23/2058
OUD_vs_Control_Female,GO_MF,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,0.11261119119024494,0.5136543162192644,3/2121
OUD_vs_Control_Female,GO_MF,G protein-coupled glutamate receptor activity,0.11261119119024494,0.5136543162192644,3/2121
OUD_vs_Control_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.2841557875007136,0.5158276956770348,28/2332
OUD_vs_Control_Female,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.237206226428998,0.5162285219170507,7/2058
OUD_vs_Control_Female,GO_BP,programmed necrotic cell death,0.24017540764791043,0.5198932688260838,9/2058
OUD_vs_Control_Female,GO_BP,"complement activation, classical pathway",0.24483818842217955,0.5198932688260838,6/2058
OUD_vs_Control_Female,GO_BP,branchiomotor neuron axon guidance,0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,neuronal signal transduction,0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of dendrite morphogenesis,0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,"negative regulation of synaptic transmission, glutamatergic",0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of oxidative phosphorylation,0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of hydrogen peroxide-mediated programmed cell death,0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.2474219639614748,0.5198932688260838,2/2058
OUD_vs_Control_Female,GO_BP,regulation of cortisol biosynthetic process,0.2474219639614748,0.5198932688260838,2/2058
OUD_Effect_Male_vs_Female,GO_BP,peripheral nervous system neuron development,0.16127154651463996,0.520470480305036,3/1775
OUD_Effect_Male_vs_Female,GO_BP,interneuron migration,0.16127154651463996,0.520470480305036,3/1775
OUD_Effect_Male_vs_Female,KEGG,Axon guidance,0.12335818452519408,0.5205113639721604,28/889
OUD_Effect_Male_vs_Female,KEGG,Cocaine addiction,0.12575293798817677,0.5221556026905719,9/889
OUD_vs_Control_Female,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.24878220071226292,0.5226072870450377,10/2058
OUD_Effect_Male_vs_Female,GO_BP,cytokine production involved in immune response,0.16299730585642233,0.5239707974536653,18/1775
OUD_vs_Control_Female,DO,autoimmune disease of the nervous system,0.26211732187836634,0.5242346437567327,6/1094
OUD_Effect_Male_vs_Female,GO_BP,cellular response to chemical stress,0.1633141625278381,0.5245308582498904,41/1775
OUD_vs_Control_Female,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.02764177385508088,0.5251937032465367,6/62
OUD_Effect_Male_vs_Female,GO_BP,vesicle-mediated transport in synapse,0.1636002170633836,0.5252202516373576,35/1775
OUD_vs_Control_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.2519885574781246,0.5255184841148068,5/2058
OUD_vs_Control_Female,GO_BP,positive regulation of macrophage cytokine production,0.2519885574781246,0.5255184841148068,5/2058
OUD_vs_Control_Female,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.2519885574781246,0.5255184841148068,5/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of immune response to tumor cell,0.16564080025042366,0.5285414689118725,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynaptic neurotransmitter receptor internalization,0.16564080025042366,0.5285414689118725,5/1775
OUD_vs_Control_Female,Reactome,Opioid Signalling,0.07093595613962805,0.528713334108499,18/1379
OUD_Effect_Male_vs_Female,GO_MF,glutamate receptor activity,0.07556379818845511,0.5289465873191858,6/1824
OUD_vs_Control_Female,GO_BP,behavioral response to pain,0.25770680631097226,0.5294232666179212,4/2058
OUD_vs_Control_Female,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.25770680631097226,0.5294232666179212,4/2058
OUD_vs_Control_Female,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.25770680631097226,0.5294232666179212,4/2058
OUD_vs_Control_Female,Reactome,Inositol phosphate metabolism,0.0716965640295927,0.5321276629875678,11/1379
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_ASTROCYTES,0.42526401281260584,0.5341730892646147,6/2407
OUD_Effect_Male_vs_Female,GO_CC,axonal growth cone,0.10276808424005082,0.53632647046997,6/1867
OUD_vs_Control_Female,Reactome,"Unblocking of NMDA receptors, glutamate binding and activation",0.07564833346183598,0.5365541070942318,6/1379
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.23445559306335859,0.5372848774245922,26/2013
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter receptor activity,0.16987900881807327,0.5376334379763034,6/1775
OUD_vs_Control_Female,Reactome,MECP2 regulates neuronal receptors and channels,0.0770601163156024,0.5378102952223326,5/1379
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.17092867866379843,0.538176554611403,7/1775
OUD_vs_Control_Female,GO_CC,kainate selective glutamate receptor complex,0.14044592451091756,0.5384839133321816,2/2168
OUD_vs_Control_Female,GO_CC,neuronal dense core vesicle lumen,0.14044592451091756,0.5384839133321816,2/2168
OUD_Effect_Male_vs_Female,WikiPathways,WP_RETINOL_METABOLISM,0.120149217048326,0.5387725246515394,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.12727543926142368,0.5387725246515394,5/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.1291045368153696,0.5387725246515394,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_D_METABOLISM,0.13058989670361815,0.5387725246515394,3/1002
OUD_Effect_Male_vs_Female,GO_CC,axon cytoplasm,0.10611027073414876,0.5390117522223027,11/1867
OUD_Effect_Male_vs_Female,GO_CC,neuronal dense core vesicle lumen,0.10843648191766325,0.5390117522223027,2/1867
OUD_Effect_Male_vs_Female,GO_MF,immune receptor activity,0.10664689094895859,0.5395817508496489,21/1824
OUD_Effect_Male_vs_Female,GO_MF,high-affinity L-glutamate transmembrane transporter activity,0.10775607672009414,0.5395817508496489,2/1824
OUD_Effect_Male_vs_Female,GO_MF,glutamate:sodium symporter activity,0.10775607672009414,0.5395817508496489,2/1824
OUD_Effect_Male_vs_Female,DO,newborn respiratory distress syndrome,0.16520906590033146,0.5397114821251762,3/920
OUD_Effect_Male_vs_Female,GO_BP,T cell activation involved in immune response,0.17185223922097828,0.5405619850008041,18/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.3178194903000685,0.5416173813863667,3/2057
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.3178194903000685,0.5416173813863667,3/2057
OUD_Effect_Male_vs_Female,C8_CellType,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.31863661802708526,0.5418809845034422,24/2057
OUD_vs_Control_Female,GO_BP,neuron fate commitment,0.26659117621742207,0.5426440273939769,10/2058
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter secretion,0.1732354787569466,0.5431146403483982,21/1775
OUD_Effect_Male_vs_Female,GO_BP,signal release from synapse,0.1732354787569466,0.5431146403483982,21/1775
OUD_vs_Control_Female,GO_MF,C-C chemokine binding,0.1258089420876075,0.5439389194233485,5/2121
OUD_vs_Control_Female,GO_MF,G protein-coupled opioid receptor activity,0.13991683703118482,0.5439389194233485,2/2121
OUD_vs_Control_Female,GO_MF,high-affinity L-glutamate transmembrane transporter activity,0.13991683703118482,0.5439389194233485,2/2121
OUD_vs_Control_Female,GO_MF,kainate selective glutamate receptor activity,0.13991683703118482,0.5439389194233485,2/2121
OUD_vs_Control_Female,GO_MF,glutamate:sodium symporter activity,0.13991683703118482,0.5439389194233485,2/2121
OUD_vs_Control_Female,GO_MF,CXCR chemokine receptor binding,0.14524533869906617,0.5439389194233485,3/2121
OUD_vs_Control_Female,Reactome,Triglyceride metabolism,0.07968466153521399,0.5475207798454742,8/1379
OUD_Effect_Male_vs_Female,KEGG,Cholesterol metabolism,0.13862160899321174,0.5504199149031768,9/889
OUD_Effect_Male_vs_Female,KEGG,Fatty acid metabolism,0.14281174912500924,0.5552007325534067,10/889
OUD_Effect_Male_vs_Female,GO_BP,behavioral response to pain,0.17951954934275183,0.5578226807840894,4/1775
OUD_vs_Control_Female,GO_MF,ionotropic glutamate receptor binding,0.1521204117642947,0.5609021350075536,6/2121
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of response to endoplasmic reticulum stress,0.18524381957447422,0.561995014157204,8/1775
OUD_Effect_Male_vs_Female,GO_BP,response to toxic substance,0.1857006970309581,0.561995014157204,32/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor transport,0.18643822589946413,0.561995014157204,5/1775
OUD_Effect_Male_vs_Female,GO_BP,G protein-coupled dopamine receptor signaling pathway,0.18827771558767875,0.561995014157204,6/1775
OUD_Effect_Male_vs_Female,GO_BP,dopaminergic neuron differentiation,0.18827771558767875,0.561995014157204,6/1775
OUD_Effect_Male_vs_Female,GO_BP,postsynaptic neurotransmitter receptor internalization,0.18827771558767875,0.561995014157204,6/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to oxidative stress,0.18827771558767875,0.561995014157204,6/1775
OUD_Effect_Male_vs_Female,GO_BP,adaptive immune response,0.18846521131346364,0.561995014157204,58/1775
OUD_Effect_Male_vs_Female,GO_BP,microglia differentiation,0.19225567778212296,0.561995014157204,3/1775
OUD_Effect_Male_vs_Female,GO_BP,peripheral nervous system neuron differentiation,0.19225567778212296,0.561995014157204,3/1775
OUD_Effect_Male_vs_Female,GO_BP,axon choice point recognition,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,branchiomotor neuron axon guidance,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,T-helper 1 cell cytokine production,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,"negative regulation of complement activation, classical pathway",0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron fate determination,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,"negative regulation of synaptic transmission, glutamatergic",0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,spontaneous neurotransmitter secretion,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,hippocampal neuron apoptotic process,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of glutamate receptor signaling pathway,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of complement-dependent cytotoxicity,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of microglial cell activation,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 1 cell cytokine production,0.19642169173653276,0.561995014157204,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 1 cell cytokine production,0.19642169173653276,0.561995014157204,2/1775
OUD_vs_Control_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.4564442165154501,0.5630389736657647,3/2407
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor transport,0.2796839229624998,0.5635853019061801,5/2058
OUD_vs_Control_Female,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.17489150160213524,0.5640440203185747,5/1231
OUD_Effect_Male_vs_Female,GO_MF,CCR chemokine receptor binding,0.12348393616528242,0.5646084632917668,5/1824
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.25565585982556693,0.5646216450907353,20/2013
OUD_vs_Control_Female,WikiPathways,WP_OPIOID_RECEPTOR_PATHWAYS,0.17761843936023633,0.5654946039460516,9/1231
OUD_Effect_Male_vs_Female,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.03403169093729768,0.5658866240148946,9/1194
OUD_Effect_Male_vs_Female,Reactome,Sema3A PAK dependent Axon repulsion,0.03575756758943352,0.5658866240148946,5/1194
OUD_Effect_Male_vs_Female,Reactome,Cytokine Signaling in Immune system,0.03852357695215474,0.5658866240148946,101/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases associated with glycosaminoglycan metabolism,0.0396666197491992,0.5658866240148946,9/1194
OUD_Effect_Male_vs_Female,Reactome,Heparan sulfate/heparin (HS-GAG) metabolism,0.04219824848157609,0.5658866240148946,12/1194
OUD_Effect_Male_vs_Female,Reactome,MECP2 regulates neuronal receptors and channels,0.04576404583660785,0.5658866240148946,5/1194
OUD_Effect_Male_vs_Female,Reactome,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.04748244086561759,0.5658866240148946,4/1194
OUD_Effect_Male_vs_Female,Reactome,alpha-linolenic acid (ALA) metabolism,0.04748244086561759,0.5658866240148946,4/1194
OUD_Effect_Male_vs_Female,GO_BP,innate immune response,0.19929261533552176,0.5685792031779529,110/1775
OUD_Effect_Male_vs_Female,GO_MF,type 5 metabotropic glutamate receptor binding,0.149429682313827,0.5709126049276053,2/1824
OUD_Effect_Male_vs_Female,GO_MF,neurotransmitter transmembrane transporter activity,0.1516722585785267,0.5709126049276053,4/1824
OUD_Effect_Male_vs_Female,GO_BP,complement activation,0.20089396752455843,0.5711538968469762,8/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron recognition,0.20089396752455843,0.5711538968469762,8/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.34147409277263013,0.5723889505901874,9/2057
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.4670512379476667,0.5744033135356379,4/2407
OUD_vs_Control_Female,WikiPathways,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.18284647508769042,0.5750623618152777,2/1231
OUD_Effect_Male_vs_Female,GO_BP,dopamine transport,0.2046819368277775,0.575587067973421,7/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of neurotransmitter uptake,0.2048010002564844,0.575587067973421,4/1775
OUD_Effect_Male_vs_Female,DO,alcohol dependence,0.20474513460316685,0.576302711461146,10/920
OUD_vs_Control_Female,GO_BP,regulation of translation in response to stress,0.2900507263235351,0.5786159092471338,4/2058
OUD_vs_Control_Female,GO_BP,immunological synapse formation,0.29908692679242666,0.5786159092471338,3/2058
OUD_vs_Control_Female,GO_BP,hydrogen peroxide-mediated programmed cell death,0.29908692679242666,0.5786159092471338,3/2058
OUD_vs_Control_Female,GO_BP,regulation of response to endoplasmic reticulum stress,0.301134192424722,0.5786159092471338,14/2058
OUD_vs_Control_Female,GO_BP,noradrenergic neuron differentiation,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,regulation of neuron maturation,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,interneuron migration from the subpallium to the cortex,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,substrate-independent telencephalic tangential interneuron migration,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of translation in response to stress,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,meiotic cytokinesis,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,cortisol biosynthetic process,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,regulation of dopamine uptake involved in synaptic transmission,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,ventral spinal cord interneuron fate commitment,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of synapse maturation,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter loading into synaptic vesicle,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of microglial cell activation,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,regulation of synapse pruning,0.30172802829586653,0.5786159092471338,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of dendrite development,0.30172802829586653,0.5786159092471338,2/2058
OUD_Effect_Male_vs_Female,GO_BP,L-glutamate transmembrane transport,0.20740188619988217,0.5797950866591157,6/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 1 type immune response,0.20811496490394274,0.5800248453461534,5/1775
OUD_Effect_Male_vs_Female,GO_BP,dopamine secretion,0.20811496490394274,0.5800248453461534,5/1775
OUD_vs_Control_Female,Reactome,Glycogen metabolism,0.08542145320112209,0.5801402941342616,7/1379
OUD_vs_Control_Female,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.3044342593576415,0.5826320988761697,7/2058
OUD_Effect_Male_vs_Female,GO_MF,chemokine activity,0.16117425203109378,0.5838772682243514,5/1824
OUD_vs_Control_Female,GO_CC,inhibitory synapse,0.1648617025548301,0.588690714702226,4/2168
OUD_Effect_Male_vs_Female,C8_CellType,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.3568636616353461,0.5921186109892761,2/2057
OUD_vs_Control_Female,KEGG,Purine metabolism,0.29477350761601706,0.5922003876186159,21/1075
OUD_vs_Control_Female,KEGG,Metabolism of xenobiotics by cytochrome P450,0.29677139269310415,0.5922003876186159,9/1075
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.4885064281864827,0.5954575396829316,2/2407
OUD_vs_Control_Female,DO,nicotine dependence,0.3232121696808214,0.5971903276190071,7/1094
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of innate immune response,0.21635965574572974,0.5973739491411666,48/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.21681139753539386,0.5973739491411666,17/1775
OUD_Effect_Male_vs_Female,GO_BP,axon regeneration,0.21705327587625237,0.5973739491411666,8/1775
OUD_vs_Control_Female,GO_BP,immune system development,0.3150462891263524,0.5982611668680369,28/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.1561325643013759,0.5983760713073035,10/1002
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.28758774891645605,0.5991390448487516,26/2013
OUD_vs_Control_Female,GO_BP,innate immune response activating cell surface receptor signaling pathway,0.31662884091758814,0.6008375389310585,14/2058
OUD_vs_Control_Female,Reactome,Serotonin Neurotransmitter Release Cycle,0.09494523365156948,0.602009542754179,5/1379
OUD_vs_Control_Female,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.09494523365156948,0.602009542754179,5/1379
OUD_vs_Control_Female,Reactome,Programmed Cell Death,0.0951827616701417,0.602009542754179,33/1379
OUD_vs_Control_Female,GO_BP,forebrain neuron development,0.3195817226715916,0.6043331632545961,6/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor localization to postsynaptic specialization membrane,0.3195817226715916,0.6043331632545961,6/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of postsynapse assembly,0.22243944074530456,0.6045225272122596,7/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to endoplasmic reticulum stress,0.22428678996060963,0.6045225272122596,13/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of T cell mediated immune response to tumor cell,0.2245486804002574,0.6045225272122596,3/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immunoglobulin mediated immune response,0.2245486804002574,0.6045225272122596,3/1775
OUD_Effect_Male_vs_Female,GO_BP,"complement activation, alternative pathway",0.2245486804002574,0.6045225272122596,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of response to osmotic stress,0.2245486804002574,0.6045225272122596,3/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of synapse organization,0.2245486804002574,0.6045225272122596,3/1775
OUD_vs_Control_Female,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.19865622008536699,0.6065528031295017,6/1231
OUD_vs_Control_Female,GO_BP,regulation of dendrite morphogenesis,0.3221291143006693,0.6066747209983911,10/2058
OUD_Effect_Male_vs_Female,GO_BP,intrinsic apoptotic signaling pathway in response to oxidative stress,0.22665535529901043,0.6069306782694336,9/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.296844798485547,0.6076199746045816,26/2013
OUD_Effect_Male_vs_Female,GO_BP,detection of stimulus involved in sensory perception of pain,0.23055686884064955,0.6086092273685632,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of protein localization to synapse,0.23055686884064955,0.6086092273685632,5/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,0.2310315381119005,0.6086092273685632,4/1775
OUD_Effect_Male_vs_Female,GO_MF,complement binding,0.1753754111184664,0.6103096823997426,4/1824
OUD_Effect_Male_vs_Female,GO_MF,structural constituent of synapse,0.18155769342219819,0.6103096823997426,5/1824
OUD_Effect_Male_vs_Female,GO_MF,cytokine activity,0.19242186995688892,0.6103096823997426,24/1824
OUD_Effect_Male_vs_Female,GO_MF,NMDA glutamate receptor activity,0.19358491136650433,0.6103096823997426,2/1824
OUD_Effect_Male_vs_Female,GO_MF,CCR5 chemokine receptor binding,0.19358491136650433,0.6103096823997426,2/1824
OUD_Effect_Male_vs_Female,WikiPathways,WP_GABA_METABOLISM_AKA_GHB,0.163027473749353,0.611462917374639,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.163027473749353,0.611462917374639,3/1002
OUD_Effect_Male_vs_Female,GO_BP,immune response-inhibiting cell surface receptor signaling pathway,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T cell mediated immune response to tumor cell,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,glutamate catabolic process,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron maturation,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,"regulation of complement activation, classical pathway",0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of translation in response to stress,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,microglial cell proliferation,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of dendrite development,0.2424075132040807,0.6127424147138987,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 2 cell cytokine production,0.2424075132040807,0.6127424147138987,2/1775
OUD_vs_Control_Female,DO,autoimmune hepatitis,0.3411059634466738,0.6154942315635574,4/1094
OUD_Effect_Male_vs_Female,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.166407743738029,0.6189056478926693,6/1002
OUD_Effect_Male_vs_Female,GO_MF,C-C chemokine binding,0.20022931864501542,0.6194360194785871,4/1824
OUD_vs_Control_Female,Reactome,Nicotinate metabolism,0.09967815039078332,0.619554298718685,7/1379
OUD_vs_Control_Female,DO,lipid metabolism disorder,0.3464481930108713,0.6196560749523895,19/1094
OUD_vs_Control_Female,DO,neuronal ceroid lipofuscinosis,0.3467235900306118,0.6196560749523895,5/1094
OUD_vs_Control_Female,KEGG,Arginine and proline metabolism,0.31899765309091094,0.6199728399054992,9/1075
OUD_Effect_Male_vs_Female,DO,adult respiratory distress syndrome,0.2421803195737796,0.6207101280132847,7/920
OUD_vs_Control_Female,GO_BP,B cell activation involved in immune response,0.332320065632877,0.622548435790857,14/2058
OUD_Effect_Male_vs_Female,GO_BP,neuron projection arborization,0.24752201915622732,0.6227280108860491,6/1775
OUD_Effect_Male_vs_Female,GO_CC,astrocyte end-foot,0.130352610830398,0.6235063373067476,3/1867
OUD_vs_Control_Female,GO_BP,neuron maturation,0.3335339611174411,0.6237486329073284,8/2058
OUD_vs_Control_Female,KEGG,beta-Alanine metabolism,0.32492864627818097,0.6244438788809734,6/1075
OUD_Effect_Male_vs_Female,Reactome,Cellular response to heat stress,0.05602290140529988,0.624733336682544,16/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of MITF-M-dependent genes involved in apoptosis,0.05727069524011435,0.624733336682544,5/1194
OUD_Effect_Male_vs_Female,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.058643394674165086,0.624733336682544,19/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of steroids,0.05916955654012331,0.624733336682544,24/1194
OUD_vs_Control_Female,GO_BP,regulation of postsynaptic membrane neurotransmitter receptor levels,0.3363430197767618,0.6254682120072061,18/2058
OUD_vs_Control_Female,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.3378874006255429,0.6254682120072061,9/2058
OUD_vs_Control_Female,GO_BP,dendritic cell cytokine production,0.33905189016381176,0.6254682120072061,3/2058
OUD_vs_Control_Female,GO_BP,regulation of dendritic cell cytokine production,0.33905189016381176,0.6254682120072061,3/2058
OUD_vs_Control_Female,GO_BP,neuron remodeling,0.33905189016381176,0.6254682120072061,3/2058
OUD_vs_Control_Female,GO_BP,response to morphine,0.33905189016381176,0.6254682120072061,3/2058
OUD_vs_Control_Female,GO_BP,regulation of short-term neuronal synaptic plasticity,0.33905189016381176,0.6254682120072061,3/2058
OUD_vs_Control_Female,GO_BP,programmed cell death in response to reactive oxygen species,0.33905189016381176,0.6254682120072061,3/2058
OUD_vs_Control_Female,GO_MF,AMPA glutamate receptor activity,0.1915566791204476,0.6258149196605962,2/2121
OUD_vs_Control_Female,GO_MF,opioid receptor binding,0.1915566791204476,0.6258149196605962,2/2121
OUD_Effect_Male_vs_Female,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.1750251979400336,0.6271390010255307,11/1002
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.31709066256235907,0.6277382435027307,24/2013
OUD_vs_Control_Female,GO_CC,paranode region of axon,0.1813448244700778,0.6312924433435345,3/2168
OUD_vs_Control_Female,GO_CC,juxtaparanode region of axon,0.1813448244700778,0.6312924433435345,3/2168
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendrite development,0.25291999464686615,0.6317361243613732,14/1775
OUD_Effect_Male_vs_Female,GO_BP,dendritic cell cytokine production,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,T cell mediated immune response to tumor cell,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendritic cell cytokine production,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron remodeling,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of short-term neuronal synaptic plasticity,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of astrocyte differentiation,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T-helper 17 type immune response,0.2577740466990393,0.6317361243613732,3/1775
OUD_Effect_Male_vs_Female,GO_BP,retinal ganglion cell axon guidance,0.25801975765894836,0.6317361243613732,4/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of chemokine production,0.25801975765894836,0.6317361243613732,4/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress-activated MAPK cascade,0.25801975765894836,0.6317361243613732,4/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.25801975765894836,0.6317361243613732,4/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine production involved in inflammatory response,0.25801975765894836,0.6317361243613732,4/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cellular response to oxidative stress,0.25801975765894836,0.6317361243613732,4/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine production,0.258253020165001,0.632096826393871,36/1775
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.3814207580420756,0.6329298137537439,28/2332
OUD_Effect_Male_vs_Female,GO_BP,L-glutamate import,0.2594375135194149,0.6339411667559125,7/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSIS,0.18418740570104064,0.6361296573739136,14/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.18809930313839013,0.6368384478452221,8/1002
OUD_vs_Control_Female,GO_BP,regulation of stress fiber assembly,0.3481793047099462,0.6376576579902138,14/2058
OUD_vs_Control_Female,GO_BP,innate immune response in mucosa,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of T cell tolerance induction,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of long-term neuronal synaptic plasticity,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,regulation of synapse structural plasticity,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,axonogenesis involved in innervation,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,anterograde axonal protein transport,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.35529028723181,0.6376576579902138,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of stress-activated MAPK cascade,0.3559564607817236,0.6376576579902138,4/2058
OUD_vs_Control_Female,GO_BP,positive regulation of stress-activated protein kinase signaling cascade,0.3559564607817236,0.6376576579902138,4/2058
OUD_vs_Control_Female,GO_BP,regulation of cellular response to oxidative stress,0.3559564607817236,0.6376576579902138,4/2058
OUD_vs_Control_Female,KEGG,Dopaminergic synapse,0.336566337870687,0.6385435166776868,21/1075
OUD_vs_Control_Female,DO,mineral metabolism disease,0.37984467408542144,0.6412326327988429,5/1094
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.543090097266076,0.6420462555914586,1/2407
OUD_Effect_Male_vs_Female,WikiPathways,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.19780340206742356,0.6427696232249268,7/1002
OUD_Effect_Male_vs_Female,KEGG,beta-Alanine metabolism,0.1840548922031685,0.6432625525484474,6/889
OUD_Effect_Male_vs_Female,KEGG,Starch and sucrose metabolism,0.1840548922031685,0.6432625525484474,6/889
OUD_vs_Control_Female,Reactome,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),0.10743311419502075,0.6449653510888789,6/1379
OUD_vs_Control_Female,KEGG,Riboflavin metabolism,0.3470884653892836,0.6453577876904172,2/1075
OUD_vs_Control_Female,KEGG,"Glycine, serine and threonine metabolism",0.34982442682765874,0.6453577876904172,7/1075
OUD_Effect_Male_vs_Female,GO_BP,mitochondrial outer membrane permeabilization involved in programmed cell death,0.2683595401997677,0.649912551257587,6/1775
OUD_Effect_Male_vs_Female,GO_CC,basal dendrite,0.15033043770461024,0.6543413920901193,2/1867
OUD_Effect_Male_vs_Female,GO_CC,glycinergic synapse,0.15033043770461024,0.6543413920901193,2/1867
OUD_Effect_Male_vs_Female,GO_MF,L-glutamate transmembrane transporter activity,0.22045380979879167,0.6559759935233406,3/1824
OUD_Effect_Male_vs_Female,GO_MF,chemokine receptor activity,0.22604758045658904,0.6559759935233406,4/1824
OUD_Effect_Male_vs_Female,GO_MF,G protein-coupled glutamate receptor binding,0.23906958176673557,0.6559759935233406,2/1824
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.4151997628917993,0.6582042752819608,5/2057
OUD_Effect_Male_vs_Female,WikiPathways,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.2078347972448786,0.6593078652095938,6/1002
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.40711364435852043,0.6604920663718653,26/2332
OUD_vs_Control_Female,KEGG,Carbon metabolism,0.36702139442534953,0.6610228255618861,18/1075
OUD_vs_Control_Female,DO,morphine dependence,0.41680544857111756,0.6634193729570925,4/1094
OUD_vs_Control_Female,DO,substance-induced psychosis,0.4195636790928109,0.6634193729570925,2/1094
OUD_Effect_Male_vs_Female,Reactome,Activation of kainate receptors upon glutamate binding,0.07263967084671344,0.6637412030757586,7/1194
OUD_Effect_Male_vs_Female,KEGG,Butanoate metabolism,0.19572942351629602,0.6639449072219453,5/889
OUD_Effect_Male_vs_Female,GO_BP,immune response to tumor cell,0.27726909327285537,0.6643714505038328,5/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of adaptive immune response,0.282846966976019,0.6643714505038328,17/1775
OUD_Effect_Male_vs_Female,GO_BP,production of molecular mediator of immune response,0.2849627073986145,0.6643714505038328,28/1775
OUD_Effect_Male_vs_Female,GO_BP,retrograde axonal transport,0.2855785184261635,0.6643714505038328,4/1775
OUD_Effect_Male_vs_Female,GO_BP,response to immobilization stress,0.2855785184261635,0.6643714505038328,4/1775
OUD_Effect_Male_vs_Female,GO_BP,assembly of actomyosin apparatus involved in cytokinesis,0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,intrinsic apoptotic signaling pathway in response to osmotic stress,0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,"regulation of synaptic transmission, dopaminergic",0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,astrocyte cell migration,0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of long-term neuronal synaptic plasticity,0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,axonogenesis involved in innervation,0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cardiac muscle hypertrophy in response to stress,0.2887544351799971,0.6643714505038328,2/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to arsenic-containing substance,0.2915827385759854,0.6643714505038328,3/1775
OUD_Effect_Male_vs_Female,GO_BP,synapse pruning,0.2915827385759854,0.6643714505038328,3/1775
OUD_Effect_Male_vs_Female,Reactome,Neurotransmitter release cycle,0.07331594843285726,0.6644257826727689,10/1194
OUD_vs_Control_Female,Reactome,TRIF-mediated programmed cell death,0.11944822153868097,0.6644881195942238,3/1379
OUD_vs_Control_Female,GO_BP,positive regulation of neuron projection development,0.3742551632946593,0.6646541335545395,23/2058
OUD_vs_Control_Female,GO_BP,anterograde axonal transport,0.3772469767191112,0.6665950304752479,8/2058
OUD_vs_Control_Female,GO_BP,cellular response to dopamine,0.3772469767191112,0.6665950304752479,8/2058
OUD_vs_Control_Female,GO_BP,cellular response to arsenic-containing substance,0.3788486132240184,0.6665950304752479,3/2058
OUD_Effect_Male_vs_Female,KEGG,"Alanine, aspartate and glutamate metabolism",0.20425853973083935,0.6667307051591549,6/889
OUD_Effect_Male_vs_Female,GO_CC,dendrite cytoplasm,0.1629257666444492,0.6681602589279895,5/1867
OUD_Effect_Male_vs_Female,GO_CC,parallel fiber to Purkinje cell synapse,0.1629257666444492,0.6681602589279895,5/1867
OUD_vs_Control_Female,Reactome,Regulation of Complement cascade,0.12260860758417066,0.6697780768340255,9/1379
OUD_vs_Control_Female,GO_MF,C-C chemokine receptor activity,0.222766931744237,0.6743432979020846,4/2121
OUD_Effect_Male_vs_Female,DO,substance dependence,0.2770650789954222,0.6773248046700673,18/920
OUD_Effect_Male_vs_Female,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.21727043121530112,0.6782107228672358,7/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.2178998589549628,0.6782107228672358,5/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.22804645181478475,0.6782107228672358,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.22804645181478475,0.6782107228672358,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.2335560105238163,0.6782107228672358,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.2335560105238163,0.6782107228672358,3/1002
OUD_Effect_Male_vs_Female,KEGG,Cholinergic synapse,0.20980931644528553,0.6784488176641943,17/889
OUD_Effect_Male_vs_Female,GO_BP,response to fluid shear stress,0.3013059997334782,0.6802043057212193,5/1775
OUD_vs_Control_Female,Reactome,Neurotransmitter receptors and postsynaptic signal transmission,0.12707196679480895,0.6835461455414953,34/1379
OUD_Effect_Male_vs_Female,GO_BP,innate immune response-activating signaling pathway,0.30419648719542486,0.6848378216474901,36/1775
OUD_Effect_Male_vs_Female,Reactome,Chondroitin sulfate/dermatan sulfate metabolism,0.08179100961907484,0.6852897061409543,10/1194
OUD_vs_Control_Female,GO_BP,response to arsenic-containing substance,0.39421612582011156,0.6885448819930726,5/2058
OUD_Effect_Male_vs_Female,GO_BP,immunoglobulin mediated immune response,0.30625068070741235,0.6888298949856324,17/1775
OUD_vs_Control_Female,KEGG,Histidine metabolism,0.39556455706466376,0.6907320184276362,4/1075
OUD_vs_Control_Female,GO_BP,execution phase of apoptosis,0.3981275849572858,0.6927989964239195,12/2058
OUD_vs_Control_Female,KEGG,Sulfur metabolism,0.405222116088623,0.6929782279057742,2/1075
OUD_vs_Control_Female,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.23561588653933102,0.6938096263707573,5/1231
OUD_vs_Control_Female,GO_BP,positive regulation of dendritic cell cytokine production,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,ventral spinal cord interneuron differentiation,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,olfactory bulb interneuron differentiation,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,cortisol metabolic process,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,regulation of translation in response to endoplasmic reticulum stress,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,regulation of translational initiation in response to stress,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of axon extension involved in axon guidance,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,response to nitrosative stress,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,AMPA glutamate receptor clustering,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,glutamate receptor clustering,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,regulation of axon guidance,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of response to oxidative stress,0.4072929308189397,0.6948152864608877,2/2058
OUD_vs_Control_Female,DO,cocaine dependence,0.4456862020853265,0.6950582437283068,5/1094
OUD_Effect_Male_vs_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.24313182830039407,0.695320190783324,5/1002
OUD_Effect_Male_vs_Female,GO_MF,cytokine binding,0.2816892468904742,0.6953702912212266,18/1824
OUD_Effect_Male_vs_Female,DO,autoimmune thrombocytopenic purpura,0.2915184621699697,0.6962211757506284,4/920
OUD_vs_Control_Female,GO_MF,complement component C3b binding,0.24508935180623728,0.6977543791218388,2/2121
OUD_vs_Control_Female,GO_MF,NMDA glutamate receptor activity,0.24508935180623728,0.6977543791218388,2/2121
OUD_vs_Control_Female,Reactome,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.13179039481574145,0.6982509171111121,7/1379
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.60935400856815225,0.6983417288736543,1/2407
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.60935400856815225,0.6983417288736543,1/2407
OUD_vs_Control_Female,WikiPathways,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.23972060202727696,0.7031175138201627,9/1231
OUD_vs_Control_Female,WikiPathways,WP_NAD_METABOLISM,0.24470957572715366,0.7038943394468319,4/1231
OUD_vs_Control_Female,WikiPathways,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.24470957572715366,0.7038943394468319,4/1231
OUD_vs_Control_Female,WikiPathways,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,0.24643102329142602,0.7050961371457385,2/1231
OUD_vs_Control_Female,WikiPathways,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.25101312824323624,0.7056173614732807,3/1231
OUD_vs_Control_Female,GO_BP,antifungal innate immune response,0.4180999680279789,0.7080185541283048,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of programmed necrotic cell death,0.4180999680279789,0.7080185541283048,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of dendrite development,0.4180999680279789,0.7080185541283048,3/2058
OUD_vs_Control_Female,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.42127160678931985,0.7085010297192307,8/2058
OUD_vs_Control_Female,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.42127160678931985,0.7085010297192307,8/2058
OUD_vs_Control_Female,GO_BP,antiviral innate immune response,0.42127160678931985,0.7085010297192307,8/2058
OUD_vs_Control_Female,GO_BP,response to dopamine,0.42127160678931985,0.7085010297192307,8/2058
OUD_vs_Control_Female,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.1363044308309702,0.7087658581228653,5/1379
OUD_Effect_Male_vs_Female,DO,autoimmune disease of the nervous system,0.3001335069141605,0.7099494001943524,5/920
OUD_Effect_Male_vs_Female,DO,cocaine dependence,0.3001335069141605,0.7099494001943524,5/920
OUD_Effect_Male_vs_Female,GO_BP,cytokine production involved in inflammatory response,0.3222642163172789,0.7103225447486615,8/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokine production involved in inflammatory response,0.3222642163172789,0.7103225447486615,8/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neurotransmitter secretion,0.3256570524666875,0.7103225447486615,3/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 1 type immune response,0.3256570524666875,0.7103225447486615,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of humoral immune response mediated by circulating immunoglobulin,0.3256570524666875,0.7103225447486615,3/1775
OUD_vs_Control_Female,KEGG,Glutathione metabolism,0.419238018049655,0.7104328975816814,8/1075
OUD_vs_Control_Female,GO_BP,stress fiber assembly,0.4247929140627324,0.7112876734262107,16/2058
OUD_Effect_Male_vs_Female,GO_BP,activation of innate immune response,0.33328948781766105,0.7117595008586828,38/1775
OUD_Effect_Male_vs_Female,GO_BP,immune response-inhibiting signal transduction,0.3347350256247701,0.7117595008586828,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of humoral immune response mediated by circulating immunoglobulin,0.3347350256247701,0.7117595008586828,2/1775
OUD_Effect_Male_vs_Female,GO_BP,amino acid neurotransmitter reuptake,0.3347350256247701,0.7117595008586828,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine-mediated signaling pathway,0.3347350256247701,0.7117595008586828,2/1775
OUD_Effect_Male_vs_Female,GO_BP,complement-dependent cytotoxicity,0.3347350256247701,0.7117595008586828,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon guidance,0.3347350256247701,0.7117595008586828,2/1775
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.623172216742756,0.712672857148759,4/2407
OUD_Effect_Male_vs_Female,GO_CC,axon hillock,0.19469787048057813,0.7133327151228078,2/1867
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLYCOSPHINGOLIPID_METABOLISM,0.25705635238403146,0.7135203898894992,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.25808110916344745,0.7137407964044059,7/1002
OUD_vs_Control_Female,DO,plasma protein metabolism disease,0.47590758529917054,0.7150650531408508,2/1094
OUD_vs_Control_Female,Reactome,Alternative complement activation,0.14607216374412751,0.716334514972579,2/1379
OUD_vs_Control_Female,Reactome,Drug-mediated inhibition of CDK4/CDK6 activity,0.14607216374412751,0.716334514972579,2/1379
OUD_vs_Control_Female,DO,autoimmune disease of gastrointestinal tract,0.4779860639218473,0.7172528565150286,5/1094
OUD_Effect_Male_vs_Female,DO,substance abuse,0.31060242696408863,0.7198280624060206,38/920
OUD_Effect_Male_vs_Female,DO,glucose intolerance,0.31167813011394707,0.7198280624060206,3/920
OUD_Effect_Male_vs_Female,GO_BP,regulation of long-term neuronal synaptic plasticity,0.3416967038813732,0.720315063642161,4/1775
OUD_vs_Control_Female,KEGG,Linoleic acid metabolism,0.43200316462232435,0.721403342864464,4/1075
OUD_Effect_Male_vs_Female,DO,autoimmune disease of blood,0.32277144025490045,0.7226224458629108,4/920
OUD_Effect_Male_vs_Female,DO,substance-induced psychosis,0.33319490382543104,0.7226224458629108,2/920
OUD_vs_Control_Female,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.2679202747315772,0.7258203806364546,5/1231
OUD_Effect_Male_vs_Female,Reactome,Triglyceride metabolism,0.09572347881641145,0.7274662786442309,7/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of lipids,0.10075826043290784,0.7274662786442309,97/1194
OUD_vs_Control_Female,Reactome,Regulation of pyruvate metabolism,0.14954949399812373,0.7286913017803314,7/1379
OUD_vs_Control_Female,Reactome,Neurotransmitter release cycle,0.1515384065788943,0.7305666990018819,10/1379
OUD_vs_Control_Female,Reactome,SARS-CoV-1 activates/modulates innate immune responses,0.15161759772171735,0.7305666990018819,8/1379
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.48390508743226957,0.7316716479105296,1/2057
OUD_Effect_Male_vs_Female,KEGG,Cysteine and methionine metabolism,0.24685867158947686,0.7322331004574685,8/889
OUD_Effect_Male_vs_Female,KEGG,Ether lipid metabolism,0.24760483454775667,0.7322331004574685,7/889
OUD_Effect_Male_vs_Female,KEGG,Complement and coagulation cascades,0.25148245185252993,0.737397697804876,12/889
OUD_Effect_Male_vs_Female,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.2756741731034572,0.7400463134284188,6/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.27935523089682035,0.7400463134284188,2/1002
OUD_Effect_Male_vs_Female,GO_BP,mast cell activation involved in immune response,0.35781809552698274,0.7433111525824724,7/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of microglial cell activation,0.3597125876244003,0.7433111525824724,3/1775
OUD_vs_Control_Female,GO_BP,positive regulation of response to endoplasmic reticulum stress,0.4486241671184228,0.7435765335627171,6/2058
OUD_vs_Control_Female,GO_BP,regulation of long-term neuronal synaptic plasticity,0.4541350615393476,0.7435765335627171,4/2058
OUD_vs_Control_Female,GO_BP,regulation of execution phase of apoptosis,0.4541350615393476,0.7435765335627171,4/2058
OUD_vs_Control_Female,GO_BP,somatic diversification of immune receptors,0.45422032326840267,0.7435765335627171,11/2058
OUD_vs_Control_Female,GO_BP,natural killer cell activation involved in immune response,0.4564904097832396,0.7435765335627171,3/2058
OUD_vs_Control_Female,GO_BP,neurotransmitter-gated ion channel clustering,0.4564904097832396,0.7435765335627171,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neuron migration,0.4564904097832396,0.7435765335627171,3/2058
OUD_vs_Control_Female,GO_BP,positive regulation of tolerance induction,0.4571575300872003,0.7435765335627171,2/2058
OUD_vs_Control_Female,GO_BP,dopamine uptake involved in synaptic transmission,0.4571575300872003,0.7435765335627171,2/2058
OUD_vs_Control_Female,GO_BP,regulation of dopamine receptor signaling pathway,0.4571575300872003,0.7435765335627171,2/2058
OUD_vs_Control_Female,GO_BP,chemokine (C-C motif) ligand 5 production,0.4571575300872003,0.7435765335627171,2/2058
OUD_vs_Control_Female,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.4571575300872003,0.7435765335627171,2/2058
OUD_Effect_Male_vs_Female,DO,autoimmune thyroiditis,0.3496912673236381,0.7436099293340769,3/920
OUD_vs_Control_Female,KEGG,Folate transport and metabolism,0.452783085290663,0.7452506284209955,5/1075
OUD_vs_Control_Female,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.2826674170232237,0.7456833182903019,4/1231
OUD_Effect_Male_vs_Female,Reactome,Keratan sulfate/keratin metabolism,0.10861867088785375,0.7457010950187228,7/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of commissural axon pathfinding by SLIT and ROBO,0.11060007812900949,0.7457010950187228,3/1194
OUD_Effect_Male_vs_Female,Reactome,NFE2L2 regulating inflammation associated genes,0.11396220179676249,0.7457010950187228,2/1194
OUD_Effect_Male_vs_Female,GO_MF,CXCR chemokine receptor binding,0.33055723558958183,0.7490816916241279,2/1824
OUD_Effect_Male_vs_Female,DO,motor neuron disease,0.3540199865190303,0.7491296305009566,21/920
OUD_vs_Control_Female,GO_CC,proximal dendrite,0.24591772501429535,0.7494635429007096,2/2168
OUD_Effect_Male_vs_Female,GO_MF,cytokine receptor activity,0.3329926030155448,0.7510513186952548,12/1824
OUD_Effect_Male_vs_Female,GO_BP,response to endoplasmic reticulum stress,0.36482592282395804,0.7524662541699976,34/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendrite morphogenesis,0.37478998041317346,0.7533293355093477,5/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokine production involved in immune response,0.3757206401948436,0.7533293355093477,11/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of production of molecular mediator of immune response,0.3780149670520498,0.7533293355093477,23/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to dopamine,0.3780265857879544,0.7533293355093477,7/1775
OUD_Effect_Male_vs_Female,GO_BP,T-helper 2 cell cytokine production,0.3797886031364597,0.7533293355093477,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopamine receptor signaling pathway,0.3797886031364597,0.7533293355093477,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of execution phase of apoptosis,0.3797886031364597,0.7533293355093477,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of T-helper 2 cell cytokine production,0.3797886031364597,0.7533293355093477,2/1775
OUD_Effect_Male_vs_Female,Reactome,"Unblocking of NMDA receptors, glutamate binding and activation",0.11799507186997867,0.7533739733849717,5/1194
OUD_Effect_Male_vs_Female,Reactome,Negative regulation of NMDA receptor-mediated neuronal transmission,0.11799507186997867,0.7533739733849717,5/1194
OUD_vs_Control_Female,GO_CC,parallel fiber to Purkinje cell synapse,0.2493114479090564,0.7542804533103088,5/2168
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.297827064764673,0.754889486414627,3/1231
OUD_vs_Control_Female,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.3011062477771397,0.754889486414627,5/1231
OUD_vs_Control_Female,WikiPathways,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.3020750260171726,0.754889486414627,8/1231
OUD_vs_Control_Female,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.3020750260171726,0.754889486414627,8/1231
OUD_vs_Control_Female,WikiPathways,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.3105587187458182,0.754889486414627,2/1231
OUD_vs_Control_Female,WikiPathways,WP_OXIDATIVE_STRESS_RESPONSE,0.3131018138283487,0.754889486414627,6/1231
OUD_Effect_Male_vs_Female,KEGG,Histidine metabolism,0.26401685056925195,0.7549572751814972,4/889
OUD_vs_Control_Female,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.316525443190401,0.7582361902792564,11/1231
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_STRESS_PATHWAY,0.12092530717930548,0.759759509946324,6/207
OUD_vs_Control_Female,GO_BP,presynapse assembly,0.4693211566915255,0.7599530719641475,7/2058
OUD_vs_Control_Female,GO_CC,dendrite terminus,0.2573807747547684,0.7620669202703462,3/2168
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.4589176624913278,0.7630876626818257,22/2013
OUD_vs_Control_Female,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.47687584033267727,0.7702212204864297,10/2058
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immune effector process,0.3913776896688142,0.7724001985142124,30/1775
OUD_Effect_Male_vs_Female,GO_BP,chemokine (C-X-C motif) ligand 2 production,0.3934987823022099,0.7724001985142124,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.3934987823022099,0.7724001985142124,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine (C-X-C motif) ligand 2 production,0.3934987823022099,0.7724001985142124,3/1775
OUD_vs_Control_Female,GO_BP,postsynaptic neurotransmitter receptor internalization,0.47947999536900743,0.7724617438083184,5/2058
OUD_vs_Control_Female,GO_BP,regulation of synapse maturation,0.4858534503715023,0.7733938494950586,4/2058
OUD_vs_Control_Female,GO_BP,receptor localization to synapse,0.4908662231682648,0.7733938494950586,11/2058
OUD_vs_Control_Female,GO_BP,regulation of cellular response to osmotic stress,0.5044933435335799,0.7733938494950586,2/2058
OUD_vs_Control_Female,GO_BP,dendrite arborization,0.5044933435335799,0.7733938494950586,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.5044933435335799,0.7733938494950586,2/2058
OUD_vs_Control_Female,GO_BP,interneuron migration,0.5044933435335799,0.7733938494950586,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.5044933435335799,0.7733938494950586,2/2058
OUD_vs_Control_Female,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.51679624997695,0.7733938494950586,4/2058
OUD_vs_Control_Female,GO_BP,response to endoplasmic reticulum stress,0.5177058674122903,0.7733938494950586,37/2058
OUD_vs_Control_Female,GO_BP,tolerance induction dependent upon immune response,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of T cell mediated immune response to tumor cell,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of translation in response to stress,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of translational initiation in response to stress,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,regulation of mast cell activation involved in immune response,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of translation in response to endoplasmic reticulum stress,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of dopamine receptor signaling pathway,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,regulation of astrocyte activation,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,microglial cell mediated cytotoxicity,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,NMDA glutamate receptor clustering,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,regulation of glutamate receptor clustering,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,"regulation of glutamate secretion, neurotransmission",0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,regulation of microglial cell mediated cytotoxicity,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,axonemal central apparatus assembly,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,regulation of AMPA glutamate receptor clustering,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,GO_BP,regulation of antifungal innate immune response,0.5214849430230565,0.7733938494950586,1/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.5207534366960855,0.7737452709921709,27/2332
OUD_Effect_Male_vs_Female,GO_BP,"synaptic transmission, dopaminergic",0.3980664838261563,0.7740527880674789,4/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.3980664838261563,0.7740527880674789,4/1775
OUD_Effect_Male_vs_Female,GO_BP,central nervous system neuron axonogenesis,0.3993922951347495,0.7740527880674789,5/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.47224132951094444,0.774666584975529,24/2013
OUD_vs_Control_Female,GO_BP,regulation of postsynapse assembly,0.5238308190767744,0.7758155451891485,6/2058
OUD_vs_Control_Female,KEGG,Apoptosis - multiple species,0.48402559512432297,0.7787368721836133,5/1075
OUD_vs_Control_Female,KEGG,Nitrogen metabolism,0.4867105451147583,0.7787368721836133,3/1075
OUD_vs_Control_Female,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.5269140622266713,0.7796240116512345,11/2058
OUD_Effect_Male_vs_Female,GO_CC,ribbon synapse,0.22206019760380746,0.7799635039803154,3/1867
OUD_Effect_Male_vs_Female,GO_CC,cholinergic synapse,0.22206019760380746,0.7799635039803154,3/1867
OUD_Effect_Male_vs_Female,DO,autoimmune disease of central nervous system,0.3833905869995624,0.780488795947891,2/920
OUD_Effect_Male_vs_Female,WikiPathways,WP_PHOSPHOINOSITIDES_METABOLISM,0.3009787112148129,0.780889783392384,8/1002
OUD_vs_Control_Female,DO,alcohol dependence,0.5365580077784405,0.78098998909973,9/1094
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.6972141308209328,0.7816386990427873,2/2407
OUD_vs_Control_Female,DO,complement deficiency,0.5467286716821476,0.7818871140516345,3/1094
OUD_Effect_Male_vs_Female,GO_MF,C-C chemokine receptor activity,0.35414482187273877,0.7821487242430005,3/1824
OUD_vs_Control_Female,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.05387466226387404,0.7827671517162875,5/265
OUD_Effect_Male_vs_Female,KEGG,Inositol phosphate metabolism,0.28636172611982685,0.7829510677793471,11/889
OUD_vs_Control_Female,WikiPathways,WP_AXON_GUIDANCE,0.34122771454243833,0.7885144069445096,13/1231
OUD_Effect_Male_vs_Female,GO_BP,antiviral innate immune response,0.4185184248840649,0.7914285210045485,7/1775
OUD_Effect_Male_vs_Female,GO_BP,response to dopamine,0.4185184248840649,0.7914285210045485,7/1775
OUD_Effect_Male_vs_Female,GO_BP,microglial cell activation,0.421299886744114,0.7914285210045485,6/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.4234920144608234,0.7914285210045485,2/1775
OUD_Effect_Male_vs_Female,GO_BP,stress response to copper ion,0.4234920144608234,0.7914285210045485,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of chemokine (C-X-C motif) ligand 2 production,0.4234920144608234,0.7914285210045485,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron migration,0.4234920144608234,0.7914285210045485,2/1775
OUD_Effect_Male_vs_Female,GO_BP,central nervous system projection neuron axonogenesis,0.4259847529904073,0.7914285210045485,4/1775
OUD_Effect_Male_vs_Female,GO_BP,peripheral nervous system axon ensheathment,0.4259847529904073,0.7914285210045485,4/1775
OUD_Effect_Male_vs_Female,GO_BP,detection of temperature stimulus involved in sensory perception of pain,0.426798390898514,0.7914285210045485,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of dendrite morphogenesis,0.43443359830736816,0.7914285210045485,8/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron cellular homeostasis,0.43443359830736816,0.7914285210045485,8/1775
OUD_Effect_Male_vs_Female,GO_BP,macrophage cytokine production,0.4481887448030444,0.7914285210045485,5/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of macrophage cytokine production,0.4481887448030444,0.7914285210045485,5/1775
OUD_Effect_Male_vs_Female,GO_BP,dopamine metabolic process,0.4481887448030444,0.7914285210045485,5/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to oxidative stress,0.4544378255047029,0.7914285210045485,28/1775
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immune receptors via somatic mutation,0.46553498476604205,0.7914285210045485,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of T cell tolerance induction,0.46553498476604205,0.7914285210045485,2/1775
OUD_Effect_Male_vs_Female,GO_BP,microglial cell activation involved in immune response,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,T cell proliferation involved in immune response,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,tolerance induction dependent upon immune response,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T cell mediated immune response to tumor cell,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of glutamate secretion,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,commitment of neuronal cell to specific neuron type in forebrain,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of translation in response to stress,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,C-X-C chemokine receptor CXCR4 signaling pathway,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dopamine receptor signaling pathway,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,microglial cell mediated cytotoxicity,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,NMDA selective glutamate receptor signaling pathway,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation protein catabolic process at postsynapse,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,pyroptotic cell death,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,"regulation of glutamate secretion, neurotransmission",0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of microglial cell mediated cytotoxicity,0.466894405525321,0.7914285210045485,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of inhibitory synapse assembly,0.466894405525321,0.7914285210045485,1/1775
OUD_vs_Control_Female,GO_BP,protein localization to synapse,0.5377400416319187,0.7915059880037099,12/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.33037942124370867,0.7918617874253969,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.33037942124370867,0.7918617874253969,2/1002
OUD_Effect_Male_vs_Female,KEGG,Choline metabolism in cancer,0.31186862662983567,0.7941168644010601,14/889
OUD_Effect_Male_vs_Female,KEGG,Sulfur metabolism,0.31334221868368084,0.7941168644010601,2/889
OUD_Effect_Male_vs_Female,KEGG,Nicotinate and nicotinamide metabolism,0.31464046196109374,0.7941168644010601,6/889
OUD_Effect_Male_vs_Female,KEGG,Arachidonic acid metabolism,0.3228855910224418,0.7941168644010601,8/889
OUD_Effect_Male_vs_Female,KEGG,Taurine and hypotaurine metabolism,0.3236140979206632,0.7941168644010601,3/889
OUD_Effect_Male_vs_Female,GO_CC,photoreceptor ribbon synapse,0.24037924177864478,0.7950286206686694,2/1867
OUD_Effect_Male_vs_Female,Reactome,Metabolism of fat-soluble vitamins,0.12768102058470776,0.7957866810831528,8/1194
OUD_Effect_Male_vs_Female,GO_BP,myeloid cell activation involved in immune response,0.47025129159647827,0.7960180091351203,11/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.49780134468461945,0.7975298097018961,23/2013
OUD_Effect_Male_vs_Female,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.3498304039717543,0.7979515256757538,4/1002
OUD_vs_Control_Female,GO_BP,axonemal dynein complex assembly,0.546836981308376,0.7979708957000299,4/2058
OUD_vs_Control_Female,GO_BP,regulation of T cell tolerance induction,0.5490567762063616,0.7979708957000299,2/2058
OUD_Effect_Male_vs_Female,KEGG,Drug metabolism - cytochrome P450,0.3302814098629597,0.7991424322558325,7/889
OUD_vs_Control_Female,Reactome,Negative regulation of NMDA receptor-mediated neuronal transmission,0.18417138267983976,0.7996674577404621,5/1379
OUD_vs_Control_Female,Reactome,Metabolism of water-soluble vitamins and cofactors,0.19031497342695064,0.7996674577404621,21/1379
OUD_Effect_Male_vs_Female,Reactome,Nicotinate metabolism,0.12985184579646555,0.8012135166164897,6/1194
OUD_vs_Control_Female,Reactome,Response of endothelial cells to shear stress,0.19544069997760094,0.8105312657326836,16/1379
OUD_vs_Control_Female,Reactome,RUNX3 Regulates Immune Response and Cell Migration,0.19952247757944971,0.8105312657326836,2/1379
OUD_Effect_Male_vs_Female,KEGG,"Glycine, serine and threonine metabolism",0.3379148053450169,0.811571676495363,6/889
OUD_vs_Control_Female,GO_BP,neuron projection arborization,0.5602828554988424,0.811962425862763,5/2058
OUD_vs_Control_Female,GO_BP,dopamine metabolic process,0.5857874099760191,0.8138003595939318,5/2058
OUD_vs_Control_Female,GO_BP,eosinophil activation involved in immune response,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,B cell proliferation involved in immune response,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,tolerance induction to self antigen,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,adenylate cyclase-inhibiting dopamine receptor signaling pathway,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,spinal cord motor neuron cell fate specification,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,cerebral cortex GABAergic interneuron migration,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,hypothalamic tangential migration using cell-axon interactions,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,olfactory bulb interneuron development,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,anterior/posterior axon guidance,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,dopaminergic neuron axon guidance,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,dopamine catabolic process,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of dopamine metabolic process,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,response to cortisol,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neurotransmitter uptake,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,phospholipase C-activating dopamine receptor signaling pathway,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,cellular response to nitrosative stress,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of chemokine (C-C motif) ligand 5 production,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of chemokine (C-C motif) ligand 5 production,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,intracellular glutamate homeostasis,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,sympathetic neuron projection extension,0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,"regulation of translation at synapse, modulating synaptic transmission",0.5870847290115022,0.8138003595939318,1/2058
OUD_vs_Control_Female,GO_BP,regulation of T cell mediated immune response to tumor cell,0.5907184177753511,0.8138003595939318,2/2058
OUD_vs_Control_Female,Reactome,Dopamine Neurotransmitter Release Cycle,0.21011163550476358,0.8141026535063186,5/1379
OUD_vs_Control_Female,Reactome,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.2105836880871944,0.8141026535063186,6/1379
OUD_vs_Control_Female,GO_BP,negative regulation of response to cytokine stimulus,0.5962154039343839,0.8188332509333833,11/2058
OUD_vs_Control_Female,GO_BP,regulation of oxidative phosphorylation,0.5970591933417371,0.8188332509333833,3/2058
OUD_vs_Control_Female,GO_BP,motor neuron axon guidance,0.5970591933417371,0.8188332509333833,3/2058
OUD_vs_Control_Female,GO_BP,axonal transport,0.5984001831533622,0.8205246075750062,9/2058
OUD_Effect_Male_vs_Female,GO_MF,NAD+-protein-glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824
OUD_Effect_Male_vs_Female,GO_MF,NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824
OUD_Effect_Male_vs_Female,GO_MF,NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824
OUD_Effect_Male_vs_Female,GO_MF,NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity,0.41872026318312894,0.8218151708480751,2/1824
OUD_Effect_Male_vs_Female,GO_MF,G protein-coupled opioid receptor activity,0.4636390673307542,0.8218151708480751,1/1824
OUD_Effect_Male_vs_Female,GO_MF,oxidative RNA demethylase activity,0.4636390673307542,0.8218151708480751,1/1824
OUD_Effect_Male_vs_Female,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.37221996969631155,0.8226582942844964,6/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.37694721068845416,0.8226582942844964,5/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.3803268023787313,0.8226582942844964,2/1002
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress fiber assembly,0.5013759445699122,0.8231513144131495,11/1775
OUD_Effect_Male_vs_Female,GO_BP,immunological synapse formation,0.505699368827006,0.8231513144131495,2/1775
OUD_Effect_Male_vs_Female,GO_BP,hydrogen peroxide-mediated programmed cell death,0.505699368827006,0.8231513144131495,2/1775
OUD_Effect_Male_vs_Female,GO_BP,commissural neuron axon guidance,0.505699368827006,0.8231513144131495,2/1775
OUD_Effect_Male_vs_Female,GO_BP,myeloid leukocyte cytokine production,0.5078702330857034,0.8231513144131495,6/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.5191661841845963,0.8231513144131495,5/1775
OUD_Effect_Male_vs_Female,GO_BP,spinal cord motor neuron differentiation,0.5220745216251592,0.8231513144131495,3/1775
OUD_Effect_Male_vs_Female,GO_BP,astrocyte activation,0.5220745216251592,0.8231513144131495,3/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neurotransmitter transport,0.5220745216251592,0.8231513144131495,3/1775
OUD_Effect_Male_vs_Female,GO_BP,eosinophil activation involved in immune response,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,B cell proliferation involved in immune response,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,adenylate cyclase-inhibiting dopamine receptor signaling pathway,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,spinal cord motor neuron cell fate specification,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex GABAergic interneuron migration,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,hypothalamic tangential migration using cell-axon interactions,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,olfactory bulb interneuron development,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of axon diameter,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,mast cell cytokine production,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of mast cell cytokine production,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,anterior/posterior axon guidance,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,dopamine catabolic process,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dopamine metabolic process,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,response to cortisol,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of chemokine (C-C motif) ligand 5 production,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,intracellular glutamate homeostasis,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,sympathetic neuron projection extension,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,anterograde axonal transport of mitochondrion,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,postsynapse to nucleus signaling pathway,0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,"regulation of translation at synapse, modulating synaptic transmission",0.5299281405501377,0.8231513144131495,1/1775
OUD_Effect_Male_vs_Female,GO_BP,stress fiber assembly,0.5305947706896994,0.8233174131693543,13/1775
OUD_vs_Control_Female,GO_MF,glutamate binding,0.35230815760236955,0.8236925360703444,2/2121
OUD_vs_Control_Female,GO_BP,protein localization to postsynapse,0.6025056960822339,0.8252627022223297,7/2058
OUD_Effect_Male_vs_Female,C2_Curated,SA_MMP_CYTOKINE_CONNECTION,0.08300641043834077,0.8265256505505465,4/42
OUD_vs_Control_Female,Reactome,Intrinsic Pathway for Apoptosis,0.21474447425759657,0.8265547707201584,10/1379
OUD_vs_Control_Female,GO_CC,nuclear stress granule,0.2999958343765481,0.8292243661172359,2/2168
OUD_Effect_Male_vs_Female,GO_BP,cellular response to toxic substance,0.5367458384403305,0.8299405671960312,14/1775
OUD_Effect_Male_vs_Female,GO_BP,immune effector process,0.5367665978569947,0.8299405671960312,70/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron fate commitment,0.5370070916772145,0.8299405671960312,7/1775
OUD_Effect_Male_vs_Female,GO_BP,humoral immune response,0.5378334144864614,0.8303832043387446,23/1775
OUD_Effect_Male_vs_Female,GO_BP,astrocyte development,0.5419651803928532,0.8303832043387446,5/1775
OUD_Effect_Male_vs_Female,GO_BP,T cell tolerance induction,0.543841726077462,0.8303832043387446,2/1775
OUD_Effect_Male_vs_Female,GO_BP,programmed cell death in response to reactive oxygen species,0.543841726077462,0.8303832043387446,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of execution phase of apoptosis,0.543841726077462,0.8303832043387446,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of motor neuron apoptotic process,0.543841726077462,0.8303832043387446,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neuron differentiation,0.54420540857042,0.8304213236588047,8/1775
OUD_Effect_Male_vs_Female,DO,substance-related disorder,0.4711360020531621,0.8311579642387953,47/920
OUD_Effect_Male_vs_Female,DO,autoimmune disease of gastrointestinal tract,0.5367003332067418,0.8311579642387953,4/920
OUD_Effect_Male_vs_Female,DO,autoimmune disease of skin and connective tissue,0.5633779352582933,0.8311579642387953,3/920
OUD_Effect_Male_vs_Female,DO,post-traumatic stress disorder,0.5636083335820965,0.8311579642387953,2/920
OUD_vs_Control_Female,DO,motor neuron disease,0.687698257386157,0.8317141911540835,21/1094
OUD_Effect_Male_vs_Female,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.3897396736621241,0.8335791887107753,7/1002
OUD_Effect_Male_vs_Female,Reactome,Metabolism of vitamins and cofactors,0.1548648372525865,0.833698638790623,28/1194
OUD_Effect_Male_vs_Female,Reactome,TP53 Regulates Transcription of Cell Death Genes,0.15547158059739485,0.833698638790623,8/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of water-soluble vitamins and cofactors,0.1563691135853563,0.833698638790623,19/1194
OUD_Effect_Male_vs_Female,Reactome,Glutamate Neurotransmitter Release Cycle,0.15637437987749672,0.833698638790623,5/1194
OUD_Effect_Male_vs_Female,Reactome,Surfactant metabolism,0.15637437987749672,0.833698638790623,5/1194
OUD_vs_Control_Female,GO_BP,neuron cellular homeostasis,0.6098207604814986,0.8340823725242548,8/2058
OUD_vs_Control_Female,KEGG,Drug metabolism - cytochrome P450,0.5322634076373768,0.8360667224988931,7/1075
OUD_Effect_Male_vs_Female,DO,lipid metabolism disorder,0.58695235519619815,0.8361097072299309,14/920
OUD_Effect_Male_vs_Female,GO_BP,regulation of neuron migration,0.5493688072244118,0.8370155093456967,6/1775
OUD_Effect_Male_vs_Female,GO_BP,neuronal stem cell population maintenance,0.5518669162429792,0.8370155093456967,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of immunoglobulin mediated immune response,0.5743869526366276,0.8370155093456967,7/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of humoral immune response,0.579878724291959,0.8370155093456967,2/1775
OUD_Effect_Male_vs_Female,GO_BP,dendrite self-avoidance,0.579878724291959,0.8370155093456967,2/1775
OUD_Effect_Male_vs_Female,GO_BP,response to L-glutamate,0.579878724291959,0.8370155093456967,2/1775
OUD_Effect_Male_vs_Female,GO_BP,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.5805264906559255,0.8370155093456967,3/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of execution phase of apoptosis,0.5805264906559255,0.8370155093456967,3/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of natural killer cell cytokine production,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of natural killer cell mediated immune response to tumor cell,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of humoral immune response mediated by circulating immunoglobulin,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,forebrain neuron fate commitment,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex GABAergic interneuron development,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,neuronal signal transduction,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of dendrite morphogenesis,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of stress granule assembly,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of chemokine-mediated signaling pathway,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,stress-induced premature senescence,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,anterograde dendritic transport of neurotransmitter receptor complex,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to L-glutamate,0.5855125486857389,0.8370155093456967,1/1775
OUD_Effect_Male_vs_Female,GO_BP,anterograde neuronal dense core vesicle transport,0.5855125486857389,0.8370155093456967,1/1775
OUD_vs_Control_Female,Reactome,Fatty acid metabolism,0.2237802542442257,0.8381654508693892,27/1379
OUD_vs_Control_Female,Reactome,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.22919703346684264,0.8381654508693892,3/1379
OUD_vs_Control_Female,Reactome,alpha-linolenic acid (ALA) metabolism,0.22919703346684264,0.8381654508693892,3/1379
OUD_Effect_Male_vs_Female,KEGG,Retinol metabolism,0.373135244618453,0.8383428223245761,7/889
OUD_vs_Control_Female,Reactome,Metabolism of porphyrins,0.23713229900732738,0.8392670300883076,5/1379
OUD_Effect_Male_vs_Female,GO_MF,dopamine receptor binding,0.5005759475203068,0.8395236679922763,2/1824
OUD_Effect_Male_vs_Female,GO_MF,complement component C1q complex binding,0.5264809443341394,0.8395236679922763,1/1824
OUD_Effect_Male_vs_Female,GO_MF,AMPA glutamate receptor activity,0.5264809443341394,0.8395236679922763,1/1824
OUD_Effect_Male_vs_Female,GO_MF,C-X-C chemokine receptor activity,0.5264809443341394,0.8395236679922763,1/1824
OUD_vs_Control_Female,GO_BP,axoneme assembly,0.6290518525785792,0.8434588441616417,11/2058
OUD_vs_Control_Female,GO_BP,T cell mediated immune response to tumor cell,0.6294363451002034,0.8434588441616417,2/2058
OUD_vs_Control_Female,GO_BP,T cell tolerance induction,0.6294363451002034,0.8434588441616417,2/2058
OUD_vs_Control_Female,GO_BP,calcium ion-regulated exocytosis of neurotransmitter,0.6294363451002034,0.8434588441616417,2/2058
OUD_vs_Control_Female,GO_BP,positive regulation of execution phase of apoptosis,0.6294363451002034,0.8434588441616417,2/2058
OUD_vs_Control_Female,GO_BP,glutamate metabolic process,0.6306155786548491,0.8434588441616417,4/2058
OUD_vs_Control_Female,GO_BP,stress-activated protein kinase signaling cascade,0.6428496346209455,0.8434588441616417,7/2058
OUD_vs_Control_Female,GO_BP,positive regulation of natural killer cell cytokine production,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,peripheral nervous system axon regeneration,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,cerebral cortex GABAergic interneuron development,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of cytokinesis,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of chemokine-mediated signaling pathway,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,stress-induced premature senescence,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,regulation of glutamate receptor signaling pathway,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,cellular response to L-glutamate,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,GO_BP,anterograde neuronal dense core vesicle transport,0.6436951898531736,0.8434588441616417,1/2058
OUD_vs_Control_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.402996231425479,0.8478878683244763,5/1231
OUD_vs_Control_Female,WikiPathways,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.40516520956176316,0.8478878683244763,7/1231
OUD_Effect_Male_vs_Female,GO_BP,execution phase of apoptosis,0.5991081570401642,0.8532998634838125,9/1775
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.6087825094477866,0.8552446326498316,25/2332
OUD_Effect_Male_vs_Female,GO_CC,NMDA selective glutamate receptor complex,0.2864531953902292,0.8557703582175401,2/1867
OUD_Effect_Male_vs_Female,KEGG,Glycerophospholipid metabolism,0.3948431607082083,0.8558524613782845,13/889
OUD_Effect_Male_vs_Female,GO_BP,response to oxidative stress,0.6019812622366241,0.8570600433121119,43/1775
OUD_vs_Control_Female,GO_BP,sperm axoneme assembly,0.6562168663744423,0.8571763348680501,4/2058
OUD_vs_Control_Female,GO_BP,regulation of presynapse assembly,0.6562168663744423,0.8571763348680501,4/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse maturation,0.6079961827336675,0.8577375772587199,3/1775
OUD_Effect_Male_vs_Female,GO_BP,immune system development,0.612960676474565,0.8577375772587199,21/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopamine metabolic process,0.6137749472019951,0.8577375772587199,2/1775
OUD_Effect_Male_vs_Female,GO_BP,GABAergic neuron differentiation,0.6137749472019951,0.8577375772587199,2/1775
OUD_Effect_Male_vs_Female,GO_BP,humoral immune response mediated by circulating immunoglobulin,0.6275409665633134,0.8577375772587199,5/1775
OUD_Effect_Male_vs_Female,GO_BP,"complement activation, lectin pathway",0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of immune response to tumor cell,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,noradrenergic neuron differentiation,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,interneuron migration from the subpallium to the cortex,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,substrate-independent telencephalic tangential interneuron migration,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron differentiation,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron development,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,ventral spinal cord interneuron fate commitment,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,"glutamate secretion, neurotransmission",0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to laminar fluid shear stress,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of synapse maturation,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter loading into synaptic vesicle,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation protein catabolic process at synapse,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of microglial cell activation,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of dopaminergic neuron differentiation,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse pruning,0.6345275537545473,0.8577375772587199,1/1775
OUD_Effect_Male_vs_Female,GO_MF,complement component C3b binding,0.5819636164954123,0.8583963343307331,1/1824
OUD_vs_Control_Female,GO_BP,cytokinetic process,0.6592992769862331,0.8585882360752501,6/2058
OUD_vs_Control_Female,KEGG,Nucleotide metabolism,0.5617540270398031,0.8595555863349469,12/1075
OUD_vs_Control_Female,KEGG,alpha-Linolenic acid metabolism,0.5654309070466219,0.8595555863349469,3/1075
OUD_Effect_Male_vs_Female,Reactome,Retinoid metabolism and transport,0.16860209269929669,0.8597670607449122,7/1194
OUD_Effect_Male_vs_Female,Reactome,SUMOylation of immune response proteins,0.16948281714684188,0.8597670607449122,3/1194
OUD_Effect_Male_vs_Female,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.4041977493659771,0.8608630179856658,5/1002
OUD_vs_Control_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.4310975257660099,0.8610256428216556,8/1231
OUD_vs_Control_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.4338278924947233,0.8610256428216556,2/1231
OUD_vs_Control_Female,WikiPathways,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.4338278924947233,0.8610256428216556,2/1231
OUD_vs_Control_Female,WikiPathways,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.4338278924947233,0.8610256428216556,2/1231
OUD_vs_Control_Female,WikiPathways,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.4338278924947233,0.8610256428216556,2/1231
OUD_vs_Control_Female,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.43683741989171454,0.8610256428216556,5/1231
OUD_vs_Control_Female,WikiPathways,WP_RETINOL_METABOLISM,0.4379163016116545,0.8610256428216556,3/1231
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron apoptotic process,0.6444742149304332,0.864196090008614,7/1775
OUD_Effect_Male_vs_Female,GO_BP,stress-activated protein kinase signaling cascade,0.6453112521731452,0.864196090008614,6/1775
OUD_Effect_Male_vs_Female,GO_BP,macrophage activation involved in immune response,0.6455327421491944,0.864196090008614,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of tolerance induction,0.6455327421491944,0.864196090008614,2/1775
OUD_Effect_Male_vs_Female,GO_BP,axonal transport of mitochondrion,0.6455327421491944,0.864196090008614,2/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to fluid shear stress,0.6455327421491944,0.864196090008614,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron migration,0.6455327421491944,0.864196090008614,2/1775
OUD_Effect_Male_vs_Female,DO,autoimmune disease of peripheral nervous system,0.7169542835658518,0.8659763903989839,1/920
OUD_Effect_Male_vs_Female,DO,autosomal recessive distal hereditary motor neuronopathy,0.7169542835658518,0.8659763903989839,1/920
OUD_vs_Control_Female,GO_BP,regulation of presynapse organization,0.6805943658234679,0.8686210086180843,4/2058
OUD_vs_Control_Female,GO_BP,vesicle-mediated transport in synapse,0.6899713640376712,0.8686210086180843,32/2058
OUD_vs_Control_Female,GO_BP,"complement activation, lectin pathway",0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,negative regulation of immune response to tumor cell,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of T cell mediated immune response to tumor cell,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,glutamate catabolic process,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,neuron-neuron synaptic transmission,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron differentiation,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,hypothalamus gonadotrophin-releasing hormone neuron development,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,retinal bipolar neuron differentiation,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,"glutamate secretion, neurotransmission",0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,cellular response to laminar fluid shear stress,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,positive regulation of neuron projection arborization,0.6925476415042177,0.8686210086180843,1/2058
OUD_vs_Control_Female,GO_BP,regulation of dopaminergic neuron differentiation,0.6925476415042177,0.8686210086180843,1/2058
OUD_Effect_Male_vs_Female,GO_BP,leukocyte activation involved in immune response,0.6501799425851783,0.8689939083616185,32/1775
OUD_vs_Control_Female,KEGG,Cocaine addiction,0.5810590870601098,0.8690622867333816,7/1075
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress-activated MAPK cascade,0.6514247005898188,0.8692359711244771,4/1775
OUD_Effect_Male_vs_Female,GO_BP,tolerance induction,0.6592277121499103,0.8696520095523677,3/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron projection development,0.6664006494082765,0.8696520095523677,17/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T-helper 17 type immune response,0.6751837962488398,0.8696520095523677,2/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of L-glutamate import across plasma membrane,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,innate immune response in mucosa,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,natural killer cell cytokine production,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of T cell tolerance induction,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of T cell cytokine production,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of natural killer cell cytokine production,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,adenylate cyclase-activating dopamine receptor signaling pathway,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,autophagic cell death,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of neurotransmitter transport,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of synapse structural plasticity,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,neuronal dense core vesicle exocytosis,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,protein localization to axon,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.677749193576366,0.8696520095523677,1/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.65875033644611,0.8705295237688498,19/2057
OUD_vs_Control_Female,GO_BP,mucosal immune response,0.6981858757755017,0.871530943261553,2/2058
OUD_vs_Control_Female,GO_BP,regulation of dopamine metabolic process,0.6981858757755017,0.871530943261553,2/2058
OUD_vs_Control_Female,GO_BP,dopamine uptake,0.6981858757755017,0.871530943261553,2/2058
OUD_vs_Control_Female,Reactome,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.25471076634669687,0.8716658326922953,2/1379
OUD_Effect_Male_vs_Female,GO_BP,cell activation involved in immune response,0.6814955664635013,0.8736970352691393,32/1775
OUD_Effect_Male_vs_Female,GO_BP,cytokinetic process,0.6849400357752187,0.876280042290265,5/1775
OUD_vs_Control_Female,GO_BP,positive regulation of dendrite morphogenesis,0.7037337928565357,0.8764454382256757,4/2058
OUD_vs_Control_Female,Reactome,Complement cascade,0.25791161290477976,0.877754277491727,9/1379
OUD_Effect_Male_vs_Female,DO,autoimmune hepatitis,0.7312824868881016,0.878235443777044,2/920
OUD_vs_Control_Female,KEGG,Ether lipid metabolism,0.6026637606842218,0.8813206864300118,6/1075
OUD_vs_Control_Female,KEGG,Fatty acid metabolism,0.6066026212799085,0.8813206864300118,8/1075
OUD_vs_Control_Female,KEGG,Ascorbate and aldarate metabolism,0.6071889612904442,0.8813206864300118,2/1075
OUD_vs_Control_Female,WikiPathways,WP_FOLATE_METABOLISM,0.44987440088797714,0.8817566386876263,10/1231
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.6926921636255674,0.8819025209392501,4/1775
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.6079165054761992,0.8822666710396314,22/2013
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of production of molecular mediator of immune response,0.6965250491421091,0.8857091522199537,14/1775
OUD_vs_Control_Female,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.5673323638572967,0.8864568185270261,31/703
OUD_Effect_Male_vs_Female,GO_BP,mature B cell differentiation involved in immune response,0.7054341383209192,0.886839164450275,3/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendritic cell cytokine production,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of natural killer cell mediated immune response to tumor cell,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,activation-induced cell death of T cells,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,ventral spinal cord interneuron differentiation,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,olfactory bulb interneuron differentiation,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of axon regeneration,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of axon extension involved in axon guidance,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of neuron projection regeneration,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of response to oxidative stress,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron projection maintenance,0.7158618789043212,0.886839164450275,1/1775
OUD_Effect_Male_vs_Female,GO_MF,structural constituent of postsynapse,0.6700325609961748,0.8895942784205991,2/1824
OUD_Effect_Male_vs_Female,GO_BP,programmed necrotic cell death,0.7197171792408616,0.8904154505158178,5/1775
OUD_vs_Control_Female,GO_BP,stress-activated MAPK cascade,0.7171856136507535,0.8911586980714175,6/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_AXON_GUIDANCE,0.44468028455626685,0.8917882933691809,10/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_APOPTOSIS_MODULATION_BY_HSP70,0.4568332174490429,0.8917882933691809,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.47313537702732456,0.8917882933691809,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_TLR4_SIGNALING_AND_TOLERANCE,0.47313537702732456,0.8917882933691809,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.47483297209855724,0.8917882933691809,2/1002
OUD_vs_Control_Female,WikiPathways,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.46533867970653797,0.8923219296924368,6/1231
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.48264393313034204,0.8923219296924368,8/1231
OUD_vs_Control_Female,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.49092459729258897,0.8923219296924368,2/1231
OUD_vs_Control_Female,WikiPathways,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.49107649821999877,0.8923219296924368,19/1231
OUD_Effect_Male_vs_Female,KEGG,alpha-Linolenic acid metabolism,0.4311326699836334,0.8925092613510252,3/889
OUD_vs_Control_Female,GO_BP,regulation of tolerance induction,0.728397809024534,0.8941119258306824,2/2058
OUD_vs_Control_Female,GO_BP,neuronal dense core vesicle exocytosis,0.7347048107882685,0.8941119258306824,1/2058
OUD_Effect_Male_vs_Female,GO_BP,"complement activation, classical pathway",0.7266677046262628,0.8949835702918156,3/1775
OUD_Effect_Male_vs_Female,GO_BP,axonal fasciculation,0.7283985930342364,0.8949835702918156,2/1775
OUD_Effect_Male_vs_Female,GO_BP,motor neuron apoptotic process,0.7283985930342364,0.8949835702918156,2/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron projection fasciculation,0.7283985930342364,0.8949835702918156,2/1775
OUD_vs_Control_Female,DO,autoimmune disease of central nervous system,0.8157351704596183,0.8957360212088012,1/1094
OUD_vs_Control_Female,DO,autosomal dominant distal hereditary motor neuronopathy,0.8157351704596183,0.8957360212088012,1/1094
OUD_Effect_Male_vs_Female,KEGG,Intestinal immune network for IgA production,0.4551887018038626,0.8960653972767224,6/889
OUD_Effect_Male_vs_Female,KEGG,Sphingolipid metabolism,0.4591210784129647,0.8960653972767224,7/889
OUD_Effect_Male_vs_Female,KEGG,Caffeine metabolism,0.4876583544356029,0.8960653972767224,1/889
OUD_Effect_Male_vs_Female,KEGG,Vitamin B6 metabolism,0.4876583544356029,0.8960653972767224,1/889
OUD_Effect_Male_vs_Female,KEGG,Apoptosis,0.4893666140338495,0.8960653972767224,17/889
OUD_Effect_Male_vs_Female,KEGG,Galactose metabolism,0.5001827556726479,0.8960653972767224,4/889
OUD_Effect_Male_vs_Female,KEGG,Folate transport and metabolism,0.5001827556726479,0.8960653972767224,4/889
OUD_Effect_Male_vs_Female,KEGG,Pyruvate metabolism,0.5010158685167916,0.8960653972767224,6/889
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of immunoglobulin mediated immune response,0.7303520331554696,0.8961860533631095,4/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine-mediated signaling pathway,0.7307600677856456,0.896387641521585,8/1775
OUD_Effect_Male_vs_Female,GO_BP,lymphocyte activation involved in immune response,0.7347459769590043,0.8980212985296928,22/1775
OUD_Effect_Male_vs_Female,GO_BP,stress-activated MAPK cascade,0.7360435862166509,0.8980212985296928,5/1775
OUD_Effect_Male_vs_Female,GO_BP,sperm axoneme assembly,0.7466817653356216,0.8980212985296928,3/1775
OUD_Effect_Male_vs_Female,GO_BP,antimicrobial humoral immune response mediated by antimicrobial peptide,0.7493078175553807,0.8980212985296928,7/1775
OUD_Effect_Male_vs_Female,GO_BP,natural killer cell mediated immune response to tumor cell,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of tolerance induction,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,cerebral cortex GABAergic interneuron differentiation,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of stress granule assembly,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,chemokine (C-C motif) ligand 5 production,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of chemokine (C-C motif) ligand 5 production,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,"neurotransmitter receptor transport, endosome to postsynaptic membrane",0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,"neurotransmitter receptor transport, endosome to plasma membrane",0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of motor neuron apoptotic process,0.749469206481107,0.8980212985296928,1/1775
OUD_Effect_Male_vs_Female,GO_BP,somatic recombination of immunoglobulin genes involved in immune response,0.751664250629147,0.8980212985296928,5/1775
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immunoglobulins involved in immune response,0.751664250629147,0.8980212985296928,5/1775
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.7149230852697888,0.9024800675164927,3/2057
OUD_Effect_Male_vs_Female,GO_MF,complement receptor activity,0.712378249437175,0.9031840890792119,1/1824
OUD_Effect_Male_vs_Female,GO_MF,toxic substance binding,0.712378249437175,0.9031840890792119,1/1824
OUD_Effect_Male_vs_Female,WikiPathways,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,0.5016125424975176,0.9080339185945148,1/1002
OUD_vs_Control_Female,DO,calcium metabolism disease,0.8410163770145713,0.9104560886609848,2/1094
OUD_vs_Control_Female,WikiPathways,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.5126093522728992,0.9114414497453696,4/1231
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of type 2 immune response,0.7791034966647696,0.9117432327715801,1/1775
OUD_Effect_Male_vs_Female,GO_BP,dopamine biosynthetic process,0.7791034966647696,0.9117432327715801,1/1775
OUD_Effect_Male_vs_Female,GO_BP,neuronal ion channel clustering,0.7791034966647696,0.9117432327715801,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cellular response to osmotic stress,0.7791034966647696,0.9117432327715801,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of response to cytokine stimulus,0.779741672041723,0.9122946390479174,8/1775
OUD_Effect_Male_vs_Female,GO_BP,cytoskeleton-dependent cytokinesis,0.7820342148919002,0.91260232878238,12/1775
OUD_Effect_Male_vs_Female,GO_BP,stress granule assembly,0.7831742036916584,0.91260232878238,3/1775
OUD_Effect_Male_vs_Female,GO_MF,axon guidance receptor activity,0.7460878216935904,0.9138393385602852,1/1824
OUD_vs_Control_Female,GO_BP,tolerance induction,0.7586160970965202,0.9147346543587455,3/2058
OUD_vs_Control_Female,GO_BP,negative regulation of stress fiber assembly,0.7586160970965202,0.9147346543587455,3/2058
OUD_vs_Control_Female,GO_BP,regulation of protein localization to synapse,0.7586160970965202,0.9147346543587455,3/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.5169087401002856,0.915342594579284,6/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.518701510566692,0.915342594579284,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.518701510566692,0.915342594579284,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.5261704450959063,0.915342594579284,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_POSTCOVID_NEUROINFLAMMATION,0.5261704450959063,0.915342594579284,3/1002
OUD_vs_Control_Female,GO_BP,regulation of stress-activated MAPK cascade,0.7657585365565172,0.9169939315412361,4/2058
OUD_vs_Control_Female,GO_BP,regulation of cellular response to stress,0.7664050685890073,0.9169939315412361,64/2058
OUD_vs_Control_Female,GO_BP,activation-induced cell death of T cells,0.7710839085626385,0.9169939315412361,1/2058
OUD_vs_Control_Female,GO_BP,neuron projection maintenance,0.7710839085626385,0.9169939315412361,1/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.5589456027696038,0.9177202638066796,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.5589456027696038,0.9177202638066796,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.5600505721633462,0.9177202638066796,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_ENERGY_METABOLISM,0.5624521793169271,0.9177202638066796,6/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.5664339641508778,0.9177202638066796,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.5664339641508778,0.9177202638066796,1/1002
OUD_vs_Control_Female,GO_CC,NMDA selective glutamate receptor complex,0.3533668526890522,0.9187538169915358,2/2168
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.6890452863905674,0.9202381127452972,24/2332
OUD_vs_Control_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.5253242660020844,0.920862536874242,3/1231
OUD_Effect_Male_vs_Female,GO_BP,immunoglobulin production involved in immunoglobulin-mediated immune response,0.7943654387646439,0.9219753514461033,5/1775
OUD_Effect_Male_vs_Female,KEGG,Amino sugar and nucleotide sugar metabolism,0.525338213077693,0.9220637815624453,5/889
OUD_Effect_Male_vs_Female,KEGG,Linoleic acid metabolism,0.5318347477740493,0.9220637815624453,3/889
OUD_Effect_Male_vs_Female,KEGG,Phenylalanine metabolism,0.538297491550622,0.9220637815624453,2/889
OUD_Effect_Male_vs_Female,KEGG,Phosphonate and phosphinate metabolism,0.5518273771049111,0.9220637815624453,1/889
OUD_Effect_Male_vs_Female,KEGG,D-Amino acid metabolism,0.5518273771049111,0.9220637815624453,1/889
OUD_Effect_Male_vs_Female,KEGG,Serotonergic synapse,0.5616507805226271,0.9220637815624453,13/889
OUD_Effect_Male_vs_Female,KEGG,Metabolism of xenobiotics by cytochrome P450,0.5669467458850628,0.9220637815624453,6/889
OUD_Effect_Male_vs_Female,KEGG,Purine metabolism,0.5713657191373053,0.9220637815624453,15/889
OUD_Effect_Male_vs_Female,KEGG,Viral protein interaction with cytokine and cytokine receptor,0.5728795039123766,0.9220637815624453,9/889
OUD_vs_Control_Female,Reactome,Vitamin B5 (pantothenate) metabolism,0.3025533302376636,0.9230491629006676,4/1379
OUD_vs_Control_Female,Reactome,STING mediated induction of host immune responses,0.3098175232645972,0.9230491629006676,3/1379
OUD_vs_Control_Female,Reactome,Defects in cobalamin (B12) metabolism,0.3098175232645972,0.9230491629006676,3/1379
OUD_vs_Control_Female,Reactome,Na+/Cl- dependent neurotransmitter transporters,0.3098175232645972,0.9230491629006676,3/1379
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immune receptors,0.7983498175766324,0.924234953972218,7/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of cellular response to stress,0.8017309524675413,0.924234953972218,54/1775
OUD_Effect_Male_vs_Female,GO_BP,complement receptor mediated signaling pathway,0.8052342059896633,0.924234953972218,1/1775
OUD_Effect_Male_vs_Female,GO_BP,cellular response to salt stress,0.8052342059896633,0.924234953972218,1/1775
OUD_vs_Control_Female,GO_BP,organ or tissue specific immune response,0.7811453756618336,0.9246284889535643,2/2058
OUD_Effect_Male_vs_Female,GO_BP,cytokinesis,0.8080684670616106,0.9258986719486129,18/1775
OUD_Effect_Male_vs_Female,GO_BP,neuron fate specification,0.8128026461153224,0.9271345319755268,2/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of macrophage cytokine production,0.8128026461153224,0.9271345319755268,2/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of cytokine production involved in inflammatory response,0.8128026461153224,0.9271345319755268,2/1775
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.7667170967408933,0.9281455139759224,1/2057
OUD_vs_Control_Female,KEGG,Drug metabolism - other enzymes,0.6485006341624705,0.9295175756328744,8/1075
OUD_vs_Control_Female,WikiPathways,WP_AMINO_ACID_METABOLISM,0.5392407287751704,0.9299483979944818,13/1231
OUD_Effect_Male_vs_Female,Reactome,Opioid Signalling,0.19449580892277543,0.9303421962614848,14/1194
OUD_Effect_Male_vs_Female,Reactome,Chemokine receptors bind chemokines,0.20305774834920617,0.9303421962614848,7/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases associated with surfactant metabolism,0.20371286021587687,0.9303421962614848,2/1194
OUD_Effect_Male_vs_Female,KEGG,Tyrosine metabolism,0.5811227278887587,0.930872517821808,4/889
OUD_vs_Control_Female,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.5460390019614324,0.9308902893850506,12/1231
OUD_Effect_Male_vs_Female,KEGG,Arginine and proline metabolism,0.5879736911887551,0.9321276520840835,6/889
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.6925741361466744,0.9331363914011608,21/2013
OUD_vs_Control_Female,GO_BP,regulation of stress-activated protein kinase signaling cascade,0.8011443315636617,0.9336703216361603,4/2058
OUD_vs_Control_Female,GO_BP,negative regulation of motor neuron apoptotic process,0.8024765464101823,0.9336703216361603,1/2058
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.7761350563058471,0.9351523180816161,3/2057
OUD_Effect_Male_vs_Female,DO,neuronal ceroid lipofuscinosis,0.8572468389777448,0.9378049047269031,2/920
OUD_Effect_Male_vs_Female,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.6126530581158824,0.9399137212069147,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_AMINO_ACID_METABOLISM,0.6197378761455316,0.9399137212069147,10/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.6228318828735598,0.9399137212069147,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.6228318828735598,0.9399137212069147,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.6237483210584392,0.9399137212069147,7/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.6237483210584392,0.9399137212069147,7/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.6309820345127024,0.9399137212069147,5/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_NAD_METABOLISM,0.6349086063781808,0.9399137212069147,2/1002
OUD_Effect_Male_vs_Female,GO_BP,somatic diversification of immune receptors via germline recombination within a single locus,0.8400860733477392,0.9415287998261042,6/1775
OUD_Effect_Male_vs_Female,GO_BP,G protein-coupled glutamate receptor signaling pathway,0.8485920345407538,0.9415287998261042,1/1775
OUD_Effect_Male_vs_Female,GO_BP,calcium ion-regulated exocytosis of neurotransmitter,0.8485920345407538,0.9415287998261042,1/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.8485920345407538,0.9415287998261042,1/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.6425572420155424,0.942907958903134,7/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.6485701379187183,0.942907958903134,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.6485701379187183,0.942907958903134,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.6536700853500519,0.942907958903134,9/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.6684238873013392,0.942907958903134,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.6684238873013392,0.942907958903134,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SERINE_METABOLISM,0.6718999760130941,0.942907958903134,1/1002
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.7094009390677593,0.944282351748449,19/2013
OUD_Effect_Male_vs_Female,DO,nicotine dependence,0.8675403086390263,0.9447049474903387,3/920
OUD_Effect_Male_vs_Female,DO,mineral metabolism disease,0.8720431146053792,0.9453937059767573,2/920
OUD_Effect_Male_vs_Female,KEGG,Platinum drug resistance,0.6126485929771097,0.9456601618742306,8/889
OUD_Effect_Male_vs_Female,KEGG,Glycerolipid metabolism,0.6197012030994233,0.9456601618742306,7/889
OUD_vs_Control_Female,GO_BP,regulation of programmed necrotic cell death,0.8173118792708194,0.9459754724822719,3/2058
OUD_vs_Control_Female,GO_BP,response to salt stress,0.8246761213081701,0.9479153431304179,2/2058
OUD_vs_Control_Female,GO_BP,dopamine biosynthetic process,0.8295659284898734,0.9479153431304179,1/2058
OUD_vs_Control_Female,GO_BP,neuronal ion channel clustering,0.8295659284898734,0.9479153431304179,1/2058
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of stress fiber assembly,0.8598506583435298,0.9492334684498915,2/1775
OUD_Effect_Male_vs_Female,GO_BP,axonemal dynein complex assembly,0.8598506583435298,0.9492334684498915,2/1775
OUD_Effect_Male_vs_Female,GO_BP,neurotransmitter receptor transport to plasma membrane,0.866506255224007,0.9492334684498915,1/1775
OUD_vs_Control_Female,DO,post-traumatic stress disorder,0.9063947112232524,0.9493282901394718,1/1094
OUD_vs_Control_Female,GO_MF,structural constituent of postsynapse,0.4893738947677809,0.9539202792898327,3/2121
OUD_vs_Control_Female,GO_MF,oxidative phosphorylation uncoupler activity,0.5191286585621491,0.9539202792898327,1/2121
OUD_vs_Control_Female,GO_MF,dopamine binding,0.5191286585621491,0.9539202792898327,1/2121
OUD_Effect_Male_vs_Female,KEGG,Nitrogen metabolism,0.6468485192589506,0.9540399774818855,2/889
OUD_Effect_Male_vs_Female,Reactome,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.2166235486332042,0.9542404420804439,4/1194
OUD_vs_Control_Female,KEGG,Glyoxylate and dicarboxylate metabolism,0.686082033964508,0.9555150594485455,4/1075
OUD_Effect_Male_vs_Female,Reactome,Defects in cobalamin (B12) metabolism,0.23509772434530612,0.9555669870812552,3/1194
OUD_Effect_Male_vs_Female,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.23509772434530612,0.9555669870812552,3/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of Complement cascade,0.2399290451515796,0.9555669870812552,7/1194
OUD_Effect_Male_vs_Female,Reactome,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.24390062843119317,0.9555669870812552,4/1194
OUD_Effect_Male_vs_Female,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.24525569630160945,0.9555669870812552,5/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases of Immune System,0.24525569630160945,0.9555669870812552,5/1194
OUD_Effect_Male_vs_Female,Reactome,MECP2 regulates transcription of neuronal ligands,0.25097362821616875,0.9555669870812552,2/1194
OUD_vs_Control_Female,WikiPathways,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.5804770119224101,0.9563930791517988,6/1231
OUD_vs_Control_Female,WikiPathways,WP_BENZENE_METABOLISM,0.5811028648125514,0.9563930791517988,1/1231
OUD_vs_Control_Female,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.5935204955446665,0.9563930791517988,2/1231
OUD_vs_Control_Female,WikiPathways,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.5935204955446665,0.9563930791517988,2/1231
OUD_vs_Control_Female,WikiPathways,WP_PURINE_METABOLISM,0.5935204955446665,0.9563930791517988,2/1231
OUD_vs_Control_Female,WikiPathways,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.5956595821831338,0.9563930791517988,5/1231
OUD_Effect_Male_vs_Female,GO_BP,mucosal immune response,0.8823019619753827,0.9568462002844205,1/1775
OUD_Effect_Male_vs_Female,GO_BP,antifungal innate immune response,0.8823019619753827,0.9568462002844205,1/1775
OUD_Effect_Male_vs_Female,GO_BP,negative regulation of programmed necrotic cell death,0.8823019619753827,0.9568462002844205,1/1775
OUD_Effect_Male_vs_Female,GO_BP,dopamine uptake,0.8823019619753827,0.9568462002844205,1/1775
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of dendrite development,0.8823019619753827,0.9568462002844205,1/1775
OUD_vs_Control_Female,GO_BP,retrograde axonal transport,0.8433816290549281,0.9588116221658787,2/2058
OUD_vs_Control_Female,GO_BP,spinal cord motor neuron differentiation,0.8433816290549281,0.9588116221658787,2/2058
OUD_vs_Control_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.737232377086017,0.9596035642968407,24/2332
OUD_vs_Control_Female,GO_BP,somatic diversification of immune receptors via somatic mutation,0.852941691180166,0.9597956657880521,1/2058
OUD_vs_Control_Female,GO_BP,microglia differentiation,0.852941691180166,0.9597956657880521,1/2058
OUD_vs_Control_Female,GO_BP,cellular response to salt stress,0.852941691180166,0.9597956657880521,1/2058
OUD_Effect_Male_vs_Female,WikiPathways,WP_CODEINE_AND_MORPHINE_METABOLISM,0.7145900453592673,0.9608327658505841,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP697,0.7145900453592673,0.9608327658505841,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.7145900453592673,0.9608327658505841,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.7244328752694784,0.9608327658505841,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_ONECARBON_METABOLISM,0.7244328752694784,0.9608327658505841,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.7279421749225616,0.9608327658505841,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.7279421749225616,0.9608327658505841,2/1002
OUD_Effect_Male_vs_Female,GO_BP,axoneme assembly,0.888774248248987,0.9615967337262871,7/1775
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.8164882220507101,0.9623737257024221,2/2057
OUD_vs_Control_Female,GO_CC,axonemal dynein complex,0.3763085661790013,0.9633499294182434,3/2168
OUD_vs_Control_Female,GO_CC,axonemal A tubule inner sheath,0.3763085661790013,0.9633499294182434,3/2168
OUD_vs_Control_Female,Reactome,Pyruvate metabolism,0.3313187557669169,0.9633601045741409,8/1379
OUD_vs_Control_Female,Reactome,Metabolism of vitamins and cofactors,0.3321182332563913,0.9633601045741409,29/1379
OUD_vs_Control_Female,GO_MF,complement component C1q complex binding,0.5846430544504895,0.9635323749058365,1/2121
OUD_vs_Control_Female,GO_MF,C-X-C chemokine receptor activity,0.5846430544504895,0.9635323749058365,1/2121
OUD_vs_Control_Female,GO_MF,type 5 metabotropic glutamate receptor binding,0.5846430544504895,0.9635323749058365,1/2121
OUD_vs_Control_Female,GO_MF,dopamine receptor binding,0.5870985796917284,0.9635323749058365,2/2121
OUD_vs_Control_Female,GO_MF,neurotransmitter receptor regulator activity,0.5870985796917284,0.9635323749058365,2/2121
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.7447325696293036,0.9642085534013085,20/2013
OUD_Effect_Male_vs_Female,GO_BP,neutrophil activation involved in immune response,0.896229563141629,0.9644138166652059,1/1775
OUD_Effect_Male_vs_Female,GO_BP,natural killer cell activation involved in immune response,0.896229563141629,0.9644138166652059,1/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.7466872629590533,0.9650540512460403,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_B12_METABOLISM,0.7489707038301517,0.9650540512460403,5/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.751730405690438,0.9650540512460403,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,0.751730405690438,0.9650540512460403,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.751730405690438,0.9650540512460403,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.7541481989869719,0.9650540512460403,2/1002
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_CYTOKINE_PATHWAY,0.536657761484878,0.9651268939024387,2/207
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_UCALPAIN_PATHWAY,0.8702401119762995,0.9651268939024387,1/207
OUD_Effect_Male_vs_Female,BioCarta,BIOCARTA_MCALPAIN_PATHWAY,0.919233823428686,0.9651268939024387,1/207
OUD_vs_Control_Female,GO_BP,neuronal stem cell population maintenance,0.8602558719709847,0.9651889987594497,2/2058
OUD_vs_Control_Female,KEGG,Autoimmune thyroid disease,0.7018058346135323,0.9656848284282203,5/1075
OUD_Effect_Male_vs_Female,KEGG,Cobalamin transport and metabolism,0.6782333436242218,0.965714966641896,2/889
OUD_Effect_Male_vs_Female,KEGG,Nucleotide metabolism,0.6851150535082156,0.9665000195866035,9/889
OUD_Effect_Male_vs_Female,KEGG,Porphyrin metabolism,0.6990365528369973,0.9665000195866035,3/889
OUD_Effect_Male_vs_Female,KEGG,Pyrimidine metabolism,0.7018283013845148,0.9665000195866035,6/889
OUD_Effect_Male_vs_Female,KEGG,Carbon metabolism,0.7146915278296846,0.9665000195866035,12/889
OUD_Effect_Male_vs_Female,KEGG,Glutathione metabolism,0.71727761084676,0.9665000195866035,5/889
OUD_Effect_Male_vs_Female,KEGG,Drug metabolism - other enzymes,0.7346553547740607,0.9665000195866035,6/889
OUD_Effect_Male_vs_Female,KEGG,Cytokine-cytokine receptor interaction,0.7348416124977775,0.9665000195866035,26/889
OUD_Effect_Male_vs_Female,KEGG,Glyoxylate and dicarboxylate metabolism,0.7435388648786458,0.9665000195866035,3/889
OUD_Effect_Male_vs_Female,KEGG,Apoptosis - multiple species,0.7435388648786458,0.9665000195866035,3/889
OUD_vs_Control_Female,C8_CellType,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.9083518055981372,0.9670308628073192,5/2407
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.7535060026129333,0.9670920033535857,19/2013
OUD_vs_Control_Female,GO_BP,cytoskeleton-dependent cytokinesis,0.8624439226661768,0.9673443320495168,13/2058
OUD_vs_Control_Female,GO_BP,mitotic cytokinetic process,0.8634036487824159,0.9678170430172778,3/2058
OUD_vs_Control_Female,Reactome,Glycosphingolipid metabolism,0.3385350786851271,0.9682653713937214,9/1379
OUD_Effect_Male_vs_Female,DO,complement deficiency,0.920024142617543,0.9684060466116208,1/920
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.7781458572912947,0.9686802596664248,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.7781458572912947,0.9686802596664248,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_OXIDATIVE_DAMAGE_RESPONSE,0.7821523534993224,0.9686802596664248,4/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_FOLATE_METABOLISM,0.7827554640893696,0.9686802596664248,6/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.7840418920520669,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.7840418920520669,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.804882944159252,0.9686802596664248,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.8121517938660223,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.8121517938660223,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.8121517938660223,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PURINE_METABOLISM,0.8121517938660223,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.8121517938660223,0.9686802596664248,1/1002
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.761103087187685,0.9703797842583664,20/2013
OUD_vs_Control_Female,KEGG,Choline metabolism in cancer,0.7120985273327354,0.9720710055653213,13/1075
OUD_Effect_Male_vs_Female,GO_BP,B cell activation involved in immune response,0.9139172606120611,0.9733182886384336,7/1775
OUD_vs_Control_Female,GO_BP,neuron fate specification,0.8754491938821394,0.9743273684687691,2/2058
OUD_Effect_Male_vs_Female,GO_BP,organ or tissue specific immune response,0.9193376576773757,0.9754813712054592,1/1775
OUD_vs_Control_Female,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.6639438248257061,0.975653047345619,24/703
OUD_Effect_Male_vs_Female,DO,calcium metabolism disease,0.9396219613460062,0.9759860820193574,1/920
OUD_Effect_Male_vs_Female,WikiPathways,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.8366059841409665,0.9762558238430136,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.8366059841409665,0.9762558238430136,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,0.838209643964338,0.9763307721505311,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.8499294670176004,0.9763307721505311,22/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.854700035794392,0.9763307721505311,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.8763856194980515,0.9763307721505311,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GLUTATHIONE_METABOLISM,0.8763856194980515,0.9763307721505311,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.8763856194980515,0.9763307721505311,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.8763856194980515,0.9763307721505311,1/1002
OUD_Effect_Male_vs_Female,KEGG,Cortisol synthesis and secretion,0.7648342301834453,0.9765042200866129,6/889
OUD_vs_Control_Female,GO_MF,D1 dopamine receptor binding,0.6412353382245317,0.9767315342928717,1/2121
OUD_vs_Control_Female,WikiPathways,WP_NEUROINFLAMMATION,0.6386985486299297,0.9773031147206447,2/1231
OUD_vs_Control_Female,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.6408739071364711,0.9773031147206447,3/1231
OUD_vs_Control_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.6458635084047541,0.9773031147206447,4/1231
OUD_vs_Control_Female,WikiPathways,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.6480372331167764,0.9773031147206447,1/1231
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of myeloid leukocyte cytokine production involved in immune response,0.9230548294606152,0.9776884030361213,2/1775
OUD_Effect_Male_vs_Female,GO_BP,mitotic cytokinetic process,0.9230548294606152,0.9776884030361213,2/1775
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor transport to postsynaptic membrane,0.8905181670049557,0.9785165721403271,1/2058
OUD_vs_Control_Female,GO_BP,regulation of neuron projection arborization,0.8905181670049557,0.9785165721403271,1/2058
OUD_vs_Control_Female,GO_BP,midbrain dopaminergic neuron differentiation,0.8905181670049557,0.9785165721403271,1/2058
OUD_vs_Control_Female,GO_BP,regulation of motor neuron apoptotic process,0.8905181670049557,0.9785165721403271,1/2058
OUD_vs_Control_Female,Reactome,IL-6-type cytokine receptor ligand interactions,0.3506203370838553,0.9797901545453831,3/1379
OUD_Effect_Male_vs_Female,KEGG,Thiamine metabolism,0.7705214126737852,0.9801485617100355,1/889
OUD_vs_Control_Female,Reactome,Axonal growth inhibition (RHOA activation),0.3645845054988839,0.9805873779396587,2/1379
OUD_Effect_Male_vs_Female,GO_BP,response to salt stress,0.9373021766360985,0.9849888267596336,1/1775
OUD_Effect_Male_vs_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.9063822763096996,0.986164735432086,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.9064878495230035,0.986164735432086,1/1002
OUD_vs_Control_Female,GO_BP,neurotransmitter receptor transport to plasma membrane,0.9055370719712136,0.9863211160631846,1/2058
OUD_Effect_Male_vs_Female,GO_BP,regulation of cytokinesis,0.9421706584255358,0.9875278508061739,6/1775
OUD_vs_Control_Female,KEGG,"Alanine, aspartate and glutamate metabolism",0.7353478122739736,0.988123622743152,4/1075
OUD_vs_Control_Female,WikiPathways,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.6578702110089757,0.9881316677453365,6/1231
OUD_vs_Control_Female,GO_MF,G protein-coupled glutamate receptor binding,0.6901200772471303,0.988247227811545,1/2121
OUD_vs_Control_Female,Reactome,Metabolism of fat-soluble vitamins,0.3702493971034118,0.9882681176098655,7/1379
OUD_Effect_Male_vs_Female,Reactome,Axon guidance,0.26471309636236784,0.9884137074474679,68/1194
OUD_vs_Control_Female,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.3709852690567736,0.9887319519255526,12/1379
OUD_vs_Control_Female,WikiPathways,WP_COMPLEMENT_ACTIVATION,0.6746820373797071,0.9916166978567831,3/1231
OUD_vs_Control_Female,WikiPathways,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.6746820373797071,0.9916166978567831,3/1231
OUD_vs_Control_Female,WikiPathways,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.679825585412362,0.9916166978567831,2/1231
OUD_vs_Control_Female,WikiPathways,WP_BENZOAPYRENE_METABOLISM,0.7042836521786024,0.9916166978567831,1/1231
OUD_vs_Control_Female,WikiPathways,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.7042836521786024,0.9916166978567831,1/1231
OUD_vs_Control_Female,WikiPathways,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.7042836521786024,0.9916166978567831,1/1231
OUD_vs_Control_Female,WikiPathways,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.706080326913617,0.9916166978567831,3/1231
OUD_vs_Control_Female,GO_BP,regulation of receptor localization to synapse,0.9123397810760844,0.99190581108429,2/2058
OUD_vs_Control_Female,GO_BP,cytokinesis,0.9146407970020124,0.9929304578546203,19/2058
OUD_Effect_Male_vs_Female,GO_CC,AMPA glutamate receptor complex,0.39387187045684047,0.9934453705884699,4/1867
OUD_vs_Control_Female,WikiPathways,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.71704239830477845,0.9947794911304655,2/1231
OUD_vs_Control_Female,WikiPathways,WP_TAMOXIFEN_METABOLISM,0.71704239830477845,0.9947794911304655,2/1231
OUD_Effect_Male_vs_Female,Reactome,TRIF-mediated programmed cell death,0.29845889992263763,0.9958094216021639,2/1194
OUD_Effect_Male_vs_Female,Reactome,Defective Intrinsic Pathway for Apoptosis,0.30036247014636397,0.9958094216021639,4/1194
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.79539873365478575,0.9959348831575728,23/2332
OUD_vs_Control_Female,KEGG,Pyrimidine metabolism,0.7469688549169679,0.9959584732226238,7/1075
OUD_Effect_Male_vs_Female,GO_BP,positive regulation of cytokinesis,0.9627827580002906,0.9960949194805458,2/1775
OUD_vs_Control_Female,GO_CC,A axonemal microtubule,0.4186505023857535,0.9969483581218336,4/2168
OUD_vs_Control_Female,BioCarta,BIOCARTA_STRESS_PATHWAY,0.2762022006038704,0.9975439503508445,6/265
OUD_vs_Control_Female,BioCarta,BIOCARTA_UCALPAIN_PATHWAY,0.7257260666704921,0.9975439503508445,2/265
OUD_vs_Control_Female,BioCarta,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.8428150398603254,0.9975439503508445,1/265
OUD_vs_Control_Female,BioCarta,BIOCARTA_MCALPAIN_PATHWAY,0.9630613537844721,0.9975439503508445,1/265
OUD_Effect_Male_vs_Female,WikiPathways,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.9292651769758236,0.9980017192272359,1/1002
OUD_vs_Control_Female,GO_BP,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,0.9296787989516169,0.9987710908239025,1/2058
OUD_vs_Control_Female,DO,combined oxidative phosphorylation deficiency,0.995814459082619,0.9988644267980329,3/1094
OUD_Effect_Male_vs_Female,GO_BP,mitotic cytokinesis,0.9705049719219684,0.9990882631193323,6/1775
OUD_Effect_Male_vs_Female,DO,combined oxidative phosphorylation deficiency,0.9968349337311172,0.99921742089483,2/920
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_COMPLEMENT,0.580394744027459,0.9993379550137019,26/572
OUD_Effect_Male_vs_Female,KEGG,Ascorbate and aldarate metabolism,0.8244505397701458,0.9998429074110091,1/889
OUD_Effect_Male_vs_Female,KEGG,Selenocompound metabolism,0.8657167920443896,0.9998429074110091,1/889
OUD_Effect_Male_vs_Female,KEGG,Autoimmune thyroid disease,0.8712916638963368,0.9998429074110091,3/889
OUD_Effect_Male_vs_Female,KEGG,Tryptophan metabolism,0.89278586376089,0.9998429074110091,3/889
OUD_Effect_Male_vs_Female,KEGG,Lipoic acid metabolism,0.8972909353088535,0.9998429074110091,1/889
OUD_Effect_Male_vs_Female,KEGG,Propanoate metabolism,0.92314798885224425,0.9998429074110091,2/889
OUD_Effect_Male_vs_Female,KEGG,2-Oxocarboxylic acid metabolism,0.9765194365652856,0.9998429074110091,1/889
OUD_Effect_Male_vs_Female,KEGG,Oxidative phosphorylation,0.9997891278313353,0.9998429074110091,5/889
OUD_Effect_Male_vs_Female,WikiPathways,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.9384818600278685,0.9999949020973222,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_DOPAMINERGIC_NEUROGENESIS,0.9595366173210302,0.9999949020973222,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.9693996892576788,0.9999949020973222,1/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.9736737567735776,0.9999949020973222,2/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.9872541020922327,0.9999949020973222,3/1002
OUD_Effect_Male_vs_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.9949694185304736,0.9999949020973222,4/1002
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_XENOBIOTIC_METABOLISM,0.668185932816598,0.999996471122097,24/572
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_FATTY_ACID_METABOLISM,0.7797033483751998,0.999996471122097,18/572
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.9355759862639872,0.999996471122097,10/572
OUD_Effect_Male_vs_Female,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9999895380738487,0.999996471122097,10/572
OUD_vs_Control_Female,KEGG,Cobalamin transport and metabolism,0.7808638151894791,0.9999998197716712,2/1075
OUD_vs_Control_Female,KEGG,Sphingolipid metabolism,0.8049566644644051,0.9999998197716712,6/1075
OUD_vs_Control_Female,KEGG,Glycerolipid metabolism,0.8099880249521856,0.9999998197716712,7/1075
OUD_vs_Control_Female,KEGG,Pyruvate metabolism,0.8321974132953532,0.9999998197716712,5/1075
OUD_vs_Control_Female,KEGG,Retinol metabolism,0.859520322915743,0.9999998197716712,5/1075
OUD_vs_Control_Female,KEGG,Cholesterol metabolism,0.8717231502216275,0.9999998197716712,5/1075
OUD_vs_Control_Female,KEGG,Tyrosine metabolism,0.882733304888603,0.9999998197716712,3/1075
OUD_vs_Control_Female,KEGG,Butanoate metabolism,0.9101569915325672,0.9999998197716712,2/1075
OUD_vs_Control_Female,KEGG,Lipoic acid metabolism,0.9387721696475948,0.9999998197716712,1/1075
OUD_vs_Control_Female,KEGG,2-Oxocarboxylic acid metabolism,0.9397936418258491,0.9999998197716712,2/1075
OUD_vs_Control_Female,KEGG,Cysteine and methionine metabolism,0.9461147177548278,0.9999998197716712,4/1075
OUD_vs_Control_Female,KEGG,Tryptophan metabolism,0.953980872156524,0.9999998197716712,3/1075
OUD_vs_Control_Female,KEGG,Propanoate metabolism,0.965134569585263,0.9999998197716712,2/1075
OUD_vs_Control_Female,KEGG,Glycerophospholipid metabolism,0.9922923108209163,0.9999998197716712,7/1075
OUD_vs_Control_Female,KEGG,Oxidative phosphorylation,0.9999997901926629,0.9999998197716712,3/1075
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.8406161713771506,0.9999998600952271,19/2013
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.9271183899799089,0.9999998600952271,17/2013
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.9950182760838346,0.9999998600952271,12/2013
OUD_Effect_Male_vs_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.9993887516418052,0.9999998600952271,10/2013
OUD_vs_Control_Female,C7_Immunologic,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.9329475503190946,0.9999998722760689,20/2332
OUD_vs_Control_Female,C7_Immunologic,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.9701029716315648,0.9999998722760689,18/2332
OUD_vs_Control_Female,C7_Immunologic,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.9701029716315648,0.9999998722760689,18/2332
OUD_vs_Control_Female,C7_Immunologic,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.9779668713794416,0.9999998722760689,17/2332
OUD_vs_Control_Female,C7_Immunologic,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.9917763723812991,0.9999998722760689,15/2332
OUD_vs_Control_Female,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.9591650478695737,0.9999998880762061,27/2407
OUD_vs_Control_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.9995253708958711,0.9999998880762061,9/2407
OUD_vs_Control_Female,WikiPathways,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.7515475867628845,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_SERINE_METABOLISM,0.7515475867628845,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.7654027407397174,0.9999999154747237,6/1231
OUD_vs_Control_Female,WikiPathways,WP_ENERGY_METABOLISM,0.7654027407397174,0.9999999154747237,6/1231
OUD_vs_Control_Female,WikiPathways,WP_TRYPTOPHAN_METABOLISM,0.7750277062329513,0.9999999154747237,4/1231
OUD_vs_Control_Female,WikiPathways,WP_CHOLESTEROL_METABOLISM,0.7792448628572693,0.9999999154747237,9/1231
OUD_vs_Control_Female,WikiPathways,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.7805779473363981,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,0.7862859687600271,0.9999999154747237,3/1231
OUD_vs_Control_Female,WikiPathways,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.7862859687600271,0.9999999154747237,3/1231
OUD_vs_Control_Female,WikiPathways,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.8246334320190509,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_GLYOXYLATE_METABOLISM,0.8246334320190509,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_D_METABOLISM,0.8246334320190509,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.8312365125849783,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_ESTROGEN_METABOLISM_WP5276,0.8312365125849783,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.8312365125849783,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_ONECARBON_METABOLISM,0.8474504734115476,0.9999999154747237,3/1231
OUD_vs_Control_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.8523879131903681,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.8523879131903681,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.8526729495128227,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_GABA_METABOLISM_AKA_GHB,0.8526729495128227,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.8532302497370442,0.9999999154747237,5/1231
OUD_vs_Control_Female,WikiPathways,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.8641541322331294,0.9999999154747237,3/1231
OUD_vs_Control_Female,WikiPathways,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.8762322635099279,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.8960267397499276,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.8960267397499276,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.8960267397499276,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.9126575977758943,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.9454573708120502,0.9999999154747237,6/1231
OUD_vs_Control_Female,WikiPathways,WP_LIPID_METABOLISM_PATHWAY,0.9518449432313779,0.9999999154747237,2/1231
OUD_vs_Control_Female,WikiPathways,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.9742339201823429,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,0.9847360031874046,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.9871810233664944,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.9871810233664944,0.9999999154747237,1/1231
OUD_vs_Control_Female,WikiPathways,WP_PYRIMIDINE_METABOLISM,0.9923718694185908,0.9999999154747237,6/1231
OUD_vs_Control_Female,WikiPathways,WP_OXIDATIVE_PHOSPHORYLATION,0.9995887809112886,0.9999999154747237,2/1231
OUD_Effect_Male_vs_Female,DO,mitochondrial metabolism disease,0.9999999549662354,0.9999999549662354,6/920
OUD_Effect_Male_vs_Female,C8_CellType,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.8945848861568821,0.999999988220885,1/2057
OUD_Effect_Male_vs_Female,C8_CellType,ZHONG_PFC_C1_MICROGLIA,0.9203617731074665,0.999999988220885,24/2057
OUD_Effect_Male_vs_Female,C8_CellType,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.995687238494966,0.999999988220885,9/2057
OUD_vs_Control_Female,DO,mitochondrial metabolism disease,0.9999999899970164,0.9999999899970164,8/1094
OUD_Effect_Male_vs_Female,GO_CC,cytoplasmic stress granule,0.41185055168554663,0.9999999997244939,12/1867
OUD_Effect_Male_vs_Female,GO_CC,dendrite terminus,0.4625116823805727,0.9999999997244939,2/1867
OUD_Effect_Male_vs_Female,GO_CC,neuronal dense core vesicle membrane,0.46491677665782727,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,myelin sheath abaxonal region,0.5278340444484707,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.5766829631084606,0.9999999997244939,2/1867
OUD_Effect_Male_vs_Female,GO_CC,cerebellar climbing fiber to Purkinje cell synapse,0.6323535255856635,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,stress fiber,0.6809791620907444,0.9999999997244939,9/1867
OUD_Effect_Male_vs_Female,GO_CC,axoneme,0.7390008163346489,0.9999999997244939,15/1867
OUD_Effect_Male_vs_Female,GO_CC,paranode region of axon,0.7474155192672902,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,dopaminergic synapse,0.8264797782465974,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,dynein axonemal particle,0.8468945651905512,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,axonemal dynein complex,0.864908671996024,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,axonemal A tubule inner sheath,0.864908671996024,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,axonemal microtubule,0.9131525678754352,0.9999999997244939,2/1867
OUD_Effect_Male_vs_Female,GO_CC,immunological synapse,0.9325095721279043,0.9999999997244939,3/1867
OUD_Effect_Male_vs_Female,GO_CC,A axonemal microtubule,0.9503875190551228,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,axonemal microtubule doublet inner sheath,0.9562281459498883,0.9999999997244939,1/1867
OUD_Effect_Male_vs_Female,GO_CC,axonemal doublet microtubule,0.9699402747416551,0.9999999997244939,1/1867
OUD_vs_Control_Female,Hallmark,HALLMARK_BILE_ACID_METABOLISM,0.7400128511700577,0.9999999999615625,16/703
OUD_vs_Control_Female,Hallmark,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.9999999999615625,0.9999999999615625,6/703
OUD_Effect_Male_vs_Female,GO_BP,cellular component disassembly involved in execution phase of apoptosis,0.9771217173074442,0.9999999999639921,1/1775
OUD_Effect_Male_vs_Female,GO_BP,regulation of programmed necrotic cell death,0.9798313290896079,0.9999999999639921,1/1775
OUD_Effect_Male_vs_Female,GO_BP,oxidative phosphorylation,0.9999700084605535,0.9999999999639921,4/1775
OUD_vs_Control_Female,Reactome,Oxidative Stress Induced Senescence,0.38384634630509845,0.9999999999999936,10/1379
OUD_vs_Control_Female,Reactome,NRIF signals cell death from the nucleus,0.39112829285146156,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Sema3A PAK dependent Axon repulsion,0.39112829285146156,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Diseases of programmed cell death,0.39448409248455574,0.9999999999999936,7/1379
OUD_vs_Control_Female,Reactome,p75NTR regulates axonogenesis,0.4173125422444557,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Regulation of commissural axon pathfinding by SLIT and ROBO,0.4173125422444557,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Apoptosis,0.4241523593712902,0.9999999999999936,23/1379
OUD_vs_Control_Female,Reactome,Metabolism of folate and pterines,0.43095986345782844,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Translocation of ZAP-70 to Immunological synapse,0.43095986345782844,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Surfactant metabolism,0.43696337029814325,0.9999999999999936,4/1379
OUD_vs_Control_Female,Reactome,Retinoid metabolism and transport,0.441876545888668,0.9999999999999936,6/1379
OUD_vs_Control_Female,Reactome,Creatine metabolism,0.46771897228863957,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",0.46771897228863957,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.46971198093307165,0.9999999999999936,4/1379
OUD_vs_Control_Female,Reactome,Class C/3 (Metabotropic glutamate/pheromone receptors),0.46979931606674696,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Integration of energy metabolism,0.47374746895066744,0.9999999999999936,15/1379
OUD_vs_Control_Female,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.483016754517838,0.9999999999999936,10/1379
OUD_vs_Control_Female,Reactome,Diseases of metabolism,0.502077506376009,0.9999999999999936,35/1379
OUD_vs_Control_Female,Reactome,Regulation of lipid metabolism by PPARalpha,0.5029073534874324,0.9999999999999936,16/1379
OUD_vs_Control_Female,Reactome,SUMOylation of immune response proteins,0.5154233600529988,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Metabolism of amino acids and derivatives,0.5222679279707914,0.9999999999999936,46/1379
OUD_vs_Control_Female,Reactome,NFE2L2 regulating inflammation associated genes,0.5287965807347825,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Cellular responses to stress,0.553099831336535,0.9999999999999936,97/1379
OUD_vs_Control_Female,Reactome,DNA Damage/Telomere Stress Induced Senescence,0.5630086767052324,0.9999999999999936,4/1379
OUD_vs_Control_Female,Reactome,Cellular response to heat stress,0.5662288936294846,0.9999999999999936,12/1379
OUD_vs_Control_Female,Reactome,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.5780951612010765,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Phenylalanine metabolism,0.5946514013658494,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,TLR3-mediated TICAM1-dependent programmed cell death,0.5946514013658494,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.6019265564020291,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Defects in vitamin and cofactor metabolism,0.6109526201646591,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Defective Intrinsic Pathway for Apoptosis,0.6420467844269072,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Apoptosis induced DNA fragmentation,0.6513081738690416,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Vitamin B2 (riboflavin) metabolism,0.6513081738690416,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Fructose metabolism,0.6513081738690416,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Diseases associated with surfactant metabolism,0.6513081738690416,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Cobalamin (Cbl) metabolism,0.6513081738690416,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Sphingolipid metabolism,0.6543018632572066,0.9999999999999936,13/1379
OUD_vs_Control_Female,Reactome,Drug ADME,0.6555076110453562,0.9999999999999936,11/1379
OUD_vs_Control_Female,Reactome,Metabolism of nucleotides,0.6622967594406203,0.9999999999999936,12/1379
OUD_vs_Control_Female,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.6713444150167309,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Peptide hormone metabolism,0.6918366828571194,0.9999999999999936,9/1379
OUD_vs_Control_Female,Reactome,Diseases of carbohydrate metabolism,0.6960084720510874,0.9999999999999936,4/1379
OUD_vs_Control_Female,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.6963218263863138,0.9999999999999936,5/1379
OUD_vs_Control_Female,Reactome,MECP2 regulates transcription of neuronal ligands,0.7000508021746261,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Cellular response to chemical stress,0.7254320086742836,0.9999999999999936,24/1379
OUD_vs_Control_Female,Reactome,Regulation of MITF-M-dependent genes involved in apoptosis,0.738819642225585,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,PI Metabolism,0.7402583564650185,0.9999999999999936,10/1379
OUD_vs_Control_Female,Reactome,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.7598350685096052,0.9999999999999936,13/1379
OUD_vs_Control_Female,Reactome,Initial triggering of complement,0.7660463916477183,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Metabolism of steroid hormones,0.7707699091785103,0.9999999999999936,3/1379
OUD_vs_Control_Female,Reactome,Caspase activation via Dependence Receptors in the absence of ligand,0.7780587055940538,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Phenylalanine and tyrosine metabolism,0.7780587055940538,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Diseases of the neuronal system,0.7780587055940538,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Vitamin D (calciferol) metabolism,0.8357898897311041,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Bile acid and bile salt metabolism,0.8570741450525277,0.9999999999999936,4/1379
OUD_vs_Control_Female,Reactome,Metabolism of lipids,0.8587356212553808,0.9999999999999936,90/1379
OUD_vs_Control_Female,Reactome,Glutamate and glutamine metabolism,0.8785120995569426,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,FOXO-mediated transcription of cell death genes,0.9101252896454916,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Metabolism of steroids,0.9126368063990484,0.9999999999999936,15/1379
OUD_vs_Control_Female,Reactome,Hyaluronan metabolism,0.922700089318672,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Glyoxylate metabolism and glycine degradation,0.922700089318672,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Adaptive Immune System,0.9405671679823239,0.9999999999999936,87/1379
OUD_vs_Control_Female,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.9428204859042107,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Activation of ATR in response to replication stress,0.9734138273641126,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Regulation of Apoptosis,0.9794314692904733,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Phospholipid metabolism,0.9799078287376609,0.9999999999999936,19/1379
OUD_vs_Control_Female,Reactome,Sulfur amino acid metabolism,0.982891996696939,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Metabolism of cofactors,0.982891996696939,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Peroxisomal lipid metabolism,0.9852883335740259,0.9999999999999936,1/1379
OUD_vs_Control_Female,Reactome,Metabolism of polyamines,0.9917467781151466,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Metabolism of non-coding RNA,0.9957519575324996,0.9999999999999936,2/1379
OUD_vs_Control_Female,Reactome,Metabolism of RNA,0.9999999999952334,0.9999999999999936,44/1379
OUD_vs_Control_Female,GO_MF,NAD+-protein-glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121
OUD_vs_Control_Female,GO_MF,NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121
OUD_vs_Control_Female,GO_MF,NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121
OUD_vs_Control_Female,GO_MF,NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity,0.827541526350997,0.9999999999999971,1/2121
OUD_Effect_Male_vs_Female,Reactome,Metabolism of folate and pterines,0.3391395555078043,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of pyruvate metabolism,0.3438023974174456,0.9999999999999981,5/1194
OUD_Effect_Male_vs_Female,Reactome,Aspartate and asparagine metabolism,0.3454236053710449,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases of the neuronal system,0.3454236053710449,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Fatty acid metabolism,0.35672627019781217,0.9999999999999981,22/1194
OUD_Effect_Male_vs_Female,Reactome,Integration of energy metabolism,0.363076249847776,0.9999999999999981,14/1194
OUD_Effect_Male_vs_Female,Reactome,Serotonin Neurotransmitter Release Cycle,0.3739684043024597,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,ADORA2B mediated anti-inflammatory cytokines production,0.3760344991823695,0.9999999999999981,6/1194
OUD_Effect_Male_vs_Female,Reactome,Inositol phosphate metabolism,0.3807918988320279,0.9999999999999981,7/1194
OUD_Effect_Male_vs_Female,Reactome,Phospholipid metabolism,0.3879995084761872,0.9999999999999981,26/1194
OUD_Effect_Male_vs_Female,Reactome,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",0.39129935699204643,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Complement cascade,0.40156528780478795,0.9999999999999981,7/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases of programmed cell death,0.42135645655792076,0.9999999999999981,6/1194
OUD_Effect_Male_vs_Female,Reactome,PI Metabolism,0.4219039543943982,0.9999999999999981,11/1194
OUD_Effect_Male_vs_Female,Reactome,Sphingolipid metabolism,0.43542452859230574,0.9999999999999981,13/1194
OUD_Effect_Male_vs_Female,Reactome,Vitamin D (calciferol) metabolism,0.43566266496108774,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,0.44069801475757575,0.9999999999999981,9/1194
OUD_Effect_Male_vs_Female,Reactome,Glycogen metabolism,0.4441414638738508,0.9999999999999981,4/1194
OUD_Effect_Male_vs_Female,Reactome,Arachidonate metabolism,0.4635455216147406,0.9999999999999981,7/1194
OUD_Effect_Male_vs_Female,Reactome,Activation of ATR in response to replication stress,0.4690645194359847,0.9999999999999981,5/1194
OUD_Effect_Male_vs_Female,Reactome,Alternative complement activation,0.47517810286705264,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,NFE2L2 regulating ER-stress associated genes,0.47517810286705264,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Innate Immune System,0.48087705733654384,0.9999999999999981,112/1194
OUD_Effect_Male_vs_Female,Reactome,Glycosphingolipid metabolism,0.4839168353398219,0.9999999999999981,7/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of lipid metabolism by PPARalpha,0.4908656600393284,0.9999999999999981,14/1194
OUD_Effect_Male_vs_Female,Reactome,Defects in vitamin and cofactor metabolism,0.5074429215110297,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,Pyruvate metabolism,0.5100910792724931,0.9999999999999981,6/1194
OUD_Effect_Male_vs_Female,Reactome,Na+/Cl- dependent neurotransmitter transporters,0.5187266675905391,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Glutamate and glutamine metabolism,0.5187266675905391,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Dopamine Neurotransmitter Release Cycle,0.5385049892157298,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,Phenylalanine metabolism,0.5386864990540132,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Sialic acid metabolism,0.5524167637940416,0.9999999999999981,4/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of porphyrins,0.5684114036465285,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,Acetylcholine Neurotransmitter Release Cycle,0.5932144949605265,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of non-coding RNA,0.5932572695822859,0.9999999999999981,6/1194
OUD_Effect_Male_vs_Female,Reactome,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.5945154388603691,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,0.5945154388603691,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Modulation by Mtb of host immune system,0.5945154388603691,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Cobalamin (Cbl) metabolism,0.5945154388603691,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,ATF4 activates genes in response to endoplasmic reticulum  stress,0.5970909505478759,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,Programmed Cell Death,0.6002009959133032,0.9999999999999981,22/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases of metabolism,0.6075515594692322,0.9999999999999981,29/1194
OUD_Effect_Male_vs_Female,Reactome,Cellular response to mitochondrial stress,0.6435928403809693,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Intrinsic Pathway for Apoptosis,0.6504176012121482,0.9999999999999981,6/1194
OUD_Effect_Male_vs_Female,Reactome,Oxidative Stress Induced Senescence,0.6527355072825701,0.9999999999999981,7/1194
OUD_Effect_Male_vs_Female,Reactome,Peptide hormone metabolism,0.6554474161746373,0.9999999999999981,8/1194
OUD_Effect_Male_vs_Female,Reactome,Norepinephrine Neurotransmitter Release Cycle,0.6587314972106931,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Drug ADME,0.714602017684128,0.9999999999999981,9/1194
OUD_Effect_Male_vs_Female,Reactome,"Cell death signalling via NRAGE, NRIF and NADE",0.7149601944887154,0.9999999999999981,8/1194
OUD_Effect_Male_vs_Female,Reactome,Phenylalanine and tyrosine metabolism,0.7246580248901737,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Creatine metabolism,0.7579938916799862,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of necroptotic cell death,0.7613995680625552,0.9999999999999981,3/1194
OUD_Effect_Male_vs_Female,Reactome,Cellular responses to stress,0.7689324622149993,0.9999999999999981,79/1194
OUD_Effect_Male_vs_Female,Reactome,Mitotic Telophase/Cytokinesis,0.7872967304726133,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),0.8053545058985965,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of innate immune responses to cytosolic DNA,0.8130541040847532,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,STING mediated induction of host immune responses,0.8356946761227698,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Sulfur amino acid metabolism,0.8552017098282529,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of Angiotensinogen to Angiotensins,0.8555953209502614,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of amine-derived hormones,0.8555953209502614,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of steroid hormones,0.869035434798896,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,NRIF signals cell death from the nucleus,0.8730873760162436,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,FOXO-mediated transcription of cell death genes,0.8730873760162436,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Hyaluronan metabolism,0.88846213992012,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Glyoxylate metabolism and glycine degradation,0.88846213992012,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of nucleotides,0.8889306174275927,0.9999999999999981,8/1194
OUD_Effect_Male_vs_Female,Reactome,Apoptosis,0.9126402516117128,0.9999999999999981,14/1194
OUD_Effect_Male_vs_Female,Reactome,Initial triggering of complement,0.9138532193848047,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of nitric oxide: NOS3 activation and regulation,0.9138532193848047,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Diseases of carbohydrate metabolism,0.9216326604081901,0.9999999999999981,2/1194
OUD_Effect_Male_vs_Female,Reactome,Cellular response to chemical stress,0.928829604790467,0.9999999999999981,17/1194
OUD_Effect_Male_vs_Female,Reactome,Adaptive Immune System,0.9309595935619537,0.9999999999999981,75/1194
OUD_Effect_Male_vs_Female,Reactome,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.95484825516744,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of cofactors,0.9693618291375409,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Peroxisomal lipid metabolism,0.9730776215204536,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Regulation of Apoptosis,0.9935126435668091,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of polyamines,0.9973795157600317,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of amino acids and derivatives,0.9999254243296104,0.9999999999999981,20/1194
OUD_Effect_Male_vs_Female,Reactome,Selenoamino acid metabolism,0.9999987747572602,0.9999999999999981,1/1194
OUD_Effect_Male_vs_Female,Reactome,Metabolism of RNA,0.9999999999999981,0.9999999999999981,28/1194
OUD_vs_Control_Female,GO_BP,positive regulation of cytokinesis,0.9333240851496616,1,3/2058
OUD_vs_Control_Female,GO_BP,mitotic cytokinesis,0.9513564919622188,1,8/2058
OUD_vs_Control_Female,GO_BP,regulation of cytokinesis,0.9527975361044145,1,7/2058
OUD_vs_Control_Female,GO_BP,motor neuron apoptotic process,0.954836347186885,1,1/2058
OUD_vs_Control_Female,GO_BP,stress granule assembly,0.9933775022420195,1,1/2058
OUD_vs_Control_Female,GO_BP,oxidative phosphorylation,0.9997635829125253,1,7/2058
OUD_vs_Control_Female,GO_CC,astrocyte end-foot,0.4549657502564588,1,2/2168
OUD_vs_Control_Female,GO_CC,axonemal microtubule,0.4757780021841226,1,5/2168
OUD_vs_Control_Female,GO_CC,symmetric synapse,0.502221904601571,1,2/2168
OUD_vs_Control_Female,GO_CC,neuronal dense core vesicle membrane,0.5199647293784038,1,1/2168
OUD_vs_Control_Female,GO_CC,neuron projection cytoplasm,0.5318066574193947,1,12/2168
OUD_vs_Control_Female,GO_CC,axonemal doublet microtubule,0.5434700601204641,1,4/2168
OUD_vs_Control_Female,GO_CC,neuronal ribonucleoprotein granule,0.5855092857902706,1,1/2168
OUD_vs_Control_Female,GO_CC,glycinergic synapse,0.5855092857902706,1,1/2168
OUD_vs_Control_Female,GO_CC,ribbon synapse,0.5883826440685402,1,2/2168
OUD_vs_Control_Female,GO_CC,dopaminergic synapse,0.5883826440685402,1,2/2168
OUD_vs_Control_Female,GO_CC,axon cytoplasm,0.624092064062294,1,8/2168
OUD_vs_Control_Female,GO_CC,axon hillock,0.6421078792529333,1,1/2168
OUD_vs_Control_Female,GO_CC,dendrite cytoplasm,0.6827451384787422,1,3/2168
OUD_vs_Control_Female,GO_CC,axonemal microtubule doublet inner sheath,0.6827451384787422,1,3/2168
OUD_vs_Control_Female,GO_CC,axoneme,0.7851359289786494,1,17/2168
OUD_vs_Control_Female,GO_CC,dynein axonemal particle,0.8894662255081391,1,1/2168
OUD_vs_Control_Female,GO_CC,"asymmetric, glutamatergic, excitatory synapse",0.9045681427691901,1,1/2168
OUD_vs_Control_Female,GO_CC,cytoplasmic stress granule,0.9772730779262679,1,7/2168
